SCOP Search:   
        by sunid, keyword
QuickSearch:   
by PDB,NDB,UniProt,PROSITE Code or Search Term(s)  
(use 'Shift Left-Click' to collapse/expand all levels downwards; use 'Control Left-Click' to collapse/expand all levels upwards)
 
(-)
Class: All beta proteins (24004)
(-)
Fold: Trypsin-like serine proteases (1752)
(-)
Superfamily: Trypsin-like serine proteases (1752)
(-)
Family: automated matches (71)
(-)
Protein domain: automated matches (71)
(-)
Cellulomonas bogoriensis [TaxId: 301388] (1)
2EA3A:CRYSTAL STRUCTURE OF CELLULOMONAS BOGORIENSIS CHYMOTRYPSIN
(-)
Coxsackievirus a16 [TaxId: 231417] (1)
4MG3A:; B:CRYSTAL STRUCTURAL ANALYSIS OF 2A PROTEASE FROM COXSACKIEVIRUS A16
(-)
Escherichia coli K-12 [TaxId: 83333] (2)
3STIA:; B:; C:CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF DEGQ FROM ESCHERICHIA COLI
3STJA:11-236; B:11-236; K:11-236; L:11-236; C:11-236; D:11-236; E:11-236; F:11-236; G:11-236; H:11-236; I:11-236; J:11-236CRYSTAL STRUCTURE OF THE PROTEASE + PDZ1 DOMAIN OF DEGQ FROM ESCHERICHIA COLI
(-)
Human (Homo sapiens) [TaxId: 9606] (37)
2ASUB:CRYSTAL STRUCTURE OF THE BETA-CHAIN OF HGFL/MSP
2BDGA:; B:HUMAN KALLIKREIN 4 COMPLEX WITH NICKEL AND P-AMINOBENZAMIDINE
2BDHA:; B:; C:; D:HUMAN KALLIKREIN 4 COMPLEX WITH ZINC AND P-AMINOBENZAMIDINE
2BDIA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:; M:; N:; O:; P:HUMAN KALLIKREIN 4 COMPLEX WITH COBALT AND P-AMINOBENZAMIDINE
2I6QA:443-732COMPLEMENT COMPONENT C2A
2I6SA:443-732COMPLEMENT COMPONENT C2A
2ODPA:443-730COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5-CONVERTASE OF HUMAN COMPLEMENT
2ODQA:443-730COMPLEMENT COMPONENT C2A, THE CATALYTIC FRAGMENT OF C3- AND C5-CONVERTASE OF HUMAN COMPLEMENT
2OQ5A:CRYSTAL STRUCTURE OF DESC1, A NEW MEMBER OF THE TYPE II TRANSMEMBRANE SERINE PROTEINASES FAMILY
2PSXA:CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN
2PSYA:CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 5 IN COMPLEX WITH LEUPEPTIN AND ZINC
2QXGA:; B:CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH ALA-ALA-PHE-CHLOROMETHYLKETONE
2QXHA:CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE
2QXIA:HIGH RESOLUTION STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE
2QXJA:CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 IN COMPLEX WITH SUC-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE AND COPPER
2QY0B:; D:ACTIVE DIMERIC STRUCTURE OF THE CATALYTIC DOMAIN OF C1R REVEALS ENZYME-PRODUCT LIKE CONTACTS
2ZGCA:CRYSTAL STRUCTURE OF ACTIVE HUMAN GRANZYME M
2ZGHA:CRYSTAL STRUCTURE OF ACTIVE GRANZYME M BOUND TO ITS PRODUCT
2ZGJA:CRYSTAL STRUCTURE OF D86N-GZMM COMPLEXED WITH ITS OPTIMAL SYNTHESIZED SUBSTRATE
2ZKSA:STRUCTURAL INSIGHTS INTO THE PROTEOLYTIC MACHINERY OF APOPTOSIS-INDUCING GRANZYME M
3BSQA:; B:; C:CRYSTAL STRUCTURE OF HUMAN KALLIKREIN 7 PRODUCED AS A SECRETION PROTEIN IN E.COLI
3DFJA:CRYSTAL STRUCTURE OF HUMAN PROSTASIN
3DFLA:CRYSTAL STRUCTURE OF HUMAN PROSTASIN COMPLEXED TO 4-GUANIDINOBENZOIC ACID
3E0NB:THE X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH DFFR-CHLOROMETHYL KETONE INHIBITOR
3E0PB:THE X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH A COVALENT BENZOXAZOLE INHIBITOR
3E16B:X-RAY STRUCTURE OF HUMAN PROSTASIN IN COMPLEX WITH BENZOXAZOLE WARHEAD PEPTIDOMIMIC, LYSINE IN P3
3E1XB:THE CRYSTAL STRUCTURE OF APO PROSTASIN AT 1.7 ANGSTROMS RESOLUTION
3FVFB:THE CRYSTAL STRUCTURE OF PROSTASIN COMPLEXED WITH CAMOSTAT AT 1.6 ANGSTROMS RESOLUTION
3GOVB:CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-1
3GYLB:STRUCTURE OF PROSTASIN AT 1.3 ANGSTROMS RESOLUTION IN COMPLEX WITH A CALCIUM ION.
3GYMA:; B:STRUCTURE OF PROSTASIN IN COMPLEX WITH APROTININ
3NUMA:SUBSTRATE INDUCED REMODELING OF THE ACTIVE SITE REGULATES HTRA1 ACTIVITY
3TJNA:; B:; D:HTRA1 CATALYTIC DOMAIN, APO FORM
3TJOA:; B:; D:HTRA1 CATALYTIC DOMAIN, MUTATIONALLY INACTIVATED
4KP0A:CRYSTAL STRUCTURE OF THE HUMAN CHYMASE WITH TJK002
4NA7A:FACTOR XIA IN COMPLEX WITH THE INHIBITOR 3'-[(2S,4R)-6-CARBAMIMIDOYL-4-METHYL-4-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-2-YL]-4-CARBAMOYL-5'-[(3-METHYLBUTANOYL)AMINO]BIPHENYL-2-CARBOXYLIC ACID
4NA8A:FACTOR XIA IN COMPLEX WITH THE INHIBITOR 5-AMINOCARBONYL-2-[3-[(2S, 4R)-6-CARBAMIMIDOYL-4-METHYL-4-PHENYL-2,3-DIHYDRO-1H-QUINOLIN-2-YL]PHENYL]BENZOIC ACID
(-)
Human coxsackievirus b4 [TaxId: 12073] (1)
1Z8RA:2A CYSTEINE PROTEINASE FROM HUMAN COXSACKIEVIRUS B4 (STRAIN JVB / BENSCHOTEN / NEW YORK / 51)
(-)
Human enterovirus 71 [TaxId: 103922] (1)
3W95A:CRYSTAL STRUCTURE OF 2A PROTEINASE (C110A) FROM ENTEROVIRUS 71
(-)
Human enterovirus 71 [TaxId: 39054] (7)
3QZQA:; B:; C:; D:HUMAN ENTEROVIRUS 71 3C PROTEASE MUTANT E71D IN COMPLEX WITH RUPINTRIVIR
3QZRA:; B:HUMAN ENTEROVIRUS 71 3C PROTEASE MUTANT E71A IN COMPLEX WITH RUPINTRIVIR
3R0FA:; B:HUMAN ENTEROVIRUS 71 3C PROTEASE MUTANT H133G IN COMPLEX WITH RUPINTRIVIR
4FVBA:CRYSTAL STRUCTURE OF EV71 2A PROTEINASE C110A MUTANT
4FVDA:CRYSTAL STRUCTURE OF EV71 2A PROTEINASE C110A MUTANT IN COMPLEX WITH SUBSTRATE
4GHQA:CRYSTAL STRUCTURE OF EV71 3C PROTEINASE
4GHTA:; B:CRYSTAL STRUCTURE OF EV71 3C PROTEINASE IN COMPLEX WITH AG7088
(-)
Human rhinovirus 14 [TaxId: 12131] (1)
2IN2A:NMR STRUCTURE OF THE APO HUMAN RHINOVIRUS 3C PROTEASE (SEROTYPE 14)
(-)
Infectious bronchitis virus [TaxId: 11120] (2)
2Q6DA:; B:; C:CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE
2Q6FA:; B:CRYSTAL STRUCTURE OF INFECTIOUS BRONCHITIS VIRUS (IBV) MAIN PROTEASE IN COMPLEX WITH A MICHAEL ACCEPTOR INHIBITOR N3
(-)
Nocardiopsis alba [TaxId: 53437] (1)
2OUAA:; B:CRYSTAL STRUCTURE OF NOCARDIOPSIS PROTEASE (NAPASE)
(-)
Saccharopolyspora erythraea [TaxId: 1836] (1)
4M7GA:STREPTOMYCES ERYTHRAEUS TRYPSIN
(-)
Sarcoptes scabiei [TaxId: 197185] (2)
3H7OA:; B:CRYSTAL STRUCTURE OF SCABIES MITE INACTIVATED PROTEASE PARALOGUE S-I1 (SMIPP-S-I1)
3H7TA:; B:CRYSTAL STRUCTURE OF SCABIES MITE INACTIVATED PROTEASE PARALOGUE S-D1 (SMIPP-S-D1)
(-)
Staphylococcus aureus [TaxId: 1280] (2)
2AS9A:; B:FUNCTIONAL AND STRUCTURAL CHARACTERIZATION OF SPL PROTEASES FROM STAPHYLOCOCCUS AUREUS
2VIDA:; B:SERINE PROTEASE SPLB FROM STAPHYLOCOCCUS AUREUS AT 1.8A RESOLUTION
(-)
Staphylococcus aureus [TaxId: 93061] (6)
2W7SA:; B:; C:; D:SPLA SERINE PROTEASE OF STAPHYLOCOCCUS AUREUS (1.8A)
2W7UA:; B:; C:; D:SPLA SERINE PROTEASE OF STAPHYLOCOCCUS AUREUS (2.4A)
3UFAA:; B:CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL SERINE PROTEASE SPLA IN COMPLEX WITH A SPECIFIC PHOSPHONATE INHIBITOR
4INKA:CRYSTAL STRUCTURE OF SPLD PROTEASE FROM STAPHYLOCOCCUS AUREUS AT 1.56 A RESOLUTION
4INLA:CRYSTAL STRUCTURE OF SPLD PROTEASE FROM STAPHYLOCOCCUS AUREUS AT 2.1 A RESOLUTION
4MVNA:; B:; C:; D:CRYSTAL STRUCTURE OF THE STAPHYLOCOCCAL SERINE PROTEASE SPLA IN COMPLEX WITH A SPECIFIC PHOSPHONATE INHIBITOR
(-)
Thale cress (Arabidopsis thaliana) [TaxId: 3702] (1)
4IC5A:; B:; C:CRYSTAL STRUCTURE OF DEG5
(-)
Thermobifida fusca YX [TaxId: 269800] (1)
2PFEA:; B:CRYSTAL STRUCTURE OF THERMOBIFIDA FUSCA PROTEASE A (TFPA)
(-)
Tobacco vein mottling virus [TaxId: 12228] (1)
3MMGA:; B:CRYSTAL STRUCTURE OF TOBACCO VEIN MOTTLING VIRUS PROTEASE
(-)
Tylonycteris bat coronavirus hku4 [TaxId: 694007] (2)
2YNAA:; B:CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4
2YNBA:; B:CRYSTAL STRUCTURE OF THE MAIN PROTEASE OF CORONAVIRUS HKU4 IN COMPLEX WITH A MICHAEL ACCEPTOR SG85
(-)
Worm (Eisenia fetida) [TaxId: 6396] (1)
1YM0A:CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT B: A NOVEL, GLYCOSYLATED TWO-CHAINED TRYPSIN
(-)
Family: Eukaryotic proteases (1343)
(-)
Protein domain: (alpha,gamma)-chymotrypsin(ogen) (60)
(-)
Cow (Bos taurus) [TaxId: 9913] (58)
1AB9A:,B:,C:CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN
1ACBE:CRYSTAL AND MOLECULAR STRUCTURE OF THE BOVINE ALPHA-CHYMOTRYPSIN-EGLIN C COMPLEX AT 2.0 ANGSTROMS RESOLUTION
1AFQA:,B:,C:CRYSTAL STRUCTURE OF BOVINE GAMMA-CHYMOTRYPSIN COMPLEXED WITH A SYNTHETIC INHIBITOR
1CA0A:,B:,C:; F:,G:,H:BOVINE CHYMOTRYPSIN COMPLEXED TO APPI
1CBWA:,B:,C:; F:,G:,H:BOVINE CHYMOTRYPSIN COMPLEXED TO BPTI
1CGIE:THREE-DIMENSIONAL STRUCTURE OF THE COMPLEXES BETWEEN BOVINE CHYMOTRYPSINOGEN*A AND TWO RECOMBINANT VARIANTS OF HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL-TYPE)
1CGJE:THREE-DIMENSIONAL STRUCTURE OF THE COMPLEXES BETWEEN BOVINE CHYMOTRYPSINOGEN*A AND TWO RECOMBINANT VARIANTS OF HUMAN PANCREATIC SECRETORY TRYPSIN INHIBITOR (KAZAL-TYPE)
1CHGA:CHYMOTRYPSINOGEN,2.5 ANGSTROMS CRYSTAL STRUCTURE, COMPARISON WITH ALPHA-CHYMOTRYPSIN,AND IMPLICATIONS FOR ZYMOGEN ACTIVATION
1CHOE:,F:,G:CRYSTAL AND MOLECULAR STRUCTURES OF THE COMPLEX OF ALPHA-*CHYMOTRYPSIN WITH ITS INHIBITOR TURKEY OVOMUCOID THIRD DOMAIN AT 1.8 ANGSTROMS RESOLUTION
1DLKA:,B:; C:,D:CRYSTAL STRUCTURE ANALYSIS OF DELTA-CHYMOTRYPSIN BOUND TO A PEPTIDYL CHLOROMETHYL KETONE INHIBITOR
1EX3A:CRYSTAL STRUCTURE OF BOVINE CHYMOTRYPSINOGEN A (TETRAGONAL)
1GCDA:REFINED CRYSTAL STRUCTURE OF "AGED" AND "NON-AGED" ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN
1GCTA:,B:,C:IS GAMMA-CHYMOTRYPSIN A TETRAPEPTIDE ACYL-ENZYME ADDUCT OF GAMMA-CHYMOTRYPSIN?
1GG6A:,B:,C:CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-PHENYLALANINE TRIFLUOROMETHYL KETONE BOUND AT THE ACTIVE SITE
1GGDA:,B:,C:CRYSTAL STRUCTURE OF GAMMA CHYMOTRYPSIN WITH N-ACETYL-LEUCIL-PHENYLALANINE ALDEHYDE BOUND AT THE ACTIVE SITE
1GHAE:,F:,G:A SECOND ACTIVE SITE IN CHYMOTRYPSIN? THE X-RAY CRYSTAL STRUCTURE OF N-ACETYL-D-TRYPTOPHAN BOUND TO GAMMA-CHYMOTRYPSIN
1GHBF:,G:A SECOND ACTIVE SITE IN CHYMOTRYPSIN? THE X-RAY CRYSTAL STRUCTURE OF N-ACETYL-D-TRYPTOPHAN BOUND TO GAMMA-CHYMOTRYPSIN
1GL0E:STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-D2V, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA
1GL1A:; B:; C:STRUCTURE OF THE COMPLEX BETWEEN BOVINE ALPHA-CHYMOTRYPSIN AND PMP-C, AN INHIBITOR FROM THE INSECT LOCUSTA MIGRATORIA
1GMCE:,F:,G:THE X-RAY CRYSTAL STRUCTURE OF THE TETRAHEDRAL INTERMEDIATE OF GAMMA-CHYMOTRYPSIN IN HEXANE
1GMDE:,F:,G:X-RAY CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN IN HEXANE
1GMHE:,F:,G:REFINED CRYSTAL STRUCTURE OF "AGED" AND "NON-AGED" ORGANOPHOSPHORYL CONJUGATES OF GAMMA-CHYMOTRYPSIN
1HJAA:,B:,C:LYS 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH ALPHA-CHYMOTRYPSIN
1K2I1:CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN IN COMPLEX WITH 7-HYDROXYCOUMARIN
1MTNA:,B:,C:; E:,F:,G:BOVINE ALPHA-CHYMOTRYPSIN:BPTI CRYSTALLIZATION
1N8OA:,B:,C:CRYSTAL STRUCTURE OF A COMPLEX BETWEEN BOVINE CHYMOTRYPSIN AND ECOTIN
1OXGA:CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN ORGANIC SOLVENT TREATED BOVINE ALPHA-CHYMOTRYPSIN AND ITS AUTOCATALYTICALLY PRODUCED HIGHLY POTENT 14-RESIDUE PEPTIDE AT 2.2 RESOLUTION
1P2MA:; C:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1P2NA:; C:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1P2OA:; C:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1P2QA:; C:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1PYTD:TERNARY COMPLEX OF PROCARBOXYPEPTIDASE A, PROPROTEINASE E, AND CHYMOTRYPSINOGEN C
1T7CA:; C:CRYSTAL STRUCTURE OF THE P1 GLU BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX
1T8LA:; C:CRYSTAL STRUCTURE OF THE P1 MET BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX
1T8MA:; C:CRYSTAL STRUCTURE OF THE P1 HIS BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX
1T8NA:; C:CRYSTAL STRUCTURE OF THE P1 THR BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX
1T8OA:; C:CRYSTAL STRUCTURE OF THE P1 TRP BPTI MUTANT- BOVINE CHYMOTRYPSIN COMPLEX
1VGCA:,B:,C:GAMMA-CHYMOTRYPSIN L-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX
2CGAA:; B:BOVINE CHYMOTRYPSINOGEN A. X-RAY CRYSTAL STRUCTURE ANALYSIS AND REFINEMENT OF A NEW CRYSTAL FORM AT 1.8 ANGSTROMS RESOLUTION
2CHAA:,B:,C:; E:,F:,G:THE STRUCTURE OF CRYSTALLINE ALPHA-CHYMOTRYPSIN, $V.THE ATOMIC STRUCTURE OF TOSYL-ALPHA-CHYMOTRYPSIN AT 2 ANGSTROMS RESOLUTION
2GCHE:,F:,G:REFINED CRYSTAL STRUCTURE OF GAMMA-CHYMOTRYPSIN AT 1.9 ANGSTROMS RESOLUTION
2GCTA:,B:,C:STRUCTURE OF GAMMA-CHYMOTRYPSIN IN THE RANGE PH 2.0 TO PH 10.5 SUGGESTS THAT GAMMA-CHYMOTRYPSIN IS A COVALENT ACYL-ENZYME ADDUCT AT LOW PH
2GMTA:,B:,C:THREE-DIMENSIONAL STRUCTURE OF CHYMOTRYPSIN INACTIVATED WITH (2S) N-ACETYL-L-ALANYL-L-PHENYLALANYL-CHLOROETHYL KETONE: IMPLICATIONS FOR THE MECHANISM OF INACTIVATION OF SERINE PROTEASES BY CHLOROKETONES
2VGCA:,B:,C:GAMMA-CHYMOTRYPSIN D-PARA-CHLORO-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX
2Y6TA:; B:; C:; D:MOLECULAR RECOGNITION OF CHYMOTRYPSIN BY THE SERINE PROTEASE INHIBITOR ECOTIN FROM YERSINIA PESTIS
3GCHA:,B:,C:CHEMISTRY OF CAGED ENZYMES. BINDING OF PHOTOREVERSIBLE CINNAMATES TO CHYMOTRYPSIN
3GCTE:,F:,G:STRUCTURE OF GAMMA-*CHYMOTRYPSIN IN THE RANGE $P*H 2.0 TO $P*H 10.5 SUGGESTS THAT GAMMA-CHYMOTRYPSIN IS A COVALENT ACYL-ENZYME ADDUCT AT LOW $P*H
3T62A:; B:; C:CRYSTAL STRUCTURE OF RECOMBINANT KUNITZ TYPE SERINE PROTEASE INHIBITOR-1 FROM THE CARIBBEAN SEA ANEMONE STICHODACTYLA HELIANTHUS IN COMPLEX WITH BOVINE CHYMOTRYPSIN
3VGCA:,B:,C:GAMMA-CHYMOTRYPSIN L-NAPHTHYL-1-ACETAMIDO BORONIC ACID ACID INHIBITOR COMPLEX
4CHAA:,B:,C:; E:,F:,G:STRUCTURE OF ALPHA-*CHYMOTRYPSIN REFINED AT 1.68 ANGSTROMS RESOLUTION
4GCHE:,F:,G:STRUCTURE AND ACTIVITY OF TWO PHOTOREVERSIBLE CINNAMATES BOUND TO CHYMOTRYPSIN
4VGCA:,B:,C:GAMMA-CHYMOTRYPSIN D-NAPHTHYL-1-ACETAMIDO BORONIC ACID INHIBITOR COMPLEX
5CHAA:,B:,C:; E:,F:,G:THE REFINEMENT AND THE STRUCTURE OF THE DIMER OF ALPHA-*CHYMOTRYPSIN AT 1.67-*ANGSTROMS RESOLUTION
5GCHE:,F:,G:CHEMISTRY OF CAGED ENZYMES /II$. PHOTOACTIVATION OF INHIBITED CHYMOTRYPSIN
6CHAA:,B:,C:; E:,F:,G:STRUCTURE OF A TETRAHEDRAL TRANSITION STATE COMPLEX OF ALPHA-*CHYMOTRYPSIN AT 1.8-*ANGSTROMS RESOLUTION
6GCHE:,F:,G:STRUCTURE OF CHYMOTRYPSIN-*TRIFLUOROMETHYL KETONE INHIBITOR COMPLEXES. COMPARISON OF SLOWLY AND RAPIDLY EQUILIBRATING INHIBITORS
7GCHE:,F:,G:STRUCTURE OF CHYMOTRYPSIN-*TRIFLUOROMETHYL KETONE INHIBITOR COMPLEXES. COMPARISON OF SLOWLY AND RAPIDLY EQUILIBRATING INHIBITORS
8GCHE:,F:,G:GAMMA-CHYMOTRYPSIN IS A COMPLEX OF ALPHA-CHYMOTRYPSIN WITH ITS OWN AUTOLYSIS PRODUCTS
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1KDQA:,B:CRYSTAL STRUCTURE ANALYSIS OF THE MUTANT S189D RAT CHYMOTRYPSIN
(-)
Red fire ant (Solenopsis invicta) [TaxId: 13686] (1)
1EQ9A:; B:CRYSTAL STRUCTURE OF FIRE ANT CHYMOTRYPSIN COMPLEXED TO PMSF
(-)
Protein domain: 7S NGF protease subunits (1)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1SGFA:; G:; X:; Z:CRYSTAL STRUCTURE OF 7S NGF: A COMPLEX OF NERVE GROWTH FACTOR WITH FOUR BINDING PROTEINS (SERINE PROTEINASES)
(-)
Protein domain: Activated protein c (autoprothrombin IIa) (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1AUTC:HUMAN ACTIVATED PROTEIN C
3F6UH:CRYSTAL STRUCTURE OF HUMAN ACTIVATED PROTEIN C (APC) COMPLEXED WITH PPACK
(-)
Protein domain: Alpha tryptase I (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1LTOA:; B:; C:; D:HUMAN ALPHA1-TRYPTASE
(-)
Protein domain: automated matches (162)
(-)
Agkistrodon contortrix [TaxId: 8713] (2)
2AIPA:CRYSTAL STRUCTURE OF NATIVE PROTEIN C ACTIVATOR FROM THE VENOM OF COPPERHEAD SNAKE AGKISTRODON CONTORTRIX CONTORTRIX
2AIQA:CRYSTAL STRUCTURE OF BENZAMIDINE-INHIBITED PROTEIN C ACTIVATOR FROM THE VENOM OF COPPERHEAD SNAKE AGKISTRODON CONTORTRIX CONTORTRIX
(-)
Atlantic cod (Gadus morhua) [TaxId: 8049] (1)
2EEKA:CRYSTAL STRUCTURE OF ATLANTIC COD TRYPSIN COMPLEXED WITH BENZAMIDINE
(-)
Chum salmon (Oncorhynchus keta) [TaxId: 8018] (3)
2ZPQA:; B:CRYSTAL STRUCTURE OF ANIONIC TRYPSIN ISOFORM 1 FROM CHUM SALMON
2ZPRA:; B:CRYSTAL STRUCTURE OF ANIONIC TRYPSIN ISOFORM 2 FROM CHUM SALMON
2ZPSA:CRYSTAL STRUCTURE OF ANIONIC TRYPSIN ISOFORM 3 FROM CHUM SALMON
(-)
Cow (Bos taurus) [TaxId: 9913] (12)
2BY5X:IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
2BY6X:IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
2BY7X:IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
2BY8X:IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
2BY9X:IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
2BYAX:IS RADIATION DAMAGE DEPENDENT ON THE DOSE-RATE USED DURING MACROMOLECULAR CRYSTALLOGRAPHY DATA COLLECTION
3QK1A:CRYSTAL STRUCTURE OF ENTEROKINASE-LIKE TRYPSIN VARIANT
3VEQB:A BINARY COMPLEX BETWWEN BOVINE PANCREATIC TRYPSIN AND A ENGINEERED MUTANT TRYPSIN INHIBITOR
4NIVA:CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) TRIGONAL FORM
4NIWA:CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) ORTHORHOMBIC FORM
4NIXA:CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) ORTHORHOMBIC FORM, ZINC-BOUND
4NIYA:; B:; C:; D:CRYSTAL STRUCTURE OF TRYPSILIGASE (K60E/N143H/Y151H/D189K TRYPSIN) COMPLEXED TO YRH-ECOTIN (M84Y/M85R/A86H ECOTIN)
(-)
Daboia russellii [TaxId: 343250] (3)
3S9AA:RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V (CLOSED-FORM)
3S9BA:RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V (OPEN-FORM)
3SBKA:RUSSELL'S VIPER VENOM SERINE PROTEINASE, RVV-V (PPACK-BOUND FORM)
(-)
Gloydius saxatilis [TaxId: 92067] (1)
3S69A:CRYSTAL STRUCTURE OF SAXTHROMBIN
(-)
Golden hamster (Mesocricetus auratus) [TaxId: 10036] (1)
2RDLA:; B:HAMSTER CHYMASE 2
(-)
Halys viper (Agkistrodon halys) [TaxId: 8714] (1)
4E7NA:CRYSTAL STRUCTURE OF AHV_TL-I, A GLYCOSYLATED SNAKE-VENOM THROMBIN-LIKE ENZYME FROM AGKISTRODON HALYS
(-)
Human (Homo sapiens) [TaxId: 9606] (132)
1SPJA:STRUCTURE OF MATURE HUMAN TISSUE KALLIKREIN (HUMAN KALLIKREIN 1 OR KLK1) AT 1.70 ANGSTROM RESOLUTION WITH VACANT ACTIVE SITE
1W0YH:TF7A_3771 COMPLEX
1W2KH:TF7A_4380 COMPLEX
1W7XH:FACTOR7 - 413 COMPLEX
1W8BH:FACTOR7 - 413 COMPLEX
1WQVH:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH PROPYLSULFONAMIDE-D-THR-MET-P-AMINOBENZAMIDINE
1WSSH:HUMAN FACTOR VIIA-TISSUE FACTOR IN COMPLEX WITH PEPTIDE-MIMETIC INHIBITOR THAT HAS TWO CHARGED GROUPS IN P2 AND P4
1WTGH:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-BIPHENYLALANINE-GLN-P-AMINOBENZAMIDINE
1WU1A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 4-[(5-CHLOROINDOL-2-YL) SULFONYL]-2-(2-METHYLPROPYL)-1-[[5-(PYRIDIN-4-YL) PYRIMIDIN-2-YL]CARBONYL]PIPERAZINE
1WUNH:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-TRP-GLN-P-AMINOBENZAMIDINE
1WV7H:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-PROPOXY-TRP-GLN-P-AMINOBENZAMIDINE
1Z6EA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3'-AMINO-1,2-BENZISOXAZOL-5'-YL)-N-(4-(2'-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (RAZAXABAN; DPC906; BMS-561389)
1Z71A:THROMBIN AND P2 PYRIDINE N-OXIDE INHIBITOR COMPLEX STRUCTURE
1ZGIA:THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 21
1ZGVA:THROMBIN IN COMPLEX WITH AN OXAZOLOPYRIDINE INHIBITOR 2
1ZRBA:THROMBIN IN COMPLEX WITH AN AZAFLUORENYL INHIBITOR 23B
2AERH:CRYSTAL STRUCTURE OF BENZAMIDINE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX.
2ANWA:EXPRESSION, CRYSTALLIZATION AND THREE-DIMENSIONAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLASMA KALLIKREIN: IMPLICATIONS FOR STRUCTURE-BASED DESIGN OF PROTEASE INHIBITORS
2ANYA:EXPRESSION, CRYSTALLIZATION AND THE THREE-DIMENSIONAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PLASMA KALLIKREIN: IMPLICATIONS FOR STRUCTURE-BASED DESIGN OF PROTEASE INHIBITORS
2BDYA:THROMBIN IN COMPLEX WITH INHIBITOR
2BMGB:CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 50
2BOHB:CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND "1"
2BOKA:FACTOR XA - CATION
2BQ6B:CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 21
2BQ7B:CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH 43
2BQWB:CRYSTAL STRUCTURE OF FACTOR XA IN COMPLEX WITH COMPOUND 45
2BZ6H:ORALLY AVAILABLE FACTOR7A INHIBITOR
2CJIA:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2D1JA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 2-[[4-[(5-CHLOROINDOL-2-YL)SULFONYL]PIPERAZIN-1-YL] CARBONYL]THIENO[3,2-B]PYRIDINE N-OXIDE
2EC9H:CRYSTAL STRUCTURE ANALYSIS OF HUMAN FACTOR VIIA , SOULUBLE TISSUE FACTOR COMPLEXED WITH BCX-3607
2EI6A:FACTOR XA IN COMPLEX WITH THE INHIBITOR (-)-CIS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2EI7A:FACTOR XA IN COMPLEX WITH THE INHIBITOR TRANS-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL)CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2EI8A:FACTOR XA IN COMPLEX WITH THE INHIBITOR (1S,2R,4S)-N1-[(5-CHLOROINDOL-2-YL)CARBONYL]-4-(N,N-DIMETHYLCARBAMOYL)-N2-[(5-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO[5,4-C]PYRIDIN-2-YL) CARBONYL]-1,2-CYCLOHEXANEDIAMINE
2F9NA:; B:; C:; D:CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT K192Q/D216G IN COMPLEX WITH LEUPEPTIN
2F9OA:; B:; C:; D:CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G
2F9PA:; B:; C:; D:CRYSTAL STRUCTURE OF THE RECOMBINANT HUMAN ALPHA I TRYPTASE MUTANT D216G IN COMPLEX WITH LEUPEPTIN
2FZZA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-6-(2'-(((3R)-3-HYDROXY-1-PYRROLIDINYL) METHYL)-4-BIPHENYLYL)-3-(TRIFLUOROMETHYL)-1,4,5,6-TETRAHYDRO-7H-PYRAZOLO[3,4-C]PYRIDIN-7-ONE
2G00A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-(6-(2'-((DIMETHYLAMINO)METHYL)-4-BIPHENYLYL)-7-OXO-3-(TRIFLUOROMETHYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-1-YL)BENZAMIDE
2H9EH:CRYSTAL STRUCTURE OF FXA/SELECTIDE/NAPC2 TERNARY COMPLEX
2J2UA:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J34A:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J38A:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J4IA:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J94A:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2J95A:CRYSTAL STRUCTURE OF A HUMAN FACTOR XA INHIBITOR COMPLEX
2JKHA:FACTOR XA - CATION INHIBITOR COMPLEX
2O8TA:CRYSTAL STRUCTURE AND BINDING EPITOPES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (C122A/N145Q) IN COMPLEX WITH INHIBITORS
2O8UA:CRYSTAL STRUCTURE AND BINDING EPITOPES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (C122A/N145Q/S195A) IN COMPLEX WITH INHIBITORS
2O8WA:CRYSTAL STRUCTURE AND BINDING EPITOPES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR (C122A/N145Q/S195A) IN COMPLEX WITH INHIBITORS
2P16A:FACTOR XA IN COMPLEX WITH THE INHIBITOR APIXABAN (BMS-562247) AKA 1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO[3, 4-C]PYRIDINE-3-CARBOXAMIDE
2P3FH:CRYSTAL STRUCTURE OF THE FACTOR XA/NAP5 COMPLEX
2P3TB:CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-4-(2-METHYLAMINO-IMIDAZOL-1-YLMETHYL)-THIOPHENE-2-CARBOXYLIC ACID [4-CHLORO-2-(5-CHLORO-PYRIDIN-2-YLCARBAMOYL)-6-METHOXY-PHENYL]-AMIDE
2P3UB:CRYSTAL STRUCTURE OF HUMAN FACTOR XA COMPLEXED WITH 3-CHLORO-N-(4-CHLORO-2-{[(5-CHLOROPYRIDIN-2-YL) AMINO]CARBONYL}-6-METHOXYPHENYL)-4-[(1-METHYL-1H-IMIDAZOL-2-YL)METHYL]THIOPHENE-2-CARBOXAMIDE {PFIZER 320663}
2P93A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-(2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)ETHYL)THIOPHENE-2-CARBOXAMIDE
2P94A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO)CYCLOHEXYL)-1H-INDOLE-6-CARBOXAMIDE
2P95A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 5-CHLORO-N-((1R,2S)-2-(4-(2-OXOPYRIDIN-1(2H)-YL)BENZAMIDO) CYCLOPENTYL) THIOPHENE-2-CARBOXAMIDE
2Q1JA:THE DISCOVERY OF GLYCINE AND RELATED AMINO ACID-BASED FACTOR XA INHIBITORS
2RG3A:COVALENT COMPLEX STRUCTURE OF ELASTASE
2UWLA:SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2UWOA:SELECTIVE AND DUAL ACTION ORALLY ACTIVE INHIBITORS OF THROMBIN AND FACTOR XA
2UWPA:FACTOR XA INHIBITOR COMPLEX
2VH0A:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: BIARYL PYRROLIDIN-2-ONES INCORPORATING BASIC HETEROCYCLIC MOTIFS
2VH6A:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH BIARYL P4 MOTIFS
2VINA:FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2VIOA:FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2VIPA:FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2VIQA:FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2VIVA:FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2VIWA:FRAGMENT-BASED DISCOVERY OF MEXILETINE DERIVATIVES AS ORALLY BIOAVAILABLE INHIBITORS OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR
2VVCA:; B:AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VVUA:AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VVVA:AMINOPYRROLIDINE-RELATED TRIAZOLE FACTOR XA INHIBITOR
2VWLA:AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWMA:; B:AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWNA:AMINOPYRROLIDINE FACTOR XA INHIBITOR
2VWOA:AMINOPYRROLIDINE FACTOR XA INHIBITOR
2W26A:FACTOR XA IN COMPLEX WITH BAY59-7939
2W3IA:CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 2
2W3KA:CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 4,4-DISUBSTITUTED PYRROLIDINE-1,2-DICARBOXAMIDE INHIBITOR 1
2WPHS:FACTOR IXA SUPERACTIVE TRIPLE MUTANT
2WPJS:FACTOR IXA SUPERACTIVE TRIPLE MUTANT, NACL-SOAKED
2WPKS:FACTOR IXA SUPERACTIVE TRIPLE MUTANT, ETHYLENE GLYCOL-SOAKED
2WPLS:FACTOR IXA SUPERACTIVE TRIPLE MUTANT, EDTA-SOAKED
2WPMS:FACTOR IXA SUPERACTIVE MUTANT, EGR-CMK INHIBITED
2WYGA:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS
2WYJA:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH MONOARYL P4 MOTIFS
2XBVA:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBWA:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBXA:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XBYA:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC0A:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC4A:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2XC5A:FACTOR XA IN COMPLEX WITH A PYRROLIDINE-3,4-DICARBOXYLIC ACID INHIBITOR
2Y5FA:FACTOR XA - CATION INHIBITOR COMPLEX
2Y5GA:FACTOR XA - CATION INHIBITOR COMPLEX
2Y5HA:FACTOR XA - CATION INHIBITOR COMPLEX
2Y7XA:THE DISCOVERY OF POTENT AND LONG-ACTING ORAL FACTOR XA INHIBITORS WITH TETRAHYDROISOQUINOLINE AND BENZAZEPINE P4 MOTIFS
2Y7ZA:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS
2Y80A:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS
2Y81A:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS
2Y82A:STRUCTURE AND PROPERTY BASED DESIGN OF FACTOR XA INHIBITORS: PYRROLIDIN-2-ONES WITH AMINOINDANE AND PHENYLPYRROLIDINE P4 MOTIFS
2Z7FE:CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN NEUTROPHIL ELASTASE WITH 1/2SLPI
2ZCHP:CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
3C1KA:CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH INHIBITOR 15
3CENA:FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(2-(((5-CHLORO-2-PYRIDINYL) AMINO)SULFONYL)PHENYL)-4-(2-OXO-1(2H)-PYRIDINYL)BENZAMIDE
3CS7A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(4-METHOXYPHENYL)-6-(4-(1-(PYRROLIDIN-1-YLMETHYL)CYCLOPROPYL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3ENSB:; D:CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH METHYL (2Z)-3-[(3-CHLORO-1H-INDOL-7-YL)AMINO]-2-CYANO-3-{[(3S)-2-OXO-1-(2-OXO-2-PYRROLIDIN-1-YLETHYL)AZEPAN-3-YL]AMINO}ACRYLATE
3FFGA:FACTOR XA IN COMPLEX WITH THE INHIBITOR (R)-6-(2'-((3-HYDROXYPYRROLIDIN-1-YL)METHYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4, 5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3HPTB:CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-2-CYANO-1-(2-METHYLBENZOFURAN-5-YL)-3-(2-OXO-1-(2-OXO-2-(PYRROLIDIN-1-YL)ETHYL) AZEPAN-3-YL)GUANIDINE
3IITA:FACTOR XA IN COMPLEX WITH A CIS-1,2-DIAMINOCYCLOHEXANE DERIVATIVE
3K9XB:X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL) ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE
3KQBA:FACTOR XA IN COMPLEX WITH THE INHIBITOR N-(3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL)PHENYL)-3-(TRIFLUOROMETHYL)-1H- PYRAZOLE-5-CARBOXAMIDE
3KQCA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 6-(2'- (METHYLSULFONYL) BIPHENYL-4-YL)-1-(3-(5-OXO-4,5-DIHYDRO-1H- 1,2,4-TRIAZOL-3-YL) PHENYL)-3-(TRIFLUOROMETHYL)-5,6- DIHYDRO-1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3KQDA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-(3-(5-OXO-4,5- DIHYDRO-1H-1, 2,4-TRIAZOL-3-YL)PHENYL)-6-(2'-(PYRROLIDIN-1- YLMETHYL)BIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-5,6-DIHYDRO- 1H-PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3KQEA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 3-METHYL-1-(3-(5- OXO-4,5-DIHYDRO-1H-1,2,4-TRIAZOL-3-YL)PHENYL)-6-(2'- (PYRROLIDIN-1-YLMETHYL) BIPHENYL-4-YL)-5,6-DIHYDRO-1H- PYRAZOLO[3,4-C]PYRIDIN-7(4H)-ONE
3M36A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[3-(AMINOMETHYL) PHENYL]-N-[3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (DPC423)
3M37A:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[2-(AMINOMETHYL) PHENYL]-N-(3-FLUORO-2'-SULFAMOYLBIPHENYL-4-YL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (DPC602)
3PB1E:CRYSTAL STRUCTURE OF A MICHAELIS COMPLEX BETWEEN PLASMINOGEN ACTIVATOR INHIBITOR-1 AND UROKINASE-TYPE PLASMINOGEN ACTIVATOR
3Q3KA:FACTOR XA IN COMPLEX WITH A PHENYLENEDIAMINE DERIVATIVE
3Q76A:; B:STRUCTURE OF HUMAN NEUTROPHIL ELASTASE (UNCOMPLEXED)
3Q77A:STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A DIHYDROPYRIMIDONE INHIBITOR
3SQHE:CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT S195A IN THE THE OPEN FORM
3TJUA:CRYSTAL STRUCTURE OF HUMAN GRANZYME H WITH AN INHIBITOR
3TJVA:CRYSTAL STRUCTURE OF HUMAN GRANZYME H WITH A PEPTIDYL SUBSTRATE
3TK5A:FACTOR XA IN COMPLEX WITH D102-4380
3TK6A:FACTOR XA IN COMPLEX WITH D46-5241
3TK9A:CRYSTAL STRUCTURE OF HUMAN GRANZYME H
3VFEA:VIRTUAL SCREENING AND X-RAY CRYSTALLOGRAPHY FOR HUMAN KALLIKREIN 6 INHIBITORS WITH AN AMIDINOTHIOPHENE P1 GROUP
4A7IB:FACTOR XA IN COMPLEX WITH A POTENT 2-AMINO-ETHANE SULFONAMIDE INHIBITOR
4D8NA:HUMAN KALLIKREIN 6 INHIBITORS WITH A PARA-AMIDOBENZYLANMINE P1 GROUP CARRY A HIGH BINDING EFFICIENCY
4DGJA:; B:; C:; D:STRUCTURE OF A HUMAN ENTEROPEPTIDASE LIGHT CHAIN VARIANT
4GAWA:; B:; C:; D:; E:; F:; G:; H:; I:; J:; K:; L:CRYSTAL STRUCTURE OF ACTIVE HUMAN GRANZYME H
(-)
Jararacussu (Bothrops jararacussu) [TaxId: 8726] (1)
4GSOA:STRUCTURE OF JARARACUSSIN-I
(-)
Macaca mulatta [TaxId: 9541] (1)
4D9QA:; B:INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
(-)
Mouse (Mus musculus) [TaxId: 10090] (2)
3FZZA:; B:STRUCTURE OF GRC
3G01A:; B:STRUCTURE OF GRC MUTANT E192R/E193G
(-)
Oryzias latipes [TaxId: 8090] (1)
3W94A:; B:STRUCTURE OF ORYZIAS LATIPES ENTEROPEPTIDASE LIGHT CHAIN
(-)
Pig (Sus scrofa) [TaxId: 9823] (1)
4AN7A:KUNITZ TYPE TRYPSIN INHIBITOR COMPLEX WITH PORCINE TRYPSIN
(-)
Protein domain: Beta-acrosin (2)
(-)
Pig (Sus scrofa) [TaxId: 9823] (1)
1FIZL:,A:THREE DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM BOAR SPERMATOZOA
(-)
Sheep (Ovis aries) [TaxId: 9940] (1)
1FIWL:,A:THREE-DIMENSIONAL STRUCTURE OF BETA-ACROSIN FROM RAM SPERMATOZOA
(-)
Protein domain: beta-Tryptase (13)
(-)
Human (Homo sapiens) [TaxId: 9606] (13)
1A0LA:; B:; C:; D:HUMAN BETA-TRYPTASE: A RING-LIKE TETRAMER WITH ACTIVE SITES FACING A CENTRAL PORE
2BM2A:; B:; C:; D:HUMAN BETA-II TRYPTASE IN COMPLEX WITH 4-(3-AMINOMETHYL-PHENYL)-PIPERIDIN-1-YL-(5-PHENETHYL- PYRIDIN-3-YL)-METHANONE
2FPZA:; B:; C:; D:HUMAN TRYPTASE WITH 2-AMINO BENZIMIDAZOLE
2FS8A:; B:; C:; D:HUMAN BETA-TRYPTASE II WITH INHIBITOR CRA-29382
2FS9A:; B:; C:; D:HUMAN BETA TRYPTASE II WITH INHIBITOR CRA-28427
2FWWA:; B:; C:; D:HUMAN BETA-TRYPTASE II COMPLEXED WITH 4-PIPERIDINEBUTYRATE TO MAKE ACYLENZYME
2FXRA:; B:; C:; D:HUMAN BETA TRYPTASE II COMPLEXED WITH ACTIVATED KETONE INHIBITOR CRA-29382
2GDDA:; B:; C:; D:HUMAN BETA II TRYPTASE WITH INHIBITOR CRA-27592
2ZA5A:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN TRYPTASE WITH POTENT NON-PEPTIDE INHIBITOR
2ZEBA:; B:; C:; D:POTENT, NONPEPTIDE INHIBITORS OF HUMAN MAST CELL TRYPTASE
2ZECA:; C:; D:; B:POTENT, NONPEPTIDE INHIBITORS OF HUMAN MAST CELL TRYPTASE
3V7TA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN BETA-TRYPTASE COMPLEXED WITH A SYNTHETIC INHIBITOR WITH A TROPANYLAMIDE SCAFFOLD
4A6LA:; B:; C:; D:BETA-TRYPTASE INHIBITOR
(-)
Protein domain: Cathepsin G (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1AU8A:HUMAN CATHEPSIN G
1CGHA:HUMAN CATHEPSIN G
1KYNA:; B:CATHEPSIN-G
(-)
Protein domain: Chymase (mast cell protease I) (11)
(-)
Human (Homo sapiens) [TaxId: 9606] (11)
1KLTA:CRYSTAL STRUCTURE OF PMSF-TREATED HUMAN CHYMASE AT 1.9 ANGSTROMS RESOLUTION
1NN6A:HUMAN PRO-CHYMASE
1PJPA:THE 2.2 A CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SUCCINYL-ALA-ALA-PRO-PHE-CHLOROMETHYLKETONE
1T31A:A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION
2HVXA:DISCOVERY OF POTENT, ORALLY ACTIVE, NONPEPTIDE INHIBITORS OF HUMAN MAST CELL CHYMASE BY USING STRUCTURE-BASED DRUG DESIGN
3N7OA:X-RAY STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH SMALL MOLECULE INHIBITOR.
3S0NA:CRYSTAL STRUCTURE OF HUMAN CHYMASE WITH BENZIMIDAZOLONE INHIBITOR
4K2YA:CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT INHIBITOR 6-CHLORO-1,3-DIHYDRO-2H-INDOL-2-ONE
4K5ZA:CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT INHIBITOR 6-CHLORO-2,3-DIHYDRO-1H-ISOINDOL-1-ONE
4K60A:CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT 6-BROMO-1, 3-DIHYDRO-2H-INDOL-2-ONE
4K69A:CRYSTAL STRUCTURE OF HUMAN CHYMASE IN COMPLEX WITH FRAGMENT LINKED BENZIMIDAZOLONE INHIBITOR: (3S)-3-{3-[(6-BROMO-2-OXO-2,3-DIHYDRO-1H-INDOL-4-YL)METHYL]-2-OXO-2,3-DIHYDRO-1H-BENZIMIDAZOL-1-YL}HEXANOIC ACID
(-)
Protein domain: Chymase II (mast cell proteinase II) (1)
(-)
Rat (Rattus rattus) [TaxId: 10117] (1)
3RP2A:; B:THE STRUCTURE OF RAT MAST CELL PROTEASE II AT 1.9-ANGSTROMS RESOLUTION
(-)
Protein domain: Coagulation factor IXa, protease domain (7)
(-)
Human (Homo sapiens) [TaxId: 9606] (5)
1RFNA:HUMAN COAGULATION FACTOR IXA IN COMPLEX WITH P-AMINO BENZAMIDINE
2WPIS:FACTOR IXA SUPERACTIVE DOUBLE MUTANT
3KCGH:CRYSTAL STRUCTURE OF THE ANTITHROMBIN-FACTOR IXA-PENTASACCHARIDE COMPLEX
3LC3A:; C:BENZOTHIOPHENE INHIBITORS OF FACTOR IXA
3LC5A:SELECTIVE BENZOTHIOPHINE INHIBITORS OF FACTOR IXA
(-)
Pig (Sus scrofa) [TaxId: 9823] (2)
1PFXC:PORCINE FACTOR IXA
1X7AC:PORCINE FACTOR IXA COMPLEXED TO 1-{3-[AMINO(IMINO) METHYL]PHENYL}-N-[4-(1H-BENZIMIDAZOL-1-YL)-2-FLUOROPHENYL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE
(-)
Protein domain: Coagulation factor VIIa (39)
(-)
Human (Homo sapiens) [TaxId: 9606] (39)
1CVWH:CRYSTAL STRUCTURE OF ACTIVE SITE-INHIBITED HUMAN COAGULATION FACTOR VIIA (DES-GLA)
1DANH:COMPLEX OF ACTIVE SITE INHIBITED HUMAN BLOOD COAGULATION FACTOR VIIA WITH HUMAN RECOMBINANT SOLUBLE TISSUE FACTOR
1DVAH:; I:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THE PEPTIDE EXOSITE INHIBITOR E-76 AND COAGULATION FACTOR VIIA
1FAKH:HUMAN TISSUE FACTOR COMPLEXED WITH COAGULATION FACTOR VIIA INHIBITED WITH A BPTI-MUTANT
1J9CH:CRYSTAL STRUCTURE OF TISSUE FACTOR-FACTOR VIIA COMPLEX
1JBUH:COAGULATION FACTOR VII ZYMOGEN (EGF2/PROTEASE) IN COMPLEX WITH INHIBITORY EXOSITE PEPTIDE A-183
1KLIH:COFACTOR-AND SUBSTRATE-ASSISTED ACTIVATION OF FACTOR VIIA
1KLJH:CRYSTAL STRUCTURE OF UNINHIBITED FACTOR VIIA
1O5DH:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1QFKH:STRUCTURE OF HUMAN FACTOR VIIA AND ITS IMPLICATIONS FOR THE TRIGGERING OF BLOOD COAGULATION
1YGCH:SHORT FACTOR VIIA WITH A SMALL MOLECULE INHIBITOR
1Z6JH:CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR/PYRAZINONE INHIBITOR
2A2QH:COMPLEX OF ACTIVE-SITE INHIBITED HUMAN COAGULATION FACTOR VIIA WITH HUMAN SOLUBLE TISSUE FACTOR IN THE PRESENCE OF CA2+, MG2+, NA+, AND ZN2+
2AEIH:CRYSTAL STRUCTURE OF A TERNARY COMPLEX OF FACTOR VIIA/TISSUE FACTOR AND 2-[[6-[3-(AMINOIMINOMETHYL)PHENOXY]-3,5-DIFLURO-4-[(1-METHYL-3-PHENYLPROPYL)AMINO]-2-PYRIDINYL]OXY]-BENZOIC ACID
2B7DH:FACTOR VIIA INHIBITORS: CHEMICAL OPTIMIZATION, PRECLINICAL PHARMACOKINETICS, PHARMACODYNAMICS, AND EFFICACY IN A BABOON THROMBOSIS MODEL
2B8OH:CRYSTAL STRUCTURE OF GLU-GLY-ARG-CHLOROMETHYL KETONE-FACTOR VIIA/SOLUBLE TISSUE FACTOR COMPLEX
2C4FH:16-257CRYSTAL STRUCTURE OF FACTOR VII.STF COMPLEXED WITH PD0297121
2F9BH:DISCOVERY OF NOVEL HETEROCYCLIC FACTOR VIIA INHIBITORS
2FIRH:CRYSTAL STRUCTURE OF DFPR-VIIA/STF
2FLBH:DISCOVERY OF A NOVEL HYDROXY PYRAZOLE BASED FACTOR IXA INHIBITOR
2FLRH:NOVEL 5-AZAINDOLE FACTOR VIIA INHIBITORS
2PUQH:CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA IN COMPLEX WITH SOLUBLE TISSUE FACTOR
2ZP0H:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH BENZYLSULFONAMIDE-D-ILE-GLN-P-AMINOBENZAMIDINE
2ZWLH:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH HIGHLY SELECTIVE PEPTIDE INHIBITOR
2ZZUH:HUMAN FACTOR VIIA-TISSUE FACTOR COMPLEXED WITH ETHYLSULFONAMIDE-D-5-(3-CARBOXYBENZYLOXY)-TRP-GLN-P-AMINOBENZAMIDINE
3ELAH:CRYSTAL STRUCTURE OF ACTIVE SITE INHIBITED COAGULATION FACTOR VIIA MUTANT IN COMPLEX WITH SOLUBLE TISSUE FACTOR
3TH2H:MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
3TH3H:MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
3TH4H:MG2+ IS REQUIRED FOR OPTIMAL FOLDING OF THE GAMMA-CARBOXYGLUTAMIC ACID (GLA) DOMAINS OF VITAMIN K-DEPENDENT CLOTTING FACTORS AT PHYSIOLOGICAL CA2+
4ISHH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR BMS-593214 ALSO KNOWN AS 2'-[(6R,6AR,11BR)-2-CARBAMIMIDOYL-6,6A,7,11B-TETRAHYDRO-5H-INDENO[2,1-C]QUINOLIN-6-YL]-5'-HYDROXY-4'-METHOXYBIPHENYL-4-CARBOXYLIC ACID
4ISIH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (6S)-N-(4-CARBAMIMIDOYLBENZYL)-1-CHLORO-3-(CYCLOBUTYLAMINO)-8,8-DIETHYL-4-OXO-4,6,7,8-TETRAHYDROPYRROLO[1,2-A]PYRAZINE-6-CARBOXAMIDE
4JYUH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(PHENYLSULFONYL)ETHANAMIDE
4JYVH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-2-(ISOQUINOLIN-6-YLAMINO)-N-[(3-SULFAMOYLPHENYL)SULFONYL]ETHANAMIDE
4JZDH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(4-CARBAMIMIDOYLPHENYL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID
4JZEH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(1-AMINOISOQUINOLIN-6-YL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID
4JZFH:STRUCTURE OF FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 2-{2-[(3-CARBAMOYLPHENYL)CARBAMOYL]-6-METHOXYPYRIDIN-3-YL}-5-{[(2S)-1-HYDROXY-3,3-DIMETHYLBUTAN-2-YL]CARBAMOYL}BENZOIC ACID
4NA9H:FACTOR VIIA IN COMPLEX WITH THE INHIBITOR 3'-AMINO-5'-[(2S,4R)-6-CARBAMIMIDOYL-4-PHENYL-1,2,3,4-TETRAHYDROQUINOLIN-2-YL]BIPHENYL-2-CARBOXYLIC ACID
4NG9H:FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-(3-SULFAMOYLBENZYL)ETHANAMIDE
4NGAH:FACTOR VIIA IN COMPLEX WITH THE INHIBITOR (2R)-2-[(1-AMINOISOQUINOLIN-6-YL)AMINO]-2-[3-ETHOXY-4-(PROPAN-2-YLOXY)PHENYL]-N-[2-(PROPAN-2-YLSULFONYL)BENZYL]ETHANAMIDE
(-)
Protein domain: Coagulation factor Xa, protease domain (48)
(-)
Cow (Bos taurus) [TaxId: 9913] (1)
1KIGH:BOVINE FACTOR XA
(-)
Human (Homo sapiens) [TaxId: 9606] (47)
1C5MD:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1EZQA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR128515
1F0RA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208815
1F0SA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208707
1FAXA:COAGULATION FACTOR XA INHIBITOR COMPLEX
1FJSA:CRYSTAL STRUCTURE OF THE INHIBITOR ZK-807834 (CI-1031) COMPLEXED WITH FACTOR XA
1G2LA:FACTOR XA INHIBITOR COMPLEX
1G2MA:FACTOR XA INHIBITOR COMPLEX
1HCGA:STRUCTURE OF HUMAN DES(1-45) FACTOR XA AT 2.2 ANGSTROMS RESOLUTION
1IOEA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55532
1IQEA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55590
1IQFA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55165
1IQGA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55159
1IQHA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55143
1IQIA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55125
1IQJA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55124
1IQKA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55113
1IQLA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54476
1IQMA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M54471
1IQNA:HUMAN COAGULATION FACTOR XA IN COMPLEX WITH M55192
1KSNA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH FXV673
1LPGB:CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 79.
1LPKB:CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 125.
1LPZB:CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 41.
1LQDB:CRYSTAL STRUCTURE OF FXA IN COMPLEX WITH 45.
1MQ5A:CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(4-CHLOROPHENYL) AMINO]CARBONYL]PHENYL]-4-[(4-METHYL-1-PIPERAZINYL)METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1MQ6A:CRYSTAL STRUCTURE OF 3-CHLORO-N-[4-CHLORO-2-[[(5-CHLORO-2-PYRIDINYL) AMINO]CARBONYL]-6-METHOXYPHENYL]-4-[[(4,5-DIHYDRO-2-OXAZOLYL) METHYLAMINO]METHYL]-2-THIOPHENECARBOXAMIDE COMPLEXED WITH HUMAN FACTOR XA
1NFUA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR132747
1NFWA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR209685
1NFXA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR208944
1NFYA:CRYSTAL STRUCTURE OF HUMAN COAGULATION FACTOR XA COMPLEXED WITH RPR200095
1P0SH:CRYSTAL STRUCTURE OF BLOOD COAGULATION FACTOR XA IN COMPLEX WITH ECOTIN M84R
1V3XA:FACTOR XA IN COMPLEX WITH THE INHIBITOR 1-[6-METHYL-4,5,6,7-TETRAHYDROTHIAZOLO(5,4-C)PYRIDIN-2-YL] CARBONYL-2-CARBAMOYL-4-(6-CHLORONAPHTH-2-YLSULPHONYL)PIPERAZINE
1XKAC:FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
1XKBC:; D:FACTOR XA COMPLEXED WITH A SYNTHETIC INHIBITOR FX-2212A,(2S)-(3'-AMIDINO-3-BIPHENYLYL)-5-(4-PYRIDYLAMINO)PENTANOIC ACID
2GD4B:16-249; H:16-244CRYSTAL STRUCTURE OF THE ANTITHROMBIN-S195A FACTOR XA-PENTASACCHARIDE COMPLEX
2PHBA:AN ORALLY EFFICACIOUS FACTOR XA INHIBITOR
2PR3A:FACTOR XA INHIBITOR
2RA0A:X-RAY STRUCTURE OF FXA IN COMPLEX WITH 7-FLUOROINDAZOLE
3HPTD:CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-2-CYANO-1-(2-METHYLBENZOFURAN-5-YL)-3-(2-OXO-1-(2-OXO-2-(PYRROLIDIN-1-YL)ETHYL) AZEPAN-3-YL)GUANIDINE
3K9XD:X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH (S)-N-((2-METHYLBENZOFURAN-5-YLAMINO)(2-OXO-1-(2-OXO-2- (PYRROLIDIN-1-YL) ETHYL)AZEPAN-3- YLAMINO)METHYLENE)NICOTINAMIDE
3KL6A:DISCOVERY OF TETRAHYDROPYRIMIDIN-2(1H)-ONE DERIVATIVE TAK-442: A POTENT, SELECTIVE AND ORALLY ACTIVE FACTOR XA INHIBITOR
3LIWA:FACTOR XA IN COMPLEX WITH (R)-2-(1-ADAMANTYLCARBAMOYLAMINO)-3-(3-CARBAMIDOYL-PHENYL)-N-PHENETHYL-PROPIONIC ACID AMIDE
3SW2B:X-RAY CRYSTAL STRUCTURE OF HUMAN FXA IN COMPLEX WITH 6-CHLORO-N-((3S)-2-OXO-1-(2-OXO-2-((5S)-8-OXO-5,6-DIHYDRO-1H-1,5-METHANOPYRIDO[1,2-A][1,5]DIAZOCIN-3(2H,4H,8H)-YL)ETHYL)PIPERIDIN-3-YL)NAPHTHALENE-2-SULFONAMIDE
4BTIB:; F:FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 58.
4BTTB:; F:FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 31.
4BTUB:; F:FACTOR XA IN COMPLEX WITH THE DUAL THROMBIN-FXA INHIBITOR 57.
(-)
Protein domain: Coagulation factor Xa-trypsin chimera (1)
(-)
Synthetic, based on Homo sapiens sequence (1)
1FXYA:COAGULATION FACTOR XA-TRYPSIN CHIMERA INHIBITED WITH D-PHE-PRO-ARG-CHLOROMETHYLKETONE
(-)
Protein domain: Coagulation factor XI (26)
(-)
Human (Homo sapiens) [TaxId: 9606] (26)
1XX9A:; B:CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH ECOTINM84R
1XXDA:; B:CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH MUTATED ECOTIN
1XXFA:; B:CRYSTAL STRUCTURE OF THE FXIA CATALYTIC DOMAIN IN COMPLEX WITH ECOTIN MUTANT (ECOTINP)
1ZHMA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE COAGULATION FACTOR XIA IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K437 MUTANT)
1ZHPA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-K505 MUTANT)
1ZHRA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH BENZAMIDINE (S434A-T475A-C482S-K437A MUTANT)
1ZJDA:16-244CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH KUNITZ PROTEASE INHIBITOR DOMAIN OF PROTEASE NEXIN II
1ZLRA:FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH 2-GUANIDINO-1-(4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL)ETHYL NICOTINATE
1ZMJA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI IN COMPLEX WITH 4-(GUANIDINOMETHYL)-PHENYLBORONIC ACID
1ZMLA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF FACTOR XI IN COMPLEX WITH (R)-1-(4-(4-(HYDROXYMETHYL)-1,3,2-DIOXABOROLAN-2-YL)PHENETHYL)GUANIDINE
1ZMNA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH (R)-1-(4-(4-(HYDROXYMETHYL)-1,3, 2-DIOXABOROLAN-2-YL)PHENYL)GUANIDINE
1ZOMA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR
1ZPBA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 4-METHYL-PENTANOIC ACID {1-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYLCARBAMOYL]-2-METHYL-PROPYL}-AMIDE
1ZPCA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 2-[2-(3-CHLORO-PHENYL)-2-HYDROXY-ACETYLAMINO]-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-3-METHYL-BUTYRAMIDE
1ZPZA:FACTOR XI CATALYTIC DOMAIN COMPLEXED WITH N-((R)-1-(4-BROMOPHENYL)ETHYL)UREA-ASN-VAL-ARG-ALPHA-KETOTHIAZOLE
1ZRKA:FACTOR XI COMPLEXED WITH 3-HYDROXYPROPYL 3-(7-AMIDINONAPHTHALENE-1-CARBOXAMIDO)BENZENESULFONATE
1ZSJA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH N-(7-CARBAMIMIDOYL-NAPHTHALEN-1-YL)-3-HYDROXY-2-METHYL-BENZAMIDE
1ZSKA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 6-CARBAMIMIDOYL-4-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-NAPHTHALENE-2-CARBOXYLIC ACID METHYL ESTER
1ZSLA:FACTOR XI COMPLEXED WITH A PYRIMIDINONE INHIBITOR
1ZTJA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 2-(5-BENZYLAMINO-2-METHYLSULFANYL-6-OXO-6H-PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-ACETAMIDE
1ZTKA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH 2-(5-AMINO-6-OXO-2-M-TOLYL-6H-PYRIMIDIN-1-YL)-N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-ACETAMIDE
1ZTLA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF COAGULATION FACTOR XI IN COMPLEX WITH N-[4-GUANIDINO-1-(THIAZOLE-2-CARBONYL)-BUTYL]-2-{6-OXO-5-[(QUINOLIN-8-YLMETHYL)-AMINO]-2-M-TOLYL-6H-PYRIMIDIN-1-YL}-ACETAMIDE
2FDAA:CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COAGULATION FACTOR XIA IN COMPLEX WITH ALPHA-KETOTHIAZOLE ARGININE DERIVED LIGAND
3BG8A:CRYSTAL STRUCTURE OF FACTOR XIA IN COMPLEX WITH CLAVATADINE A
3SORA:FACTOR XIA IN COMPLEX WITH A CLOROPHENYL-TETRAZOLE INHIBITOR
3SOSA:BENZOTHIAZINONE INHIBITOR IN COMPLEX WITH FXIA
(-)
Protein domain: Complement C1R protease, catalytic domain (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1GPZA:434-685; B:434-685THE CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R
1MD7A:434-685MONOMERIC STRUCTURE OF THE ZYMOGEN OF COMPLEMENT PROTEASE C1R
1MD8A:434-686MONOMERIC STRUCTURE OF THE ACTIVE CATALYTIC DOMAIN OF COMPLEMENT PROTEASE C1R
(-)
Protein domain: Complement C1S protease, catalytic domain (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1ELVA:410-668CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN COMPLEMENT C1S PROTEASE
(-)
Protein domain: Crab collagenase (1)
(-)
Atlantic sand fiddler crab (Uca pugilator) [TaxId: 6772] (1)
1AZZA:; B:FIDDLER CRAB COLLAGENASE COMPLEXED TO ECOTIN
(-)
Protein domain: Duodenase (1)
(-)
Cow (Bos taurus) [TaxId: 9913] (1)
1EUFA:BOVINE DUODENASE(NEW SERINE PROTEASE), CRYSTAL STRUCTURE
(-)
Protein domain: Elastase (123)
(-)
Atlantic salmon (Salmo salar) [TaxId: 8030] (1)
1ELTA:STRUCTURE OF NATIVE PANCREATIC ELASTASE FROM NORTH ATLANTIC SALMON AT 1.61 ANGSTROMS RESOLUTION
(-)
Human (Homo sapiens) [TaxId: 9606] (5)
1B0FA:CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE WITH MDL 101, 146
1H1BA:; B:CRYSTAL STRUCTURE OF HUMAN NEUTROPHIL ELASTASE COMPLEXED WITH AN INHIBITOR (GW475151)
1HNEE:STRUCTURE OF HUMAN NEUTROPHIL ELASTASE IN COMPLEX WITH A PEPTIDE CHLOROMETHYL KETONE INHIBITOR AT 1.84-ANGSTROMS RESOLUTION
1PPFE:X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN LEUKOCYTE ELASTASE (PMN ELASTASE) AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR
1PPGE:THE REFINED 2.3 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN LEUKOCYTE ELASTASE IN A COMPLEX WITH A VALINE CHLOROMETHYL KETONE INHIBITOR
(-)
Pig (Sus scrofa) [TaxId: 9823] (116)
1B0EA:CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH MDL 101,146
1BMAA:BENZYL METHYL AMINIMIDE INHIBITOR COMPLEXED TO PORCINE PANCREATIC ELASTASE
1BRUP:STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH THE ELASTASE INHIBITOR GR143783
1BTUA:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4R)-1-TOLUENESULPHONYL-3-ETHYL-AZETIDIN-2-ONE-4-CARBOXYLIC ACID
1C1MA:PORCINE ELASTASE UNDER XENON PRESSURE (8 BAR)
1E34B:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID) PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR ONE MINUTE
1E35B:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-TOLUENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR TWO MINUTES
1E36B:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE
1E37B:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 1 MINUTE
1E38B:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3S, 4S)N-PARA-NITROBENZENESULPHONYL -3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE SOAKED IN PH 9 BUFFER FOR 2 MINUTES
1EAIA:; B:COMPLEX OF ASCARIS CHYMOTRPSIN/ELASTASE INHIBITOR WITH PORCINE ELASTASE
1EASA:NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 3. DESIGN, SYNTHESIS, X-RAY CRYSTALLOGRAPHIC ANALYSIS, AND STRUCTURE-ACTIVITY RELATIONSHIPS FOR A SERIES OF ORALLY ACTIVE 3-AMINO-6-PHENYLPYRIDIN-2-ONE TRIFLUOROMETHYL KETONES
1EATA:NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 5. DESIGN, SYNTHESIS, AND X-RAY CRYSTALLOGRAPHY OF A SERIES OF ORALLY ACTIVE 5-AMINO-PYRIMIDIN-6-ONE-CONTAINING TRIFLUOROMETHYLKETONES
1EAUA:NONPEPTIDIC INHIBITORS OF HUMAN LEUKOCYTE ELASTASE. 6. DESIGN OF A POTENT, INTRATRACHEALLY ACTIVE, PYRIDONE-BASED TRIFLUOROMETHYL KETONE
1ELAA:ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY
1ELBA:ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY
1ELCA:ANALOGOUS INHIBITORS OF ELASTASE DO NOT ALWAYS BIND ANALOGOUSLY
1ELDE:STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS
1ELEE:STRUCTURAL ANALYSIS OF THE ACTIVE SITE OF PORCINE PANCREATIC ELASTASE BASED ON THE X-RAY CRYSTAL STRUCTURES OF COMPLEXES WITH TRIFLUOROACETYL-DIPEPTIDE-ANILIDE INHIBITORS
1ELFA:NATURE OF THE INACTIVATION OF ELASTASE BY N-PEPTIDYL-O-AROYL HYDROXYLAMINE AS A FUNCTION OF PH
1ELGA:NATURE OF THE INACTIVATION OF ELASTASE BY N-PEPTIDYL-O-AROYL HYDROXYLAMINE AS A FUNCTION OF PH
1ESAA:DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE
1ESBA:DIRECT STRUCTURE OBSERVATION OF AN ACYL-ENZYME INTERMEDIATE IN THE HYDROLYSIS OF AN ESTER SUBSTRATE BY ELASTASE
1ESTA:THE ATOMIC STRUCTURE OF CRYSTALLINE PORCINE PANCREATIC ELASTASE AT 2.5 ANGSTROMS RESOLUTION. COMPARISONS WITH THE STRUCTURE OF ALPHA-CHYMOTRYPSIN
1FLEE:CRYSTAL STRUCTURE OF ELAFIN COMPLEXED WITH PORCINE PANCREATIC ELASTASE
1FZZA:THE CRYSTAL STRUCTURE OF THE COMPLEX OF NON-PEPTIDIC INHIBITOR ONO-6818 AND PORCINE PANCREATIC ELASTASE.
1GVKB:PORCINE PANCREATIC ELASTASE ACYL ENZYME AT 0.95 A RESOLUTION
1GWAA:TRIIODIDE DERIVATIVE OF PORCINE PANCREAS ELASTASE
1H9LB:PORCINE PANCREATIC ELASTASE COMPLEXED WITH ACETYL-VAL-GLU-PRO-ILE-COOH
1HAXB:SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (A) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 AT PH 5
1HAYB:SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (B) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 10 FOR 10 SECONDS
1HAZB:SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (C) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 9 FOR 1 MINUTE
1HB0B:SNAPSHOTS OF SERINE PROTEASE CATALYSIS: (D) ACYL-ENZYME INTERMEDIATE BETWEEN PORCINE PANCREATIC ELASTASE AND HUMAN BETA-CASOMORPHIN-7 JUMPED TO PH 10 FOR 2 MINUTES
1HV7A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH GW311616A
1INCA:CRYSTAL STRUCTURES OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE WITH TWO VALINE-DERIVED BENZOXAZINONE INHIBITORS
1JIMA:STEREOSPECIFIC REACTION OF 3-METHOXY-4-CHLORO-7-AMINOISOCOUMARIN WITH CRYSTALLINE PORCINE PANCREATIC ELASTASE
1L0ZA:THE STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH XENON AND BROMIDE, CRYOPROTECTED WITH DRY PARAFFIN OIL
1L1GA:THE STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH XENON AND BROMIDE, CRYOPROTECTED WITH GLYCEROL
1LKAA:PORCINE PANCREATIC ELASTASE/CA-COMPLEX
1LKBA:PORCINE PANCREATIC ELASTASE/NA-COMPLEX
1LVYA:PORCINE ELASTASE
1MCVA:CRYSTAL STRUCTURE ANALYSIS OF A HYBRID SQUASH INHIBITOR IN COMPLEX WITH PORCINE PANCREATIC ELASTASE
1MMJN:PORCINE PANCREATIC ELASTASE COMPLEXED WITH A POTENT PEPTIDYL INHIBITOR, FR136706
1NESE:STRUCTURE OF THE PRODUCT COMPLEX OF ACETYL-ALA-PRO-ALA WITH PORCINE PANCREATIC ELASTASE AT 1.65 ANGSTROMS RESOLUTION
1OKXA:; B:BINDING STRUCTURE OF ELASTASE INHIBITOR SCYPTOLIN A
1QGFA:PORCINE PANCREATIC ELASTASE COMPLEXED WITH (3R, 4S)N-PARA-TOLUENESULPHONYL-3-ETHYL-4-(CARBOXYLIC ACID)PYRROLIDIN-2-ONE
1QIXB:PORCINE PANCREATIC ELASTASE COMPLEXED WITH HUMAN BETA-CASOMORPHIN-7
1QNJA:THE STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT ATOMIC RESOLUTION (1.1 A)
1QR3E:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH FR901277, A NOVEL MACROCYCLIC INHIBITOR OF ELASTASES AT 1.6 ANGSTROM RESOLUTION
1UO6A:PORCINE PANCREATIC ELASTASE/XE-COMPLEX
1UVOA:STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL A)
1UVPA:STRUCTURE OF THE COMPLEX OF PORCINE PANCREATIC ELASTASE IN COMPLEX WITH CADMIUM REFINED AT 1.85 A RESOLUTION (CRYSTAL B)
2A7CA:ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH
2A7JA:ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH
2BB4A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ASP-PHE AT PH 5.0
2BD2A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0
2BD3A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS-ALA-NH2 AT PH 5.0
2BD4A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS-SER AT PH 5.0
2BD5A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND LYS-SER AT PH 5 AND IMMERSED IN PH 9 BUFFER FOR 30 SECONDS
2BD7A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 (50 MIN SOAK)
2BD8A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 (50 MIN SOAK) AND IMMERSED IN PH 9 BUFFER FOR 30 SECONDS
2BD9A:PORCINE PANCREATIC ELASTASE COMPLEXED WITH BETA-CASOMORPHIN-7 AND ARG-PHE AT PH 5.0 (50 MIN SOAK) AND IMMERSED IN PH 9 BUFFER FOR 28 SECONDS (2ND PH JUMP)
2BDAA:PORCINE PANCREATIC ELASTASE COMPLEXED WITH N-ACETYL-NPI AND ALA-ALA AT PH 5.0
2BDBA:PORCINE PANCREATIC ELASTASE COMPLEXED WITH ASN-PRO-ILE AND ALA-ALA AT PH 5.0
2BDCA:PORCINE PANCREATIC ELASTASE COMPLEXED WITH ASN-PRO-ILE AT PH 5.0
2BLOA:ELASTASE BEFORE A HIGH DOSE X-RAY "BURN"
2BLQA:ELASTASE AFTER A HIGH DOSE X-RAY "BURN"
2CV3A:CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH A MACROCLYCLIC PEPTIDE INHIBITOR
2D26C:20-245ACTIVE SITE DISTORTION IS SUFFICIENT FOR PROTEINASE INHIBIT SECOND CRYSTAL STRUCTURE OF COVALENT SERPIN-PROTEINASE COMPLEX
2DE8A:CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH A UNIQUE CONFORMATION INDUCED BY TRIS
2DE9A:CRYSTAL STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH TRIS AFTER SOAKING A TRIS-FREE SOLUTION
2ESTE:CRYSTALLOGRAPHIC STUDY OF THE BINDING OF A TRIFLUOROACETYL DIPEPTIDE ANILIDE INHIBITOR WITH ELASTASE
2FO9A:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 95% ACETONE
2FOAA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40/50/10 % BENZENE
2FOBA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40/50/10 CYCLOHEXANE
2FOCA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 55% DIMETHYLFORMAMIDE
2FODA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% ETHANOL
2FOEA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% HEXANE
2FOFA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 80% ISOPROPANOL
2FOGA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40% TRIFLUOROETHANOL
2FOHA:STRUCTURE OF PORCINE PANCREATIC ELASTASE IN 40% TRIFLUOROETHANOL
2G4TA:ANOMALOUS SUBSTRUCTURE OF PORCINE PANCREATIC ELASTASE (NA)
2G4UA:ANOMALOUS SUBSTRUCTURE OF PORCINE PANCREATIC ELASTAASE (CA)
2H1UA:PORCINE PANCREATIC ELASTASE COMPLEXED WITH METPHELEUGLU AT PH 5.0
2IOTA:CLAVULANIC ACID BOUND TO ELASTASE
2OQUA:HIGH PRESSURE CRYOCOOLING OF CAPILLARY SAMPLE CRYOPROTECTION AND DIFFRACTION PHASING AT LONG WAVELENGTHS
2V0BA:SAD STRUCTURE SOLUTION PORCINE PANCREATIC ELASTASE FROM A SELENATE DERIVATIVE
2V35A:PORCINE PANCREATIC ELASTASE IN COMPLEX WITH INHIBITOR JM54
3E3TA:STRUCTURE OF PORCINE PANCREATIC ELASTASE WITH THE MAGIC TRIANGLE I3C
3ESTA:STRUCTURE OF NATIVE PORCINE PANCREATIC ELASTASE AT 1.65 ANGSTROMS RESOLUTION
3HGNA:STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH A POTENT PEPTIDYL INHIBITOR FR130180 DETERMINED BY NEUTRON CRYSTALLOGRAPHY
3HGPA:STRUCTURE OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH A POTENT PEPTIDYL INHIBITOR FR130180 DETERMINED BY HIGH RESOLUTION CRYSTALLOGRAPHY
3MNBA:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. FIRST STAGE OF RADIATION DAMAGE
3MNCA:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. SECOND STAGE OF RADIATION DAMAGE
3MNSA:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. THIRD STAGE OF RADIATION DAMAGE
3MNXA:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. FOURTH STAGE OF RADIATION DAMAGE
3MO3A:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. FIFTH STAGE OF RADIATION DAMAGE
3MO6A:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. SIXTH STAGE OF RADIATION DAMAGE
3MO9A:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. SEVENTH STAGE OF RADIATION DAMAGE
3MOCA:INVESTIGATION OF GLOBAL AND LOCAL EFFECTS OF RADIATION DAMAGE ON PORCINE PANCREATIC ELASTASE. EIGHTH STAGE OF RADIATION DAMAGE
3MTYA:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION A OF THE CRYSTAL. FIRST STEP OF RADIATION DAMAGE
3MU0A:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION A OF THE CRYSTAL. THIRD STEP OF RADIATION DAMAGE
3MU1A:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION A OF THE CRYSTAL. FIFTH STEP OF RADIATION DAMAGE
3MU4A:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION B OF THE CRYSTAL. FIRST STEP OF RADIATION DAMAGE
3MU5A:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION B OF THE CRYSTAL. THIRD STEP OF RADIATION DAMAGE
3MU8A:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION B OF THE CRYSTAL. FIFTH STEP OF RADIATION DAMAGE
3ODDA:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION B OF THE CRYSTAL. SECOND STEP OF RADIATION DAMAGE
3ODFA:COMPARISON OF THE CHARACTER AND THE SPEED OF X-RAY-INDUCED STRUCTURAL CHANGES OF PORCINE PANCREATIC ELASTASE AT TWO TEMPERATURES, 100 AND 15K. THE DATA SET WAS COLLECTED FROM REGION A OF THE CRYSTAL. SECOND STEP OF RADIATION DAMAGE
3UOUA:CRYSTAL STRUCTURE OF THE KUNITZ-TYPE PROTEASE INHIBITOR SHPI-1 LYS13LEU MUTANT IN COMPLEX WITH PANCREATIC ELASTASE
4ESTE:CRYSTAL STRUCTURE OF THE COVALENT COMPLEX FORMED BY A PEPTIDYL ALPHA, ALPHA-DIFLUORO-BETA-KETO AMIDE WITH PORCINE PANCREATIC ELASTASE AT 1.78-ANGSTROMS RESOLUTION
4GVUA:LYNGBYASTATIN 7-PORCINE PANCREATIC ELASTASE CO-CRYSTAL STRUCTURE
5ESTE:CRYSTALLOGRAPHIC ANALYSIS OF THE INHIBITION OF PORCINE PANCREATIC ELASTASE BY A PEPTIDYL BORONIC ACID: STRUCTURE OF A REACTION INTERMEDIATE
6ESTA:INTERACTION OF THE PEPTIDE CF3-LEU-ALA-NH-C6H4-CF3(TFLA) WITH PORCINE PANCREATIC ELASTASE. X-RAY STUDIES AT 1.8 ANGSTROMS
7ESTE:INTERACTION OF THE PEPTIDE CF3-LEU-ALA-NH-C6H4-CF3(TFLA) WITH PORCINE PANCREATIC ELASTASE. X-RAY STUDIES AT 1.8 ANGSTROMS
8ESTE:REACTION OF PORCINE PANCREATIC ELASTASE WITH 7-SUBSTITUTED 3-ALKOXY-4-CHLOROISOCOUMARINS: DESIGN OF POTENT INHIBITORS USING THE CRYSTAL STRUCTURE OF THE COMPLEX FORMED WITH 4-CHLORO-3-ETHOXY-7-GUANIDINO-ISOCOUMARIN
9ESTA:STRUCTURAL STUDY OF PORCINE PANCREATIC ELASTASE COMPLEXED WITH 7-AMINO-3-(2-BROMOETHOXY)-4-CHLOROISOCOUMARIN AS A NONREACTIVATABLE DOUBLY COVALENT ENZYME-INHIBITOR COMPLEX
(-)
Worm (Eisenia fetida) [TaxId: 6396] (1)
1M9UA:; B:; C:CRYSTAL STRUCTURE OF EARTHWORM FIBRINOLYTIC ENZYME COMPONENT A FROM EISENIA FETIDA
(-)
Protein domain: Enteropeptidase (enterokinase light chain) (1)
(-)
Cow (Bos taurus) [TaxId: 9913] (1)
1EKBB:THE SERINE PROTEASE DOMAIN OF ENTEROPEPTIDASE BOUND TO INHIBITOR VAL-ASP-ASP-ASP-ASP-LYS-CHLOROMETHANE
(-)
Protein domain: Factor B (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
1DLEA:; B:FACTOR B SERINE PROTEASE DOMAIN
1RRKA:453-739CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B
1RS0A:453-739CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH DI-ISOPROPYL-PHOSPHATE (DIP)
1RTKA:453-739CRYSTAL STRUCTURE ANALYSIS OF THE BB SEGMENT OF FACTOR B COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
(-)
Protein domain: Factor D (12)
(-)
Human (Homo sapiens) [TaxId: 9606] (12)
1BIOA:HUMAN COMPLEMENT FACTOR D IN COMPLEX WITH ISATOIC ANHYDRIDE INHIBITOR
1DFPA:; B:FACTOR D INHIBITED BY DIISOPROPYL FLUOROPHOSPHATE
1DICA:STRUCTURE OF 3,4-DICHLOROISOCOUMARIN-INHIBITED FACTOR D
1DSTA:MUTANT OF FACTOR D WITH ENHANCED CATALYTIC ACTIVITY
1DSUA:; B:HUMAN FACTOR D, COMPLEMENT ACTIVATING ENZYME
1FDPA:; B:; C:; D:PROENZYME OF HUMAN COMPLEMENT FACTOR D, RECOMBINANT PROFACTOR D
1HFDA:HUMAN COMPLEMENT FACTOR D IN A P21 CRYSTAL FORM
2XW9A:CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT S183A
2XWAA:; B:CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT R202A
4CBNA:; B:CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT R202A AFTER CONVENTIONAL REFINEMENT
4CBOA:; B:CRYSTAL STRUCTURE OF COMPLEMENT FACTOR D MUTANT R202A AFTER ENSEMBLE REFINEMENT
4D9RA:; B:INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
(-)
Protein domain: Granzyme A (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1OP8A:; B:; C:; D:; E:; F:CRYSTAL STRUCTURE OF HUMAN GRANZYME A
1ORFA:THE OLIGOMERIC STRUCTURE OF HUMAN GRANZYME A REVEALS THE MOLECULAR DETERMINANTS OF SUBSTRATE SPECIFICITY
(-)
Protein domain: Granzyme B (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1FQ3A:; B:CRYSTAL STRUCTURE OF HUMAN GRANZYME B
1IAUA:HUMAN GRANZYME B IN COMPLEX WITH AC-IEPD-CHO
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (1)
1FI8A:; B:RAT GRANZYME B [N66Q] COMPLEXED TO ECOTIN [81-84 IEPD]
(-)
Protein domain: Granzyme K (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1MZAA:CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K
1MZDA:CRYSTAL STRUCTURE OF HUMAN PRO-GRANZYME K
(-)
Protein domain: Heparin binding protein, HBP (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
1A7SA:ATOMIC RESOLUTION STRUCTURE OF HBP
1AE5A:HUMAN HEPARIN BINDING PROTEIN
1FY1A:[R23S,F25E]HBP, A MUTANT OF HUMAN HEPARIN BINDING PROTEIN (CAP37)
1FY3A:[G175Q]HBP, A MUTANT OF HUMAN HEPARIN BINDING PROTEIN (CAP37)
(-)
Protein domain: Hepatocyte growth factor, HGF (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1SHYA:THE CRYSTAL STRUCTURE OF HGF BETA-CHAIN IN COMPLEX WITH THE SEMA DOMAIN OF THE MET RECEPTOR.
1SI5H:PROTEASE-LIKE DOMAIN FROM 2-CHAIN HEPATOCYTE GROWTH FACTOR
(-)
Protein domain: Hepsin, catalytic domain (4)
(-)
Human (Homo sapiens) [TaxId: 9606] (4)
1O5EH:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1O5FH:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1P57B:EXTRACELLULAR DOMAIN OF HUMAN HEPSIN
1Z8GA:163-417CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE TRANSMEMBRANE SERINE PROTEASE HEPSIN WITH COVALENTLY BOUND PREFERRED SUBSTRATE.
(-)
Protein domain: HL collagenase (2)
(-)
Common cattle grub (Hypoderma lineatum) [TaxId: 7389] (2)
1HYLA:; B:THE 1.8 A STRUCTURE OF COLLAGENASE FROM HYPODERMA LINEATUM
2HLCA:; B:HL COLLAGENASE STRUCTURE AT 1.7A RESOLUTION
(-)
Protein domain: Kallikrein 6 (3)
(-)
Human (Homo sapiens) [TaxId: 9606] (3)
1GVLA:HUMAN PROKALLIKREIN 6 (HK6)/ PROZYME/ PROPROTEASE M/ PRONEUROSIN
1L2EA:HUMAN KALLIKREIN 6 (HK6) ACTIVE FORM WITH BENZAMIDINE INHIBITOR
1LO6A:HUMAN KALLIKREIN 6 (HK6) ACTIVE FORM WITH BENZAMIDINE INHIBITOR AT 1.56 A RESOLUTION
(-)
Protein domain: Kallikrein A (3)
(-)
Pig (Sus scrofa) [TaxId: 9823] (3)
1HIAA:,B:; X:,Y:KALLIKREIN COMPLEXED WITH HIRUSTASIN
2KAIA:,B:REFINED 2.5 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BY PORCINE KALLIKREIN A AND THE BOVINE PANCREATIC TRYPSIN INHIBITOR. CRYSTALLIZATION, PATTERSON SEARCH, STRUCTURE DETERMINATION, REFINEMENT, STRUCTURE AND COMPARISON WITH ITS COMPONENTS AND WITH THE BOVINE TRYPSIN-PANCREATIC TRYPSIN INHIBITOR COMPLEX
2PKAA:,B:; X:,Y:REFINED 2 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF PORCINE PANCREATIC KALLIKREIN A, A SPECIFIC TRYPSIN-LIKE SERINE PROTEINASE. CRYSTALLIZATION, STRUCTURE DETERMINATION, CRYSTALLOGRAPHIC REFINEMENT, STRUCTURE AND ITS COMPARISON WITH BOVINE TRYPSIN
(-)
Protein domain: Kallikrein-13 (1)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1AO5A:; B:MOUSE GLANDULAR KALLIKREIN-13 (PRORENIN CONVERTING ENZYME)
(-)
Protein domain: Mannan-binding lectin serine protease 2 (MASP-2), catalytic domain (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1Q3XA:445-686; B:445-686CRYSTAL STRUCTURE OF THE CATALYTIC REGION OF HUMAN MASP-2
1ZJKA:445-686CRYSTAL STRUCTURE OF THE ZYMOGEN CATALYTIC REGION OF HUMAN MASP-2
(-)
Protein domain: Matriptase MTSP1 (16)
(-)
Human (Homo sapiens) [TaxId: 9606] (16)
1EAWA:; C:CRYSTAL STRUCTURE OF THE MTSP1 (MATRIPTASE)-BPTI (APROTININ) COMPLEX
1EAXA:CRYSTAL STRUCTURE OF MTSP1 (MATRIPTASE)
2GV6A:CRYSTAL STRUCTURE OF MATRIPTASE WITH INHIBITOR CJ-730
2GV7A:STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR CJ-672
3BN9A:; B:CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
3NCLA:CRYSTAL STRUCTURE OF MT-SP1 BOUND TO BENZAMIDINE PHOSPHONATE INHIBITOR
3NPSA:CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3P8GA:CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH BENZAMIDINE
3SO3A:STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON-CANONICAL MECHANISM OF INHIBITION.
4IS5A:CRYSTAL STRUCTURE OF THE LIGAND-FREE INACTIVE MATRIPTASE
4ISLA:CRYSTAL STRUCTURE OF THE INACTIVE MATRIPTASE IN COMPLEX WITH ITS INHIBITOR HAI-1
4ISNA:CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH ITS INHIBITOR HAI-1
4ISOA:CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH ITS INHIBITOR HAI-1
4JYTA:CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR
4JZ1A:CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR
4JZIA:CRYSTAL STRUCTURE OF MATRIPTASE IN COMPLEX WITH INHIBITOR".
(-)
Protein domain: Myeloblastin, PR3 (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1FUJA:; B:; C:; D:PR3 (MYELOBLASTIN)
(-)
Protein domain: Neuropsin (1)
(-)
Mouse (Mus musculus) [TaxId: 10090] (1)
1NPMA:; B:NEUROPSIN, A SERINE PROTEASE EXPRESSED IN THE LIMBIC SYSTEM OF MOUSE BRAIN
(-)
Protein domain: Plasmin(ogen), catalytic domain (8)
(-)
Human (Homo sapiens) [TaxId: 9606] (8)
1BMLA:; B:COMPLEX OF THE CATALYTIC DOMAIN OF HUMAN PLASMIN AND STREPTOKINASE
1BUIA:; B:STRUCTURE OF THE TERNARY MICROPLASMIN-STAPHYLOKINASE-MICROPLASMIN COMPLEX: A PROTEINASE-COFACTOR-SUBSTRATE COMPLEX IN ACTION
1DDJA:; B:; C:; D:CRYSTAL STRUCTURE OF HUMAN PLASMINOGEN CATALYTIC DOMAIN
1L4DA:CRYSTAL STRUCTURE OF MICROPLASMINOGEN-STREPTOKINASE ALPHA DOMAIN COMPLEX
1L4ZA:X-RAY CRYSTAL STRUCTURE OF THE COMPLEX OF MICROPLASMINOGEN WITH ALPHA DOMAIN OF STREPTOKINASE IN THE PRESENCE CADMIUM IONS
1QRZA:; B:; C:; D:CATALYTIC DOMAIN OF PLASMINOGEN
1RJXB:HUMAN PLASMINOGEN CATALYTIC DOMAIN, K698M MUTANT
3UIRA:; B:CRYSTAL STRUCTURE OF THE PLASMIN-TEXTILININ-1 COMPLEX
(-)
Protein domain: Procarboxypeptidase A-S6 subunit III (zymogen E) (2)
(-)
Cow (Bos taurus) [TaxId: 9913] (2)
1FONA:; B:CRYSTAL STRUCTURE OF BOVINE PROCARBOXYPEPTIDASE A-S6 SUBUNIT III, A HIGHLY STRUCTURED TRUNCATED ZYMOGEN E
1PYTC:TERNARY COMPLEX OF PROCARBOXYPEPTIDASE A, PROPROTEINASE E, AND CHYMOTRYPSINOGEN C
(-)
Protein domain: Prostate specific antigen (PSA kallikrein) (1)
(-)
Horse (Equus caballus) [TaxId: 9796] (1)
1GVZA:PROSTATE SPECIFIC ANTIGEN (PSA) FROM STALLION SEMINAL PLASMA
(-)
Protein domain: Single chain tissue plasminogen activator (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1BDAA:; B:CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE)
(-)
Vampire bat (Desmodus rotundus) [TaxId: 9430] (1)
1A5IA:CATALYTIC DOMAIN OF VAMPIRE BAT (DESMODUS ROTUNDUS) SALIVA PLASMINOGEN ACTIVATOR IN COMPLEX WITH EGR-CMK (GLU-GLY-ARG CHLOROMETHYL KETONE)
(-)
Protein domain: Thrombin (188)
(-)
Cow (Bos taurus) [TaxId: 9913] (19)
1A0HA:271-320,B:; D:271-320,E:THE X-RAY CRYSTAL STRUCTURE OF PPACK-MEIZOTHROMBIN DESF1: KRINGLE/THROMBIN AND CARBOHYDRATE/KRINGLE/THROMBIN INTERACTIONS AND LOCATION OF THE LINKER CHAIN
1AVGL:,H:THROMBIN INHIBITOR FROM TRIATOMA PALLIDIPENNIS
1BBRL:,H:,E:; J:,K:; M:,N:THE STRUCTURE OF RESIDUES 7-16 OF THE A ALPHA CHAIN OF HUMAN FIBRINOGEN BOUND TO BOVINE THROMBIN AT 2.3 ANGSTROMS RESOLUTION
1BTHL:,H:; J:,K:STRUCTURE OF THROMBIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1ETRL:,H:REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS
1ETSL:,H:REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS
1ETTL:,H:REFINED 2.3 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEXES FORMED WITH THE BENZAMIDINE AND ARGININE-BASED THROMBIN INHIBITORS NAPAP, 4-TAPAP AND MQPA: A STARTING POINT FOR IMPROVING ANTITHROMBOTICS
1HRTL:,H:THE STRUCTURE OF A COMPLEX OF BOVINE ALPHA-THROMBIN AND RECOMBINANT HIRUDIN AT 2.8 ANGSTROMS RESOLUTION
1ID5L:,H:CRYSTAL STRUCTURE OF BOVINE THROMBIN COMPLEX WITH PROTEASE INHIBITOR ECOTIN
1MKWL:,H:; K:THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING
1MKXL:,H:; K:THE CO-CRYSTAL STRUCTURE OF UNLIGANDED BOVINE ALPHA-THROMBIN AND PRETHROMBIN-2: MOVEMENT OF THE YPPW SEGMENT AND ACTIVE SITE RESIDUES UPON LIGAND BINDING
1TBQL:,H:; J:,K:CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN
1TBRL:,H:; J:,K:CRYSTAL STRUCTURE OF INSECT DERIVED DOUBLE DOMAIN KAZAL INHIBITOR RHODNIIN IN COMPLEX WITH THROMBIN
1TOCA:,B:; C:,D:; E:,F:; G:,H:STRUCTURE OF SERINE PROTEINASE
1UCYL:,H:,E:; J:,K:; M:,N:THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A ALPHA (RESIDUES 7-19). THREE COMPLEXES, ONE WITH EPSILON-THROMBIN AND TWO WITH ALPHA-THROMBIN
1UVTL:,H:BOVINE THROMBIN--BM14.1248 COMPLEX
1UVUL:,H:BOVINE THROMBIN--BM12.1700 COMPLEX
1VITL:,H:; M:,F:,G:THROMBIN:HIRUDIN 51-65 COMPLEX
1YCPL:,H:; J:,K:,M:THE CRYSTAL STRUCTURE OF FIBRINOGEN-AA PEPTIDE 1-23 (F8Y) BOUND TO BOVINE THROMBIN EXPLAINS WHY THE MUTATION OF PHE-8 TO TYROSINE STRONGLY INHIBITS NORMAL CLEAVAGE AT ARGININE-16
(-)
Human (Homo sapiens) [TaxId: 9606] (169)
1A2CL:,H:STRUCTURE OF THROMBIN INHIBITED BY AERUGINOSIN298-A FROM A BLUE-GREEN ALGA
1A3BL:,H:COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG1
1A3EL:,H:COMPLEX OF HUMAN ALPHA-THROMBIN WITH THE BIFUNCTIONAL BORONATE INHIBITOR BOROLOG2
1A46L:,H:THROMBIN COMPLEXED WITH HIRUGEN AND A BETA-STRAND MIMETIC INHIBITOR
1A4WL:,H:CRYSTAL STRUCTURES OF THROMBIN WITH THIAZOLE-CONTAINING INHIBITORS: PROBES OF THE S1' BINDING SITE
1A5GL:,H:HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1A61L:,H:THROMBIN COMPLEXED WITH A BETA-MIMETIC THIAZOLE-CONTAINING INHIBITOR
1ABIL:,H:STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S' SUBSITES OF SUBSTRATES AND INHIBITORS
1ABJL:,H:STRUCTURE OF THE HIRULOG 3-THROMBIN COMPLEX AND NATURE OF THE S' SUBSITES OF SUBSTRATES AND INHIBITORS
1AD8L:,H:COMPLEX OF THROMBIN WITH AND INHIBITOR CONTAINING A NOVEL P1 MOIETY
1AE8L:,H:HUMAN ALPHA-THROMBIN INHIBITION BY EOC-D-PHE-PRO-AZALYS-ONP
1AFEL:,H:HUMAN ALPHA-THROMBIN INHIBITION BY CBZ-PRO-AZALYS-ONP
1AHTL:,H:CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND P-AMIDINOPHENYLPYRUVATE AT 1.6 ANGSTROMS RESOLUTION
1AI8L:,H:HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH THE EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROMPG
1AIXL:,H:HUMAN ALPHA-THROMBIN TERNARY COMPLEX WITH EXOSITE INHIBITOR HIRUGEN AND ACTIVE SITE INHIBITOR PHCH2OCO-D-DPA-PRO-BOROVAL
1AWFL:,H:NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT
1AWHA:,B:; C:,D:NOVEL COVALENT THROMBIN INHIBITOR FROM PLANT EXTRACT
1AY6L:,H:THROMBIN INHIBITOR FROM THEONALLA, CYCLOTHEANAMIDE-BASED MACROCYCLIC TRIPEPTIDE MOTIF
1B5GL:,H:HUMAN THROMBIN COMPLEXED WITH NOVEL SYNTHETIC PEPTIDE MIMETIC INHIBITOR AND HIRUGEN
1B7XA:,B:STRUCTURE OF HUMAN ALPHA-THROMBIN Y225I MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE
1BA8A:,B:THROMBIN INHIBITOR WITH A RIGID TRIPEPTIDYL ALDEHYDES
1BB0A:,B:THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
1BCUL:,H:ALPHA-THROMBIN COMPLEXED WITH HIRUGEN AND PROFLAVIN
1BHXA:,B:,F:X-RAY STRUCTURE OF THE COMPLEX OF HUMAN ALPHA THROMBIN WITH THE INHIBITOR SDZ 229-357
1BMML:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-4-[(AMINOIMINOMETHYL) AMINO]-N-[[1-[3-HYDROXY-2-[(2-NAPHTHALENYLSULFONYL)AMINO]-1-OXOPROPYL]-2-PYRROLIDINYL] METHYL]BUTANAMIDE (BMS-186282)
1BMNL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH [S-(R*,R*)]-1-(AMINOIMINOMETHYL)-N-[[1-[N-[(2-NAPHTHALENYLSULFONYL)-L-SERYL]-PYRROLIDINYL]METHYL]-3-PIPERIDENECARBOXAMIDE (BMS-189090)
1C1UL:,H:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1VL:,H:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1WL:,H:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C4U1:,2:SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.
1C4V1:,2:SELECTIVE NON ELECTROPHILIC THROMBIN INHIBITORS WITH CYCLOHEXYL MOIETIES.
1C4Y1:,2:SELECTIVE NON-ELECTROPHILIC THROMBIN INHIBITORS
1C5LL:,H:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5NL:,H:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5OL:,H:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1CA8A:,B:THROMBIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
1D3DA:,B:CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZOTHIOPHENE INHIBITOR 4
1D3PA:,B:CRYSTAL STRUCTURE OF HUMAN APLHA-THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 3
1D3QA:,B:CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 2
1D3TA:,B:CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH BENZO[B]THIOPHENE INHIBITOR 1
1D4PA:,B:CRYSTAL STRUCTURE OF HUMAN ALPHA THROMBIN IN COMPLEX WITH 5-AMIDINOINDOLE-4-BENZYLPIPERIDINE INHIBITOR
1D6WA:STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTROPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1
1D9IA:STRUCTURE OF THROMBIN COMPLEXED WITH SELECTIVE NON-ELECTOPHILIC INHIBITORS HAVING CYCLOHEXYL MOIETIES AT P1
1DE7L:,H:; J:,K:INTERACTION OF FACTOR XIII ACTIVATION PEPTIDE WITH ALPHA-THROMBIN: CRYSTAL STRUCTURE OF THE ENZYME-SUBSTRATE COMPLEX
1DITL:,H:COMPLEX OF A DIVALENT INHIBITOR WITH THROMBIN
1DM4A:,B:SER195ALA MUTANT OF HUMAN THROMBIN COMPLEXED WITH FIBRINOPEPTIDE A (7-16)
1DOJA:CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN*RWJ-51438 COMPLEX AT 1.7 A
1DWBL:,H:CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS
1DWCL:,H:CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS
1DWDL:,H:CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS
1DWEL:,H:CRYSTALLOGRAPHIC ANALYSIS AT 3.0-ANGSTROMS RESOLUTION OF THE BINDING TO HUMAN THROMBIN OF FOUR ACTIVE SITE-DIRECTED INHIBITORS
1DX5A:,M:; B:,N:; C:,O:; D:,P:CRYSTAL STRUCTURE OF THE THROMBIN-THROMBOMODULIN COMPLEX
1E0FA:,D:; B:,E:; C:,F:CRYSTAL STRUCTURE OF THE HUMAN ALPHA-THROMBIN-HAEMADIN COMPLEX: AN EXOSITE II-BINDING INHIBITOR
1EB1L:,H:COMPLEX STRUCTURE OF HUMAN THROMBIN WITH N-METHYL-ARGININE INHIBITOR
1EOJA:DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES
1EOLA:DESIGN OF P1' AND P3' RESIDUES OF TRIVALENT THROMBIN INHIBITORS AND THEIR CRYSTAL STRUCTURES
1FPCL:,H:ACTIVE SITE MIMETIC INHIBITION OF THROMBIN
1FPHL:,H:THE INTERACTION OF THROMBIN WITH FIBRINOGEN: A STRUCTURAL BASIS FOR ITS SPECIFICITY
1G30A:,B:THROMBIN INHIBITOR COMPLEX
1G32A:,B:THROMBIN INHIBITOR COMPLEX
1G37A:CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN COMPLEXED WITH BCH-10556 AND EXOSITE-DIRECTED PEPTIDE
1GHVL:,H:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GHWL:,H:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GHXL:,H:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GHYL:,H:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GJ4L:,H:SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN
1GJ5L:,H:SELECTIVITY AT S1, H2O DISPLACEMENT, UPA, TPA, SER190/ALA190 PROTEASE, STRUCTURE-BASED DRUG DESIGN
1H8DL:,H:X-RAY STRUCTURE OF THE HUMAN ALPHA-THROMBIN COMPLEX WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.
1H8IL:,H:X-RAY CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN WITH A TRIPEPTIDE PHOSPHONATE INHIBITOR.
1HAGE:THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN
1HAHL:,H:THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN
1HAIL:,H:THE ISOMORPHOUS STRUCTURES OF PRETHROMBIN2, HIRUGEN-AND PPACK-THROMBIN: CHANGES ACCOMPANYING ACTIVATION AND EXOSITE BINDING TO THROMBIN
1HAOL:,H:COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON NMR MODEL OF DNA)
1HAPL:,H:COMPLEX OF HUMAN ALPHA-THROMBIN WITH A 15MER OLIGONUCLEOTIDE GGTTGGTGTGGTTGG (BASED ON X-RAY MODEL OF DNA)
1HBTL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH A PEPTIDYL PYRIDINIUM METHYL KETONE CONTAINING BIVALENT INHIBITOR
1HDTL:,H:STRUCTURE OF A RETRO-BINDING PEPTIDE INHIBITOR COMPLEXED WITH HUMAN ALPHA-THROMBIN
1HGTL:,H:STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN
1HLTL:,H:; J:,K:THE STRUCTURE OF A NONADECAPEPTIDE OF THE FIFTH EGF DOMAIN OF THROMBOMODULIN COMPLEXED WITH THROMBIN
1HUTL:,H:THE STRUCTURE OF ALPHA-THROMBIN INHIBITED BY A 15-MER SINGLE-STRANDED DNA APTAMER
1HXEL:,H:SERINE PROTEASE
1HXFL:,H:HUMAN THROMBIN COMPLEX WITH HIRUDIN VARIANT
1IHSL:,H:CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON-HYDROLYZABLE BIFUNCTIONAL INHIBITORS, HIRUTONIN-2 AND HIRUTONIN-6
1IHTL:,H:CRYSTAL STRUCTURE OF THE COMPLEX OF HUMAN ALPHA-THROMBIN AND NON-HYDROLYZABLE BIFUNCTIONAL INHIBITORS, HIRUTONIN-2 AND HIRUTONIN-6
1JMOL:,H:CRYSTAL STRUCTURE OF THE HEPARIN COFACTOR II-S195A THROMBIN COMPLEX
1JOUA:,B:; C:,D:; E:,F:CRYSTAL STRUCTURE OF NATIVE S195A THROMBIN WITH AN UNOCCUPIED ACTIVE SITE
1JWTA:CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH A NOVEL BICYCLIC LACTAM INHIBITOR
1K21L:,H:HUMAN THROMBIN-INHIBITOR COMPLEX
1K22L:,H:HUMAN THROMBIN-INHIBITOR COMPLEX
1KTSA:,B:THROMBIN INHIBITOR COMPLEX
1KTTA:,B:THROMBIN INHIBITOR COMPLEX
1LHCL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROARG-OH
1LHDL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROLYS-OH
1LHEL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-N-BUTYL-AMIDINO-GLYCINE-OH
1LHFL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BORO-HOMOLYS-OH
1LHGL:,H:HUMAN ALPHA-THROMBIN COMPLEXED WITH AC-(D)PHE-PRO-BOROORNITHINE-OH
1MH0A:; B:CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN
1MU6A:,B:CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH L-378,622
1MU8A:,B:THROMBIN-HIRUGEN_L-378,650
1MUEA:,B:THROMBIN-HIRUGEN-L405,426
1NM6A:THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR AT 1.8A
1NO9L:,H:DESIGN OF WEAKLY BASIC THROMBIN INHIBITORS INCORPORATING NOVEL P1 BINDING FUNCTIONS: MOLECULAR AND X-RAY CRYSTALLOGRAPHIC STUDIES.
1NRNL:,H:CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES
1NROL:,H:CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES
1NRPL:,H:CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES
1NRQL:,H:CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES
1NRRL:,H:CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES
1NRSL:,H:CRYSTALLOGRAPHIC STRUCTURES OF THROMBIN COMPLEXED WITH THROMBIN RECEPTOR PEPTIDES: EXISTENCE OF EXPECTED AND NOVEL BINDING MODES
1NT1A:THROMBIN IN COMPLEX WITH SELECTIVE MACROCYCLIC INHIBITOR
1NU7A:,B:; E:,F:STAPHYLOCOAGULASE-THROMBIN COMPLEX
1NU9A:; D:STAPHYLOCOAGULASE-PRETHROMBIN-2 COMPLEX
1NY21:,2:HUMAN ALPHA THROMBIN INHIBITED BY RPPGF AND HIRUGEN
1NZQL:,H:D-PHE-PRO-ARG-TYPE THROMBIN INHIBITOR
1O0DL:,H:HUMAN THROMBIN COMPLEXED WITH A D-PHE-PRO-ARG-TYPE INHIBITOR AND A C-TERMINAL HIRUDIN DERIVED EXO-SITE INHIBITOR
1O2GL:,H:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O5GL:,H:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1OOKA:,B:CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND HUMAN ALPHA-THROMBIN
1OYTL:,H:COMPLEX OF RECOMBINANT HUMAN THROMBIN WITH A DESIGNED FLUORINATED INHIBITOR
1P8VB:,C:CRYSTAL STRUCTURE OF THE COMPLEX OF PLATELET RECEPTOR GPIB-ALPHA AND ALPHA-THROMBIN AT 2.6A
1PPBL:,H:THE REFINED 1.9 ANGSTROMS CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN: INTERACTION WITH D-PHE-PRO-ARG CHLOROMETHYLKETONE AND SIGNIFICANCE OF THE TYR-PRO-PRO-TRP INSERTION SEGMENT
1QBVL:,H:CRYSTAL STRUCTURE OF THROMBIN COMPLEXED WITH AN GUANIDINE-MIMETIC INHIBITOR
1QHRA:,B:NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1QJ1A:,B:NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1QJ6A:,B:NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1QJ7A:,B:NOVEL COVALENT ACTIVE SITE THROMBIN INHIBITORS
1QURL:,H:HUMAN ALPHA-THROMBIN IN COMPLEX WITH BIVALENT, BENZAMIDINE-BASED SYNTHETIC INHIBITOR
1RD3A:,B:; C:,D:2.5A STRUCTURE OF ANTICOAGULANT THROMBIN VARIANT E217K
1RIWA:,B:,C:THROMBIN IN COMPLEX WITH NATURAL PRODUCT INHIBITOR OSCILLARIN
1SB1L:,H:NOVEL NON-COVALENT THROMBIN INHIBITORS INCORPORATING P1 4,5,6,7-TETRAHYDROBENZOTHIAZOLE ARGININE SIDE CHAIN MIMETICS
1SFQA:,B:; D:,E:FAST FORM OF THROMBIN MUTANT R(77A)A BOUND TO PPACK
1SG8A:,B:; D:,E:CRYSTAL STRUCTURE OF THE PROCOAGULANT FAST FORM OF THROMBIN
1SGIA:,B:; D:,E:CRYSTAL STRUCTURE OF THE ANTICOAGULANT SLOW FORM OF THROMBIN
1SHHA:,B:; D:,E:SLOW FORM OF THROMBIN BOUND WITH PPACK
1SL3A:CRYSTAL STRUCTUE OF THROMBIN IN COMPLEX WITH A POTENT P1 HETEROCYCLE-ARYL BASED INHIBITOR
1SR5B:,C:ANTITHROMBIN-ANHYDROTHROMBIN-HEPARIN TERNARY COMPLEX STRUCTURE
1TA2A:CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 1
1TA6A:CRYSTAL STRUCTURE OF THROMBIN IN COMPLEX WITH COMPOUND 14B
1TB6L:,H:2.5A CRYSTAL STRUCTURE OF THE ANTITHROMBIN-THROMBIN-HEPARIN TERNARY COMPLEX
1TBZL:,H:HUMAN THROMBIN WITH ACTIVE SITE N-METHYL-D PHENYLALANYL-N-[5-(AMINOIMINOMETHYL)AMINO]-1-{{BENZOTHIAZOLYL)CARBONYL] BUTYL]-L-PROLINAMIDE TRIFLUROACETATE AND EXOSITE-HIRUGEN
1THPA:,B:STRUCTURE OF HUMAN ALPHA-THROMBIN Y225P MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE
1THRL:,H:STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR
1THSL:,H:STRUCTURES OF THROMBIN COMPLEXES WITH A DESIGNED AND A NATURAL EXOSITE INHIBITOR
1TMBL:,H:MOLECULAR BASIS FOR THE INHIBITION OF HUMAN ALPHA-THROMBIN BY THE MACROCYCLIC PEPTIDE CYCLOTHEONAMIDE A
1TMTL:,H:CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS
1TMUL:,H:CHANGES IN INTERACTIONS IN COMPLEXES OF HIRUDIN DERIVATIVES AND HUMAN ALPHA-THROMBIN DUE TO DIFFERENT CRYSTAL FORMS
1TOML:,H:ALPHA-THROMBIN COMPLEXED WITH HIRUGEN
1TQ0A:,B:; C:,D:CRYSTAL STRUCTURE OF THE POTENT ANTICOAGULANT THROMBIN MUTANT W215A/E217A IN FREE FORM
1TQ7A:,B:CRYSTAL STRUCTURE OF THE ANTICOAGULANT THROMBIN MUTANT W215A/E217A BOUND TO PPACK
1UMAL:,H:ALPHA-THROMBIN (HIRUGEN) COMPLEXED WITH NA-(N,N-DIMETHYLCARBAMOYL)-ALPHA-AZALYSINE
1UVSL:,H:BOVINE THROMBIN--BM51.1011 COMPLEX
1VR1L:,H:SPECIFITY FOR PLASMINOGEN ACTIVATOR INHIBITOR-1
1XM1A:NONBASIC THROMBIN INHIBITOR COMPLEX
1XMNA:,B:; C:,D:; E:,F:; G:,H:CRYSTAL STRUCTURE OF THROMBIN BOUND TO HEPARIN
2A45A:,B:; D:,E:CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN THROMBIN AND THE CENTRAL "E" REGION OF FIBRIN
2HGTL:,H:STRUCTURE OF THE HIRUGEN AND HIRULOG 1 COMPLEXES OF ALPHA-THROMBIN
2HNTL:,C:,E:,F:CRYSTALLOGRAPHIC STRUCTURE OF HUMAN GAMMA-THROMBIN
2HPPL:,H:STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN FRAGMENT 2 WITH HUMAN PPACK-THROMBIN
2HPQL:,H:STRUCTURES OF THE NONCOVALENT COMPLEXES OF HUMAN AND BOVINE PROTHROMBIN FRAGMENT 2 WITH HUMAN PPACK-THROMBIN
2THFA:,B:STRUCTURE OF HUMAN ALPHA-THROMBIN Y225F MUTANT BOUND TO D-PHE-PRO-ARG-CHLOROMETHYLKETONE
3HATL:,H:ACTIVE SITE MIMETIC INHIBITION OF THROMBIN
3HTCL:,H:THE STRUCTURE OF A COMPLEX OF RECOMBINANT HIRUDIN AND HUMAN ALPHA-THROMBIN
3K65B:CRYSTAL STRUCTURE OF PRETHOMBIN-2/FRAGMENT-2 COMPLEX
3SQEE:CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT S195A IN THE ALTERNATIVE FORM
4H6TA:CRYSTAL STRUCTURE OF PRETHROMBIN-2 MUTANT E14EA/D14LA/E18A/S195A
4HFY  [entry was replaced by entry 4RN6 without any SCOP domain information]
4HTCL:,H:THE REFINED STRUCTURE OF THE HIRUDIN-THROMBIN COMPLEX
4THNL:,H:THE CRYSTAL STRUCTURE OF ALPHA-THROMBIN-HIRUNORM IV COMPLEX REVEALS A NOVEL SPECIFICITY SITE RECOGNITION MODE.
5GDSL:,H:HIRUNORMS ARE TRUE HIRUDIN MIMETICS. THE CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN:HIRUNORM V COMPLEX
7KMEL:,H:CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2711.
8KME1:,2:CRYSTAL STRUCTURE OF HUMAN ALPHA-THROMBIN INHIBITED WITH SEL2770.
(-)
Protein domain: Tonin (1)
(-)
Rat (Rattus rattus) [TaxId: 10117] (1)
1TONA:RAT SUBMAXILLARY GLAND SERINE PROTEASE, TONIN. STRUCTURE SOLUTION AND REFINEMENT AT 1.8 ANGSTROMS RESOLUTION
(-)
Protein domain: Trypsin(ogen) (500)
(-)
Atlantic salmon (Salmo salar) [TaxId: 8030] (11)
1A0JA:; B:; C:; D:CRYSTAL STRUCTURE OF A NON-PSYCHROPHILIC TRYPSIN FROM A COLD-ADAPTED FISH SPECIES.
1BITA:THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN A SECOND CRYSTAL FORM
1BZXE:THE CRYSTAL STRUCTURE OF ANIONIC SALMON TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1HJ8A:1.00 AA TRYPSIN FROM ATLANTIC SALMON
1UTJA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1UTKA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1UTLM:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1UTMA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
2STAE:ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA MAXIMA TRYPSIN INHIBITOR I)
2STBE:ANIONIC SALMON TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II)
2TBSA:COLD-ADAPTION OF ENZYMES: STRUCTURAL COMPARISON BETWEEN SALMON AND BOVINE TRYPSINS
(-)
Chum salmon (Oncorhynchus keta) [TaxId: 8018] (1)
1MBQA:ANIONIC TRYPSIN FROM PACIFIC CHUM SALMON
(-)
Cow (Bos taurus) [TaxId: 9913] (392)
1AQ7A:TRYPSIN WITH INHIBITOR AERUGINOSIN 98-B
1AUJA:BOVINE TRYPSIN COMPLEXED TO META-CYANO-BENZYLIC INHIBITOR
1AZ8A:BOVINE TRYPSIN COMPLEXED TO BIS-PHENYLAMIDINE INHIBITOR
1BJUA:BETA-TRYPSIN COMPLEXED WITH ACPU
1BJVA:BETA-TRYPSIN COMPLEXED WITH APPU
1BTPA:UNIQUE BINDING OF A NOVEL SYNTHETIC INHIBITOR, N-[3-[4-[4-(AMIDINOPHENOXY)-CARBONYL]PHENYL]-2-METHYL-2-PROPENOYL]-N-ALLYLGLYCINE METHANESULFONATE TO BOVINE TRYPSIN, REVEALED BY THE CRYSTAL STRUCTURE OF THE COMPLEX
1BTWA:EPISELECTION: NOVEL KI ~NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE
1BTXA:EPISELECTION: NOVEL KI ~NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE
1BTYA:CRYSTAL STRUCTURE OF BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE
1BTZA:EPISELECTION: NOVEL KI ~NANOMOLAR INHIBITORS OF SERINE PROTEASES SELECTED BY BINDING OR CHEMISTRY ON AN ENZYME SURFACE
1C1NA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1OA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1PA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1QA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1RA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1SA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C1TA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2DA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2EA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2FA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2GA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2HA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2IA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2JA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2KA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2LA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C2MA:RECRUITING ZINC TO MEDIATE POTENT, SPECIFIC INHIBITION OF SERINE PROTEASES
1C5PA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5QA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5RA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5SA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5TA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5UA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5VA:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C9TA:; B:; C:; D:; E:; F:COMPLEX OF BDELLASTASIN WITH BOVINE TRYPSIN
1CE5A:BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZAMIDINE
1D6RA:CRYSTAL STRUCTURE OF CANCER CHEMOPREVENTIVE BOWMAN-BIRK INHIBITOR IN TERNARY COMPLEX WITH BOVINE TRYPSIN AT 2.3 A RESOLUTION. STRUCTURAL BASIS OF JANUS-FACED SERINE PROTEASE INHIBITOR SPECIFICITY
1EB2A:TRYPSIN INHIBITOR COMPLEX (BPO)
1EJMA:; C:; E:CRYSTAL STRUCTURE OF THE BPTI ALA16LEU MUTANT IN COMPLEX WITH BOVINE TRYPSIN
1EZXC:CRYSTAL STRUCTURE OF A SERPIN:PROTEASE COMPLEX
1F0TA:BOVINE TRYPSIN COMPLEXED WITH RPR131247
1F0UA:BOVINE TRYPSIN COMPLEXED WITH RPR128515
1F2SE:CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY AT 1.8 A RESOLUTION
1G36A:TRYPSIN INHIBITOR COMPLEX
1G3BA:BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE MAGNESIUM(II) CHELATE
1G3CA:BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF BASE IRON(III) CHELATE
1G3DA:BOVINE BETA-TRYPSIN BOUND TO META-AMIDINO SCHIFF BASE COPPER (II) CHELATE
1G3EA:BOVINE BETA-TRYPSIN BOUND TO PARA-AMIDINO SCHIFF-BASE COPPER (II) CHELATE
1G9IE:CRYSTAL STRUCTURE OF BETA-TRYSIN COMPLEX IN CYCLOHEXANE
1GBTA:STRUCTURE OF AN ACYL-ENZYME INTERMEDIATE DURING CATALYSIS: (GUANIDINOBENZOYL) TRYPSIN
1GHZA:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI0A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI1A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI2A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI3A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI4A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI5A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI6A:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GJ6A:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1HJ9A:ATOMIC RESOLUTION STRUCTURES OF TRYPSIN PROVIDE INSIGHT INTO STRUCTURAL RADIATION DAMAGE
1J8AA:CRYSTAL STRUCTURE OF BENZAMIDINE INHIBITED BOVINE PANCREATIC TRYPSIN AT 105K TO 1.21A RESOLUTION FROM LABORATORY SOURCE WITH HIGH NUMBER OF WATERS MODELLED
1JIRA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEX WITH AMYLAMINE IN CYCLOHEXANE
1JRSA:HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN
1JRTA:HEMIACETAL COMPLEX BETWEEN LEUPEPTIN AND TRYPSIN
1K1IA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1K1JA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1K1LA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1K1MA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1K1NA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1K1OA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1K1PA:BOVINE TRYPSIN-INHIBITOR COMPLEX
1LQEA:CRYSTAL STRUCTURE OF TRYPSIN IN COMPLEX WITH 79.
1MAXA:BETA-TRYPSIN PHOSPHONATE INHIBITED
1MAYA:BETA-TRYPSIN PHOSPHONATE INHIBITED
1MTSA:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
1MTUA:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
1MTVA:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
1MTWA:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
1N6XA:RIP-PHASING ON BOVINE TRYPSIN
1N6YA:RIP-PHASING ON BOVINE TRYPSIN
1NC6A:POTENT, SMALL MOLECULE INHIBITORS OF HUMAN MAST CELL TRYPTASE. ANTI-ASTHMATIC ACTION OF A DIPEPTIDE-BASED TRANSITION STATE ANALOGUE CONTAINING BENZOTHIAZOLE KETONE
1NTPA:USE OF THE NEUTRON DIFFRACTION H/D EXCHANGE TECHNIQUE TO DETERMINE THE CONFORMATIONAL DYNAMICS OF TRYPSIN
1O2HA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2IA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2JA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2KA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2LA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2MA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2NA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2OA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2PA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2QA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2RA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2SA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2TA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2UA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2VA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2WA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2XA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2YA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O2ZA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O30A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O31A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O32A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O33A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O34A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O35A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O36A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O37A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O38A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O39A:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3AA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3BA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3CA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3DA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3EA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3FA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3GA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3HA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3IA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3JA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3KA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3LA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3MA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3NA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O3OA:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1OPHB:NON-COVALENT COMPLEX BETWEEN ALPHA-1-PI-PITTSBURGH AND S195A TRYPSIN
1OX1A:CRYSTAL STRUCTURE OF THE BOVINE TRYPSIN COMPLEX WITH A SYNTHETIC 11 PEPTIDE INHIBITOR
1OYQA:TRYPSIN INHIBITOR COMPLEX
1P2IA:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1P2JA:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1P2KA:STRUCTURAL CONSEQUENCES OF ACCOMMODATION OF FOUR NON-COGNATE AMINO-ACID RESIDUES IN THE S1 POCKET OF BOVINE TRYPSIN AND CHYMOTRYPSIN
1PPCE:GEOMETRY OF BINDING OF THE BENZAMIDINE-AND ARGININE-BASED INHIBITORS N-ALPHA-(2-NAPHTHYL-SULPHONYL-GLYCYL)-DL-P-AMIDINOPHENYLALANYL-PIPERIDINE (NAPAP) AND (2R,4R)-4-METHYL-1-[N-ALPHA-(3-METHYL-1,2,3,4-TETRAHYDRO-8-QUINOLINESULPHONYL)-L-ARGINYL]-2-PIPERIDINE CARBOXYLIC ACID (MQPA) TO HUMAN ALPHA-THROMBIN: X-RAY CRYSTALLOGRAPHIC DETERMINATION OF THE NAPAP-TRYPSIN COMPLEX AND MODELING OF NAPAP-THROMBIN AND MQPA-THROMBIN
1PPEE:THE REFINED 2.0 ANGSTROMS X-RAY CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE BETA-TRYPSIN AND CMTI-I, A TRYPSIN INHIBITOR FROM SQUASH SEEDS (CUCURBITA MAXIMA): TOPOLOGICAL SIMILARITY OF THE SQUASH SEED INHIBITORS WITH THE CARBOXYPEPTIDASE A INHIBITOR FROM POTATOES
1QA0A:BOVINE TRYPSIN 2-AMINOBENZIMIDAZOLE COMPLEX
1QB1A:BOVINE TRYPSIN WITH 1-[2-[5-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1-METHYL-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDIN-4-YL]PIPERIDINE-3-CARBOXYLIC ACID (ZK-806974)
1QB6A:BOVINE TRYPSIN 3,3'-[3,5-DIFLUORO-4-METHYL-2, 6-PYRIDINEDIYLBIS(OXY)]BIS(BENZENECARBOXIMIDAMIDE) (ZK-805623) COMPLEX
1QB9A:BOVINE TRYPSIN 7-[[2-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-9H-CARBOZOL-9-YL] METHYL]NAPHTHALENE-2-CARBOXIMIDAMIDE (ZK-806450) COMPLEX
1QBNA:BOVINE TRYPSIN 2-[AMINO(IMINO)METHYL]-2-HYDROXYPHENOXY]-6-[3-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENOXY]PYRIDINE-4-CARBOXYLIC ACID (ZK-806688) COMPLEX
1QBOA:BOVINE TRYPSIN 7-[[6-[[1-(1-IMINOETHYL)PIPERIDIN-4-YL]OXY]-2-METHYL-BENZIMIDAZOL-1-YL]METHYL]NAPHTHALENE-2-CARBOXIMIDAMID ZK-806711 INHIBITOR COMPLEX
1QCPA:CRYSTAL STRUCTURE OF THE RWJ-51084 BOVINE PANCREATIC BETA-TRYPSIN AT 1.8 A
1QL7A:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
1QL8A:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
1RXPA:STRUCTURE OF TRYPSIN (ORTHORHOMBIC) WITH 1-(4-TERT-BUTYLCARBAMOYL- PIPERAZINE-1-CARBONYL)-3-(3-GUANIDINO-PROPYL)-4-OXO-AZETIDINE-2-CARBOXYLIC ACID
1S0QA:NATIVE BOVINE PANCREATIC TRYPSIN
1S0RA:BOVINE PANCREATIC TRYPSIN INHIBITED WITH BENZAMIDINE AT ATOMIC RESOLUTION
1SBWA:CRYSTAL STRUCTURE OF MUNG BEAN INHIBITOR LYSINE ACTIVE FRAGMENT COMPLEX WITH BOVINE BETA-TRYPSIN AT 1.8A RESOLUTION
1SFIA:HIGH RESOLUTION STRUCTURE OF A POTENT, CYCLIC PROTEASE INHIBITOR FROM SUNFLOWER SEEDS
1SMFE:STUDIES ON AN ARTIFICIAL TRYPSIN INHIBITOR PEPTIDE DERIVED FROM THE MUNG BEAN INHIBITOR
1TABE:STRUCTURE OF THE TRYPSIN-BINDING DOMAIN OF BOWMAN-BIRK TYPE PROTEASE INHIBITOR AND ITS INTERACTION WITH TRYPSIN
1TAWA:BOVINE TRYPSIN COMPLEXED TO APPI
1TGBA:CRYSTAL STRUCTURE OF BOVINE TRYPSINOGEN AT 1.8 ANGSTROMS RESOLUTION. II. CRYSTALLOGRAPHIC REFINEMENT, REFINED CRYSTAL STRUCTURE AND COMPARISON WITH BOVINE TRYPSIN
1TGCA:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
1TGNA:STRUCTURE OF BOVINE TRYPSINOGEN AT 1.9 ANGSTROMS RESOLUTION
1TGSZ:THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN PANCREATIC SECRETORY INHIBITOR (KAZAL TYPE) AND TRYPSINOGEN AT 1.8 ANGSTROMS RESOLUTION. STRUCTURE SOLUTION, CRYSTALLOGRAPHIC REFINEMENT AND PRELIMINARY STRUCTURAL INTERPRETATION
1TGTA:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
1TIOA:HIGH PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE
1TLDA:CRYSTAL STRUCTURE OF BOVINE BETA-TRYPSIN AT 1.5 ANGSTROMS RESOLUTION IN A CRYSTAL FORM WITH LOW MOLECULAR PACKING DENSITY. ACTIVE SITE GEOMETRY, ION PAIRS AND SOLVENT STRUCTURE
1TNGA:PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS
1TNHA:PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS
1TNIA:PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS
1TNJA:PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS
1TNKA:PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS
1TNLA:PREDICTION OF NOVEL SERINE PROTEASE INHIBITORS
1TPAE:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
1TPOA:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
1TPPA:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
1TPSA:ATOMIC STRUCTURE OF THE TRYPSIN-A90720A COMPLEX: A UNIFIED APPROACH TO STRUCTURE AND FUNCTION
1TX7A:BOVINE TRYPSIN COMPLEXED WITH P-AMIDINOPHENYLMETHYLPHOSPHINIC ACID (AMPA)
1TX8A:BOVINE TRYPSIN COMPLEXED WITH AMSO
1TYNA:ATOMIC STRUCTURE OF THE TRYPSIN-CYCLOTHEONAMIDE A COMPLEX: LESSONS FOR THE DESIGN OF SERINE PROTEASE INHIBITORS
1UTNA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1UTOA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1UTPA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1UTQA:TRYPSIN SPECIFICITY AS ELUCIDATED BY LIE CALCULATIONS, X-RAY STRUCTURES AND ASSOCIATION CONSTANT MEASUREMENTS
1V2JT:BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI) BT.C1
1V2KT:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.D2
1V2LT:BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.D1
1V2MT:BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(TRIPLE.GLU)BT.A1
1V2NT:POTENT FACTOR XA INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(99/175/190)BT
1V2OT:TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSYI)BT.B4
1V2PT:TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSYI)BT.A4
1V2QT:TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSWI)BT.B4
1V2RT:TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSRI)BT.B4
1V2ST:BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSFI.GLU)BT.D1
1V2TT:TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSFI.GLU)BT.B4
1V2UT:BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARINAT X(SSAI) BT.D1
1V2VT:BENZAMIDINE IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSAI) BT.C1
1V2WT:TRYPSIN INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN VARIANT X(SSAI)BT.B4
1XUFA:TRYPSIN-BABIM-ZN+2, PH 8.2
1XUGA:TRYPSIN-BABIM-ZN+2, PH 8.2
1XUHA:TRYPSIN-KETO-BABIM-CO+2, PH 8.2
1XUIA:TRYPSIN-KETO-BABIM, ZN+2-FREE, PH 8.2
1XUJA:TRYPSIN-KETO-BABIM-ZN+2, PH 8.2
1XUKA:TRYPSIN-BABIM-SULFATE, PH 5.9
1Y3UA:TRYPSIN INHIBITOR COMPLEX
1Y3VA:TRYPSIN INHIBITOR COMPLEX
1Y3WA:TRYPSIN INHIBITOR COMPLEX
1Y3XA:TRYPSIN INHIBITOR COMPLEX
1Y3YA:TRYPSIN INHIBITOR COMPLEX
1Y59T:DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
1Y5AT:DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
1Y5BT:DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
1Y5UT:DIANHYDROSUGAR-BASED BENZAMIDINE, FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN MUTANT
1YP9A:TRYPSIN INHIBITOR COMPLEX
1YYY1:TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
1ZR0A:; C:CRYSTAL STRUCTURE OF KUNITZ DOMAIN 1 OF TISSUE FACTOR PATHWAY INHIBITOR-2 WITH BOVINE TRYPSIN
1ZZZA:TRYPSIN INHIBITORS WITH RIGID TRIPEPTIDYL ALDEHYDES
2A7HA:ON THE ROUTINE USE OF SOFT X-RAYS IN MACROMOLECULAR CRYSTALLOGRAPHY, PART III- THE OPTIMAL DATA COLLECTION WAVELENGTH
2AGEX:SUCCINYL-AAPR-TRYPSIN ACYL-ENZYME AT 1.15 A RESOLUTION
2AGGX:SUCCINYL-AAPK-TRYPSIN ACYL-ENZYME AT 1.28 A RESOLUTION
2AGIX:THE LEUPEPTIN-TRYPSIN COVALENT COMPLEX AT 1.14 A RESOLUTION
2AH4X:GUANIDINOBENZOYL-TRYPSIN ACYL-ENZYME AT 1.13 A RESOLUTION
2AYWA:CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN TRYPSIN AND A DESIGNED SYNTHETIC HIGHLY POTENT INHIBITOR IN THE PRESENCE OF BENZAMIDINE AT 0.97 A RESOLUTION
2BLVA:TRYPSIN BEFORE A HIGH DOSE X-RAY "BURN"
2BLWA:TRYPSIN AFTER A HIGH DOSE X-RAY "BURN"
2BTCE:BOVINE TRYPSIN IN COMPLEX WITH SQUASH SEED INHIBITOR (CUCURBITA PEPO TRYPSIN INHIBITOR II)
2BZAA:BOVINE PANCREAS BETA-TRYPSIN IN COMPLEX WITH BENZYLAMINE
2CMYA:CRYSTAL COMPLEX BETWEEN BOVINE TRYPSIN AND VERONICA HEDERIFOLIA TRYPSIN INHIBITOR
2D8WA:STRUCTURE OF HYPER-VIL-TRYPSIN
2F3CE:CRYSTAL STRUCTURE OF INFESTIN 1, A KAZAL-TYPE SERINEPROTEASE INHIBITOR, IN COMPLEX WITH TRYPSIN
2FI3E:CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER, CYS38->SER) IN COMPLEX WITH TRYPSIN
2FI4E:CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS14->SER) IN COMPLEX WITH TRYPSIN
2FI5E:CRYSTAL STRUCTURE OF A BPTI VARIANT (CYS38->SER) IN COMPLEX WITH TRYPSIN
2FTLE:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BPTI AT 100K
2FTMA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH THE BPTI VARIANT (TYR35->GLY)
2FX4A:BOVINE TRYPSIN BOUND BY 4-PIPERIDINEBUTYRATE TO MAKE ACYLENZYME COMPLEX
2FX6A:BOVINE TRYPSIN COMPLEXED WITH 2-AMINOBENZAMIDAZOLE
2G55A:ANOMALOUS SUBSTRUCTURE OF TRYPSIN (P3121)
2G5NA:INDOLE-AMIDINE COMPLEXES WITH BOVINE TRYPSIN
2G5VA:INDOLE-AMIDINE COMPLEXES WITH BOVINE TRYPSIN
2G81E:CRYSTAL STRUCTURE OF THE BOWMAN-BIRK INHIBITOR FROM VIGNA UNGUICULATA SEEDS IN COMPLEX WITH BETA-TRYPSIN AT 1.55 ANGSTRONS RESOLUTION
2G8TA:INDOLE-AMIDINE COMPLEXES WITH BOVINE TRYPSIN
2ILNA:; B:CRYSTAL STRUCTURE OF THE BOWMAN-BIRK INHIBITOR FROM SNAIL MEDIC SEEDS IN COMPLEX WITH BOVINE TRYPSIN
2J9NA:ROBOTICALLY HARVESTED TRYPSIN COMPLEXED WITH BENZAMIDINE CONTAINING POLYPEPTIDE MEDIATED CRYSTAL CONTACTS
2O9QA:THE CRYSTAL STRUCTURE OF BOVINE TRYPSIN COMPLEXED WITH A SMALL INHIBITION PEPTIDE ORB2K
2OTVA:CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN BOVINE TRYPSIN AND NICOTINAMIDE AT 1.56 A RESOLUTION
2OXSA:CRYSTAL STRUCTURE OF THE TRYPSIN COMPLEX WITH BENZAMIDINE AT HIGH TEMPERATURE (35 C)
2PLXA:16-245TRYPSIN COMPLEXED TO A SYNTHETIC PEPTIDE FROM VERONICA HEDERIFOLIA
2PTCE:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
2PTNA:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
2QN5T:CRYSTAL STRUCTURE AND FUNCTIONAL STUDY OF THE BOWMAN-BIRK INHIBITOR FROM RICE BRAN IN COMPLEX WITH BOVINE TRYPSIN
2QYIA:; C:CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN ENGINEERED TRYPSIN INHIBITOR AND BOVINE TRYPSIN
2TGAA:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
2TGDA:LACK OF THE TRANSITION STATE STABILIZATION SITE IS A FACTOR IN THE INACTIVITY OF TRYPSINOGEN, A SERINE PROTEASE ZYMOGEN. STRUCTURE OF DFP INHIBITED BOVINE TRYPSINOGEN AT 2.1 ANGSTROMS RESOLUTION
2TGPZ:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
2TGTA:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
2TIOA:LOW PACKING DENSITY FORM OF BOVINE BETA-TRYPSIN IN CYCLOHEXANE
2TLDE:CRYSTAL STRUCTURE OF AN ENGINEERED SUBTILISIN INHIBITOR COMPLEXED WITH BOVINE TRYPSIN
2TPIZ:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
2UUYA:STRUCTURE OF A TICK TRYPTASE INHIBITOR IN COMPLEX WITH BOVINE TRYPSIN
2ZDKA:EXPLORING TRYPSIN S3 POCKET
2ZDLA:EXPLORING TRYPSIN S3 POCKET
2ZDMA:EXPLORING TRYPSIN S3 POCKET
2ZDNA:EXPLORING TRYPSIN S3 POCKET
2ZFSA:EXPLORING TRYPSIN S3 POCKET
2ZFTA:EXPLORING TRYPSIN S3 POCKET
2ZHDA:EXPLORING TRYPSIN S3 POCKET
2ZQ1A:EXPLORING TRYPSIN S3 POCKET
2ZQ2A:EXPLORING TRYPSIN S3 POCKET
3A7TA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-FORMYLBENZIMIDAMIDE
3A7VA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 3-FORMYLBENZIMIDAMIDE
3A7WA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((TETRAHYDRO-2H-PYRAN-2-YLOXYIMINO)METHYL)BENZIMIDAMIDE (SOAKING 4HOURS)
3A7XA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID (SOAKING 45SECONDS)
3A7YA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((1-METHYLPIPERIDIN-3-YLOXYIMINO)METHYL)BENZIMIDAMIDE (SOAKING 2HOURS)
3A7ZA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((1-METHYLPIPERIDIN-4-YLOXYIMINO)METHYL)BENZIMIDAMIDE (SOAKING 3HOURS)
3A80A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)-2-METHYLPROPANOIC ACID (SOAKING 40SECONDS)
3A81A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((2-NICOTINOYLHYDRAZONO)METHYL)BENZIMIDAMIDE (SOAKING 8 HOURS)
3A84A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH(E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID (SOAKING 5 SECONDS)
3A85A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID (SOAKING 15 SECONDS)
3A86A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID (SOAKING 30 SECONDS)
3A87A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((2-NICOTINOYLHYDRAZONO)METHYL)BENZIMIDAMIDE (SOAKING 5 MINUTES)
3A88A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((2-NICOTINOYLHYDRAZONO)METHYL)BENZIMIDAMIDE (SOAKING 30 MINUTES)
3A89A:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((2-NICOTINOYLHYDRAZONO)METHYL)BENZIMIDAMIDE (SOAKING 4 HOURS)
3A8AA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-FORMYLBENZIMIDAMIDE AND ANILINE
3A8BA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-4-((4-BROMOPHENYLIMINO)METHYL)BENZIMIDAMIDE
3A8CA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID (SOAKING WITH MIXTURE OF [(E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID] AND [(E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)-2-METHYLPROPANOIC ACID])
3A8DA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (E)-2-(4-CARBAMIMIDOYLBENZYLIDENEAMINOOXY)ACETIC ACID (UNDER ANILINE-FREE CONDITION)
3AASA:BOVINE BETA-TRYPSIN BOUND TO META-GUANIDINO SCHIFF BASE COPPER (II) CHELATE
3AAUA:BOVINE BETA-TRYPSIN BOUND TO META-DIGUANIDINO SCHIFF BASE COPPER (II) CHELATE
3AAVA:; B:BOVINE BETA-TRYPSIN BOUND TO META-DIAMIDINO SCHIFF BASE COPPER (II) CHELATE
3ATIA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL) METHANAMINE
3ATKA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH CYCLOHEPTANAMINE
3ATLA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDINE
3ATMA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-(1H-INDOL-3-YL) ETHANAMINE
3BTDE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN THE BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI.
3BTEE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI.
3BTFE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI.
3BTGE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3BTHE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3BTKE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3BTME:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3BTQE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3BTTE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3BTWE:THE CRYSTAL STRUCTURES OF THE COMPLEXES BETWEEN BOVINE BETA-TRYPSIN AND TEN P1 VARIANTS OF BPTI
3D65E:CRYSTAL STRUCTURE OF TEXTILININ-1, A KUNITZ-TYPE SERINE PROTEASE INHIBITOR FROM THE AUSTRALIAN COMMON BROWN SNAKE VENOM, IN COMPLEX WITH TRYPSIN
3E8LA:; B:THE CRYSTAL STRUCTURE OF THE DOUBLE-HEADED ARROWHEAD PROTEASE INHIBITOR A IN COMPLEX WITH TWO TRYPSINS
3GY2A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE BY X-RAY CRYSTALLOGRAPHY AND ITC
3GY3A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE BY X-RAY CRYSTALLOGRAPHY AND ITC
3GY4A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE BY X-RAY CRYSTALLOGRAPHY AND ITC
3GY5A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE BY X-RAY CRYSTALLOGRAPHY AND ITC
3GY6A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY THE BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE
3GY7A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE BY X-RAY CRYSTALLOGRAPHY AND ITC
3GY8A:A COMPARATIVE STUDY ON THE INHIBITION OF BOVINE BETA-TRYPSIN BY BIS-BENZAMIDINES DIMINAZENE AND PENTAMIDINE BY X-RAY CRYSTALLOGRAPHY AND ITC
3I29A:CRYSTAL STRUCTURE OF A BINARY COMPLEX BETWEEN AN MUTANT TRYPSIN INHIBITOR WITH BOVINE TRYPSIN
3ITIA:STRUCTURE OF BOVINE TRYPSIN WITH THE MAD TRIANGLE B3C
3LJJA:BOVINE TRYPSIN IN COMPLEX WITH UB-THR 10
3LJOA:BOVINE TRYPSIN IN COMPLEX WITH UB-THR 11
3M35A:TRYPSIN IN COMPLEX WITH THE INHIBITOR 1-[3-(AMINOMETHYL) PHENYL]-N-[3-FLUORO-2'-(METHYLSULFONYL)BIPHENYL-4-YL]-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE (DPC423)
3M7QA:CRYSTAL STRUCTURE OF RECOMBINANT KUNITZ TYPE SERINE PROTEASE INHIBITOR-1 FROM THE CARIBBEAN SEA ANEMONE STICHODACTYLA HELIANTHUS IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN
3MFJA:BOVINE TRYPSIN AT 0.8 A RESOLUTION, RESTRAINED REFINEMENT
3MI4A:BOVINE TRYPSIN AT 0.8 A RESOLUTION, NON-RESTRAINED REFINEMENT
3NK8A:TRYPSIN IN COMPLEX WITH FLUORINE-CONTAINING FRAGMENT
3NKKA:TRYPSIN IN COMPLEX WITH FLUORINE CONTAINING FRAGMENT
3OTJE:A CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BPTI (BOVINE PANCREATIC TRYPSIN INHIBITOR) BY X-RAY/NEUTRON JOINT REFINEMENT
3PLBA:BOVINE TRYPSIN VARIANT X(TRIPLEILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PLKA:BOVINE TRYPSIN VARIANT X(TRIPLEILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PLPA:BOVINE TRYPSIN VARIANT X(TRIPLEILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PM3A:BOVINE TRYPSIN VARIANT X(TRIPLEILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PMJA:BOVINE TRYPSIN VARIANT X(TRIPLEILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PTBA:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
3PTNA:ON THE DISORDERED ACTIVATION DOMAIN IN TRYPSINOGEN. CHEMICAL LABELLING AND LOW-TEMPERATURE CRYSTALLOGRAPHY
3PWBA:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217ILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PWCA:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217ILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3PYHA:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217ILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3Q00A:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217ILE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3RDZA:; B:CRYSTAL STRUCTURE OF RBTI-TRYPSIN COMPLEX AT 2.26 ANGSTROM RESOLUTION
3RU4T:CRYSTAL STRUCTURE OF THE BOWMAN-BIRK SERINE PROTEASE INHIBITOR BTCI IN COMPLEX WITH TRYPSIN AND CHYMOTRYPSIN
3RXAA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH CYCLOHEPTANAMINE
3RXBA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-GUANIDINOBUTANOIC ACID
3RXCA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-AMINOPYRIDINE
3RXDA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL) METHANAMINE
3RXEA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE
3RXFA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-AMINOPYRIDINE
3RXGA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-AMINOCYCLOHEXANOL
3RXHA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-(1H-IMIDAZOL-4-YL) ETHANAMINE
3RXIA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 2-(1H-INDOL-3-YL) ETHANAMINE
3RXJA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH 4-GUANIDINOBENZOIC ACID
3RXKA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH METHYL 4-AMINO-1-METHYL-PYRROLIDINE-2-CARBOXYLATE
3RXLA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (2,5-DIMETHYL-3-FURYL) METHANAMINE
3RXMA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH [2-(2-THIENYL)THIAZOL-4-YL]METHANAMINE
3RXOA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-PYRROL-1-YLPHENYL) METHANAMINE
3RXPA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (1,5-DIMETHYLPYRAZOL-3-YL)METHANAMINE
3RXQA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE (F01 AND F05, COCKTAIL EXPERIMENT)
3RXRA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH CYCLOHEPTANAMINE (F01 AND F03, COCKTAIL EXPERIMENT)
3RXSA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL) METHANAMINE (F04 AND A06, COCKTAIL EXPERIMENT)
3RXTA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH (3-METHOXYPHENYL) METHANAMIN (F04 AND F03, COCKTAIL EXPERIMENT)
3RXUA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE (F05 AND A06, COCKTAIL EXPERIMENT)
3RXVA:CRYSTAL STRUCTURE OF TRYPSIN COMPLEXED WITH BENZAMIDE (F05 AND F03, COCKTAIL EXPERIMENT)
3T25A:TMAO-GROWN ORTHORHOMBIC TRYPSIN (BOVINE)
3T26A:ORTHORHOMBIC TRYPSIN (BOVINE) IN THE PRESENCE OF SARCOSINE
3T27A:ORTHORHOMBIC TRYPSIN (BOVINE) IN THE PRESENCE OF BETAINE
3T28A:TMAO-GROWN TRYPSIN (BOVINE)-PREVIOUSLY UNREPORTED TETRAGONAL CRYSTAL FORM
3T29A:TMAO-GROWN TRIGONAL TRYPSIN (BOVINE)
3TPIZ:THE GEOMETRY OF THE REACTIVE SITE AND OF THE PEPTIDE GROUPS IN TRYPSIN, TRYPSINOGEN AND ITS COMPLEXES WITH INHIBITORS
3UNQA:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UNRA:BOND LENGTH ANALYSIS OF ASP, GLU AND HIS RESIDUES IN TRYPSIN AT 1.2A RESOLUTION
3UNSA:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UOPA:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UPEA:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UQOA:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UQVA:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UUZA:; B:BOVINE TRYPSIN VARIANT X(TRIPLEPHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3UWIA:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3V0XA:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3V12A:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3V13A:BOVINE TRYPSIN VARIANT X(TRIPLEGLU217PHE227) IN COMPLEX WITH SMALL MOLECULE INHIBITOR
3VPKA:CRYSTAL STRUCTURE OF 6-GUANIDINOHEXANOYL TRYPSIN
4AB8A:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4AB9A:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABAA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABBA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABDA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABEA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABFA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABGA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4ABHA:FRAGMENTS BOUND TO BOVINE TRYPSIN FOR THE SAMPL CHALLENGE
4B1TA:; C:STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA ( TA) IN COMPLEX WITH EGLIN C
4B2AA:; C:STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TGA) IN COMPLEX WITH EGLIN C
4B2BA:; C:STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TGPA) IN COMPLEX WITH EGLIN C
4B2CA:; C:STRUCTURE OF THE FACTOR XA-LIKE TRYPSIN VARIANT TRIPLE-ALA (TPA) IN COMPLEX WITH EGLIN C
4I8GA:BOVINE TRYPSIN AT 0.8 RESOLUTION
4I8HA:BOVINE TRYPSIN AT 0.75 RESOLUTION
4I8JA:BOVINE TRYPSIN AT 0.87 A RESOLUTION
4I8KA:BOVINE TRYPSIN AT 0.85 RESOLUTION
4I8LA:BOVINE TRYPSIN AT 0.87 RESOLUTION
4J2YB:CRYSTAL STRUCTURE OF A PLANT TRYPSIN INHIBITOR ECTI IN COMPLEX WITH BOVINE TRYPSIN.
4KTSA:BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 8.5
4KTUA:BOVINE TRYPSIN IN COMPLEX WITH MICROVIRIDIN J AT PH 6.5
4NCYA:IN SITU TRYPSIN CRYSTALLIZED ON A MITEGEN MICROMESH WITH IMIDAZOLE LIGAND
4TPIZ:THE REFINED 2.2-ANGSTROMS (0.22-NM) X-RAY CRYSTAL STRUCTURE OF THE TERNARY COMPLEX FORMED BY BOVINE TRYPSINOGEN, VALINE-VALINE AND THE ARG15 ANALOGUE OF BOVINE PANCREATIC TRYPSIN INHIBITOR
5PTPA:STRUCTURE OF HYDROLASE (SERINE PROTEINASE)
(-)
Fungus (Fusarium oxysporum) [TaxId: 5507] (16)
1FN8A:FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION
1FY4A:FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION
1FY5A:FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION
1GDNA:FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION
1GDQA:FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION
1GDUA:FUSARIUM OXYSPORUM TRYPSIN AT ATOMIC RESOLUTION
1PPZA:TRYPSIN COMPLEXES AT ATOMIC AND ULTRA-HIGH RESOLUTION
1PQ5A:TRYPSIN AT PH 5, 0.85 A
1PQ7A:TRYPSIN AT 0.8 A, PH5 / BORAX
1PQ8A:TRYPSIN AT PH 4 AT ATOMIC RESOLUTION
1PQAA:TRYPSIN WITH PMSF AT ATOMIC RESOLUTION
1TRYA:STRUCTURE OF INHIBITED TRYPSIN FROM FUSARIUM OXYSPORUM AT 1.55 ANGSTROMS
1XVMA:TRYPSIN FROM FUSARIUM OXYSPORUM- ROOM TEMPERATURE TO ATOMIC RESOLUTION
1XVOA:TRYPSIN FROM FUSARIUM OXYSPORUM AT PH 6
2G51A:ANOMALOUS SUBSTRUCTURE OF TRYPSIN (P1)
2G52A:ANOMALOUS SUBSTRUCTURE OF TRYPSIN (P21)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1TRNA:; B:CRYSTAL STRUCTURE OF HUMAN TRYPSIN 1: UNEXPECTED PHOSPHORYLATION OF TYROSINE 151
2RA3A:; B:HUMAN CATIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)
(-)
Human (Homo sapiens), trypsin IV (brain isoform) [TaxId: 9606] (7)
1H4WA:STRUCTURE OF HUMAN TRYPSIN IV (BRAIN TRYPSIN)
2R9PA:; B:; C:; D:HUMAN MESOTRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR(BPTI)
3L33A:; B:; C:; D:HUMAN MESOTRYPSIN COMPLEXED WITH AMYLOID PRECURSOR PROTEIN INHIBITOR(APPI)
3L3TA:; B:; C:; D:HUMAN MESOTRYPSIN COMPLEXED WITH AMYLOID PRECURSOR PROTEIN INHIBITOR VARIANT (APPIR15K)
3P92A:HUMAN MESOTRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR VARIANT (BPTI-K15R/R17G)
3P95A:HUMAN MESOTRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR VARIANT (BPTI-K15R/R17D)
4DG4A:; B:; D:; G:HUMAN MESOTRYPSIN-S39Y COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)
(-)
Narrow-clawed crayfish (Pontastacus leptodactylus) [TaxId: 6717] (2)
2F91A:16-2441.2A RESOLUTION STRUCTURE OF A CRAYFISH TRYPSIN COMPLEXED WITH A PEPTIDE INHIBITOR, SGTI
4BNRA:; B:EXTREMELY STABLE COMPLEX OF CRAYFISH TRYPSIN WITH BOVINE TRYPSIN INHIBITOR
(-)
Norway rat (Rattus norvegicus) [TaxId: 10116] (36)
1AMHA:; B:UNCOMPLEXED RAT TRYPSIN MUTANT WITH ASP 189 REPLACED WITH SER (D189S)
1ANBA:ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY GLU
1ANCA:ANIONIC TRYPSIN MUTANT WITH SER 214 REPLACED BY LYS
1ANDA:ANIONIC TRYPSIN MUTANT WITH ARG 96 REPLACED BY HIS
1ANEA:ANIONIC TRYPSIN WILD TYPE
1BRAA:RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN
1BRBE:CRYSTAL STRUCTURES OF RAT ANIONIC TRYPSIN COMPLEXED WITH THE PROTEIN INHIBITORS APPI AND BPTI
1BRCE:RELOCATING A NEGATIVE CHARGE IN THE BINDING POCKET OF TRYPSIN
1CO7E:R117H MUTANT RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)
1DPOA:STRUCTURE OF RAT TRYPSIN
1EZSC:; D:CRYSTAL STRUCTURE OF ECOTIN MUTANT M84R, W67A, G68A, Y69A, D70A BOUND TO RAT ANIONIC TRYPSIN II
1EZUC:; D:ECOTIN Y69F, D70P BOUND TO D102N TRYPSIN
1F5RA:RAT TRYPSINOGEN MUTANT COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1F7ZA:RAT TRYPSINOGEN K15A COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
1FY8E:CRYSTAL STRUCTURE OF THE DELTAILE16VAL17 RAT ANIONIC TRYPSINOGEN-BPTI COMPLEX
1J14A:BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT
1J15A:BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT
1J16A:BENZAMIDINE IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT
1J17T:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99/175/190RT
1K9OE:CRYSTAL STRUCTURE OF MICHAELIS SERPIN-TRYPSIN COMPLEX
1QL9A:FACTOR XA SPECIFIC INHIBITOR IN COMPLEX WITH RAT TRYPSIN MUTANT X99RT
1SLUB:RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN
1SLVB:RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN; COPPER-BOUND
1SLWB:RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN; NICKEL-BOUND
1SLXB:RAT ANIONIC N143H, E151H TRYPSIN COMPLEXED TO A86H ECOTIN; ZINC-BOUND
1TRMA:; B:THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS
1YKTA:TRYPSIN/BPTI COMPLEX MUTANT
1YLCA:TRYPSIN/BPTI COMPLEX MUTANT
1YLDA:TRYPSIN/BPTI COMPLEX MUTANT
2TRMA:THE THREE-DIMENSIONAL STRUCTURE OF ASN102 MUTANT OF TRYPSIN. ROLE OF ASP102 IN SERINE PROTEASE CATALYSIS
3FP6E:ANIONIC TRYPSIN IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) DETERMINED TO THE 1.49 A RESOLUTION LIMIT
3FP7E:ANIONIC TRYPSIN VARIANT S195A IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) CLEAVED AT THE SCISSILE BOND (LYS15-ALA16) DETERMINED TO THE 1.46 A RESOLUTION LIMIT
3FP8E:ANIONIC TRYPSIN VARIANT S195A IN COMPLEX WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI) DETERMINED TO THE 1.46 A RESOLUTION LIMIT
3TGIE:WILD-TYPE RAT ANIONIC TRYPSIN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)
3TGJE:S195A TRYPSINOGEN COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)
3TGKE:TRYPSINOGEN MUTANT D194N AND DELETION OF ILE 16-VAL 17 COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR (BPTI)
(-)
Pig (Sus scrofa) [TaxId: 9823] (33)
1AKSA:,B:CRYSTAL STRUCTURE OF THE FIRST ACTIVE AUTOLYSATE FORM OF THE PORCINE ALPHA TRYPSIN
1AN1E:LEECH-DERIVED TRYPTASE INHIBITOR/TRYPSIN COMPLEX
1AVWA:COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, ORTHORHOMBIC CRYSTAL FORM
1AVXA:COMPLEX PORCINE PANCREATIC TRYPSIN/SOYBEAN TRYPSIN INHIBITOR, TETRAGONAL CRYSTAL FORM
1C9PA:COMPLEX OF BDELLASTASIN WITH PORCINE TRYPSIN
1EJAA:STRUCTURE OF PORCINE TRYPSIN COMPLEXED WITH BDELLASTASIN, AN ANTISTASIN-TYPE INHIBITOR
1EPTA:,B:,C:REFINED 1.8 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF PORCINE EPSILON-TRYPSIN
1FMGA:CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.04% POLYDOCANOL
1FN6A:CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.1% POLYDOCANOL
1FNIA:CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH 0.01% POLYDOCANOL
1H9HE:COMPLEX OF EETI-II WITH PORCINE TRYPSIN
1H9IE:COMPLEX OF EETI-II MUTANT WITH PORCINE TRYPSIN
1LDTT:COMPLEX OF LEECH-DERIVED TRYPTASE INHIBITOR WITH PORCINE TRYPSIN
1MCTA:THE REFINED 1.6 ANGSTROMS RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN PORCINE BETA-TRYPSIN AND MCTI-A, A TRYPSIN INHIBITOR OF SQUASH FAMILY
1PPHE:GEOMETRY OF BINDING OF THE NALPHA-TOSYLATED PIPERIDIDES OF M-AMIDINO-, P-AMIDINO-AND P-GUANIDINO PHENYLALANINE TO THROMBIN AND TRYPSIN: X-RAY CRYSTAL STRUCTURES OF THEIR TRYPSIN COMPLEXES AND MODELING OF THEIR THROMBIN COMPLEXES
1QQUA:CRYSTAL STRUCTURE OF PORCINE BETA TRYPSIN WITH BOUND ACETATE ION
1S5SA:PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR
1S6FA:PORCINE TRYPSIN COVALENT COMPLEX WITH BORATE AND GUANIDINE-3 INHIBITOR
1S6HA:PORCINE TRYPSIN COMPLEXED WITH GUANIDINE-3-PROPANOL INHIBITOR
1S81A:PORCINE TRYPSIN WITH NO INHIBITOR BOUND
1S82A:PORCINE TRYPSIN COMPLEXED WITH BORATE AND ETHYLENE GLYCOL
1S83A:PORCINE TRYPSIN COMPLEXED WITH 4-AMINO PROPANOL
1S84A:PORCINE TRYPSIN COVALENT COMPLEX WITH 4-AMINO BUTANOL, BORATE AND ETHYLENE GLYCOL
1S85A:PORCINE TRYPSIN COMPLEXED WITH P-HYDROXYMETHYL BENZAMIDINE AND BORATE
1TFXA:; B:COMPLEX OF THE SECOND KUNITZ DOMAIN OF TISSUE FACTOR PATHWAY INHIBITOR WITH PORCINE TRYPSIN
1TX6A:; B:; C:; D:TRYPSIN:BBI COMPLEX
1UHBA:,B:CRYSTAL STRUCTURE OF PORCINE ALPHA TRYPSIN BOUND WITH AUTO CATALYTICALY PRODUCED NATIVE PEPTIDE AT 2.15 A RESOLUTION
1V6DA:THE CRYSTAL STRUCTURE OF THE TRYPSIN COMPLEX WITH SYNTHETIC HETEROCHIRAL PEPTIDE
1YF4A:CRYSTAL STRUCTURE OF TRYPSIN-VASOPRESSIN COMPLEX
1Z7KA:CRYSTAL STRUCTURE OF TRYPSIN- OVOMUCOID TURKEY EGG WHITE INHIBITOR COMPLEX
2A31A:TRYPSIN IN COMPLEX WITH BORATE
2A32A:TRYPSIN IN COMPLEX WITH BENZENE BORONIC ACID
3MYWA:; B:THE BOWMAN-BIRK TYPE INHIBITOR FROM MUNG BEAN IN TERNARY COMPLEX WITH PORCINE TRYPSIN
(-)
Protein domain: Two-chain tissue plasminogen activator (TC)-T-PA (2)
(-)
Human (Homo sapiens) [TaxId: 9606] (2)
1A5HC:,A:; D:,B:CATALYTIC DOMAIN OF HUMAN TWO-CHAIN TISSUE PLASMINOGEN ACTIVATOR COMPLEX OF A BIS-BENZAMIDINE
1RTFA:,B:COMPLEX OF BENZAMIDINE WITH THE CATALYTIC DOMAIN OF HUMAN TWO CHAIN TISSUE PLASMINOGEN ACTIVATOR [(TC)-T-PA]
(-)
Protein domain: Urokinase (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1FV9A:CRYSTAL STRUCTURE OF HUMAN MICROUROKINASE IN COMPLEX WITH 2-AMINO-5-HYDROXY-BENZIMIDAZOLE
(-)
Protein domain: Urokinase-type plasminogen activator (LMW U-PA), catalytic domain (66)
(-)
Human (Homo sapiens) [TaxId: 9606] (66)
1C5WA:,B:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5XA:,B:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5YA:,B:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1C5ZA:,B:STRUCTURAL BASIS FOR SELECTIVITY OF A SMALL MOLECULE, S1-BINDING, SUB-MICROMOLAR INHIBITOR OF UROKINASE TYPE PLASMINOGEN ACTIVATOR
1EJNA:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN INHIBITOR COMPLEX
1F5KU:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-BENZAMIDINE COMPLEX
1F5LA:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-AMILORIDE COMPLEX
1F92A:UROKINASE PLASMINOGEN ACTIVATOR B CHAIN-UKI-1D COMPLEX
1GI7A:,B:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI8A:,B:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GI9A:,B:A NOVEL SERINE PROTEASE INHIBITION MOTIF INVOLVING A MULTI-CENTERED SHORT HYDROGEN BONDING NETWORK AT THE ACTIVE SITE
1GJ7A:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1GJ8A:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1GJ9A:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1GJAA:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1GJBA:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1GJCA:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1GJDA:,B:ENGINEERING INHIBITORS HIGHLY SELECTIVE FOR THE S1 SITES OF SER190 TRYPSIN-LIKE SERINE PROTEASE DRUG TARGETS
1LMWA:,B:; C:,D:LMW U-PA STRUCTURE COMPLEXED WITH EGRCMK (GLU-GLY-ARG CHLOROMETHYL KETONE)
1O3PA:,B:ELABORATE MANIFOLD OF SHORT HYDROGEN BOND ARRAYS MEDIATING BINDING OF ACTIVE SITE-DIRECTED SERINE PROTEASE INHIBITORS
1O5AA:,B:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1O5BA:,B:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1O5CA:,B:DISSECTING AND DESIGNING INHIBITOR SELECTIVITY DETERMINANTS AT THE S1 SITE USING AN ARTIFICIAL ALA190 PROTEASE (ALA190 UPA)
1OWDA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1OWEA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1OWHA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1OWIA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1OWJA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1OWKA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1SC8U:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-J435 COMPLEX
1SQAA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1SQOA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1SQTA:SUBSTITUTED 2-NAPHTHAMIDINE INHIBITORS OF UROKINASE
1T32A:A DUAL INHIBITOR OF THE LEUKOCYTE PROTEASES CATHEPSIN G AND CHYMASE WITH THERAPEUTIC EFFICACY IN ANIMALS MODELS OF INFLAMMATION
1U6QA:SUBSTITUTED 2-NAPHTHAMADINE INHIBITORS OF UROKINASE
1VJ9U:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-JT464 COMPLEX
1VJAU:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-JT463 COMPLEX
1W0ZU:UROKINASE TYPE PLASMINOGEN ACTIVATOR
1W10U:UROKINASE TYPE PLASMINOGEN ACTIVATOR
1W11U:UROKINASE TYPE PLASMINOGEN ACTIVATOR
1W12U:UROKINASE TYPE PLASMINOGEN ACTIVATOR
1W13U:UROKINASE TYPE PLASMINOGEN ACTIVATOR
1W14U:UROKINASE TYPE PLASMINOGEN ACTIVATOR
2R2WU:UROKINASE PLASMINOGEN ACTIVATOR B-CHAIN-GPPE COMPLEX
3KGPA:CRYSTAL STRUCTURES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN COMPLEX WITH 4-(AMINOMETHYL) BENZOIC ACID AND 4-(AMINOMETHYL-PHENYL)-METHANOL
3KHVA:CRYSTAL STRUCTURES OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR IN COMPLEX WITH 4-(AMINOMETHYL) BENZOIC ACID AND 4-(AMINOMETHYL-PHENYL)-METHANOL
3KIDU:THE CRYSTAL STRUCTURES OF 2-AMINOBENZOTHIAZOLE-BASED INHIBITORS IN COMPLEXES WITH UROKINASE-TYPE PLASMINOGEN ACTIVATOR
3MHWU:THE COMPLEX CRYSTAL STRUCTURE OF UROKIANSE AND 2-AMINOBENZOTHIAZOLE
3MWIU:THE COMPLEX CRYSTAL STRUCTURE OF UROKIANSE AND 5-NITRO-1H-INDOLE-2-AMIDINE
4DVAU:THE CRYSTAL STRUCTURE OF HUMAN UROKINASE-TYPE PLASMINOGEN ACTIVATOR CATALYTIC DOMAIN
4DW2U:THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB-112
4FU7A:CRYSTAL STRUCTURE OF THE UROKINASE
4FU8A:CRYSTAL STRUCTURE OF THE UROKINASE
4FU9A:CRYSTAL STRUCTURE OF THE UROKINASE
4FUBA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUCA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUDA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUEA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUFA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUGA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUHA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUIA:CRYSTAL STRUCTURE OF THE UROKINASE
4FUJA:CRYSTAL STRUCTURE OF THE UROKINASE
4H42U:SYNTHESIS OF A WEAK BASIC UPA INHIBITOR AND CRYSTAL STRUCTURE OF COMPLEX WITH UPA
4JNIU:CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH ITS INHIBITOR 4-BROMOBENZYLAMINE AT PH 4.6
4JNLU:CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH ITS INHIBITOR 4-BROMOBENZYLAMINE AT PH 7.4
(-)
Protein domain: Venom serine protease (3)
(-)
Chinese green tree viper (Trimeresurus stejnegeri) [TaxId: 39682] (1)
1BQYA:; B:PLASMINOGEN ACTIVATOR (TSV-PA) FROM SNAKE VENOM
(-)
Hundred-pace snake (Agkistrodon acutus) [TaxId: 36307] (2)
1OP0A:CRYSTAL STRUCTURE OF AAV-SP-I, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS
1OP2A:CRYSTAL STRUCTURE OF AAV-SP-II, A GLYCOSYLATED SNAKE VENOM SERINE PROTEINASE FROM AGKISTRODON ACUTUS
(-)
Family: Prokaryotic proteases (131)
(-)
Protein domain: Achromobacter protease (3)
(-)
Achromobacter lyticus, strain m497-1 [TaxId: 224] (3)
1ARBA:THE PRIMARY STRUCTURE AND STRUCTURAL CHARACTERISTICS OF ACHROMOBACTER LYTICUS PROTEASE I, A LYSINE-SPECIFIC SERINE PROTEASE
1ARCA:THE PRIMARY STRUCTURE AND STRUCTURAL CHARACTERISTICS OF ACHROMOBACTER LYTICUS PROTEASE I, A LYSINE-SPECIFIC SERINE PROTEASE
4GPGA:X/N JOINT REFINEMENT OF ACHROMOBACTER LYTICUS PROTEASE I FREE FORM AT PD8.0
(-)
Protein domain: alpha-Lytic protease (45)
(-)
Lysobacter enzymogenes, 495 [TaxId: 69] (45)
1BOQA:PRO REGION C-TERMINUS: PROTEASE ACTIVE SITE INTERACTIONS ARE CRITICAL IN CATALYZING THE FOLDING OF ALPHA-LYTIC PROTEASE
1GBAA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA
1GBBA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID
1GBCA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID
1GBDA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID
1GBEA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU
1GBFA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID
1GBHA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID
1GBIA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA AND GLY 216 REPLACED BY LEU COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID
1GBJA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA
1GBKA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-ALANINE BORONIC ACID
1GBLA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-LEUCINE BORONIC ACID
1GBMA:ALPHA-LYTIC PROTEASE WITH MET 190 REPLACED BY ALA COMPLEX WITH METHOXYSUCCINYL-ALA-ALA-PRO-PHENYLALANINE BORONIC ACID
1P01A:SERINE PROTEASE MECHANISM. STRUCTURE OF AN INHIBITORY COMPLEX OF ALPHA-LYTIC PROTEASE AND A TIGHTLY BOUND PEPTIDE BORONIC ACID
1P02A:STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES
1P03A:STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES
1P04A:STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES
1P05A:STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES
1P06A:STRUCTURE ANALYSIS OF SPECIFICITY. ALPHA-LYTIC PROTEASE COMPLEXES WITH ANALOGUES OF REACTION INTERMEDIATES
1P09A:STRUCTURAL PLASTICITY AS A DETERMINANT OF ENZYME SPECIFICITY. CREATING BROADLY SPECIFIC PROTEASES
1P10A:STRUCTURAL PLASTICITY AS A DETERMINANT OF ENZYME SPECIFICITY. CREATING BROADLY SPECIFIC PROTEASES
1P11E:CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS
1P12E:CRYSTAL STRUCTURES OF ALPHA-LYTIC PROTEASE COMPLEXES WITH IRREVERSIBLY BOUND PHOSPHONATE ESTERS
1QQ4A:CRYSTAL STRUCTURE OF AN ALPHA-LYTIC PROTEASE MUTANT WITH ACCELERATED FOLDING KINETICS, R102H/G134S
1QRWA:CRYSTAL STRUCTURE OF AN ALPHA-LYTIC PROTEASE MUTANT WITH ACCELERATED FOLDING KINETICS, R102H/G134S, PH 8
1QRXA:CRYSTAL STRUCTURE OF WILD-TYPE ALPHA-LYTIC PROTEASE AT 1.6 A, PH 5.14
1SSXA:0.83A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE AT PH 8
1TALA:ALPHA-LYTIC PROTEASE AT 120 K (SINGLE STRUCTURE MODEL)
2ALPA:REFINED STRUCTURE OF ALPHA-LYTIC PROTEASE AT 1.7 ANGSTROMS RESOLUTION. ANALYSIS OF HYDROGEN BONDING AND SOLVENT STRUCTURE
2H5CA:0.82A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE AT PH 5
2H5DA:0.9A RESOLUTION CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE COMPLEXED WITH A TRANSITION STATE ANALOGUE, MEOSUC-ALA-ALA-PRO-VAL BORONIC ACID
2LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
2ULLA:MULTIPLE CONFORMATION STRUCTURE OF ALPHA-LYTIC PROTEASE AT 120 K
3LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
3PROA:; B:ALPHA-LYTIC PROTEASE COMPLEXED WITH C-TERMINAL TRUNCATED PRO REGION
3QGJA:; C:1.3A STRUCTURE OF ALPHA-LYTIC PROTEASE BOUND TO AC-ALAALAPRO-ALANAL
3URCA:T181G MUTANT OF ALPHA-LYTIC PROTEASE
3URDA:T181A MUTANT OF ALPHA-LYTIC PROTEASE
3UREA:; B:REPACK MUTANT (T181I, W199L, Q210I) OF ALPHA-LYTIC PROTEASE
4PROA:; B:ALPHA-LYTIC PROTEASE COMPLEXED WITH PRO REGION
5LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
6LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
7LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
8LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
9LPRA:STRUCTURAL BASIS FOR BROAD SPECIFICITY IN ALPHA-LYTIC PROTEASE MUTANTS
(-)
Protein domain: automated matches (19)
(-)
Escherichia coli K-12 [TaxId: 83333] (8)
3LGIA:; B:; C:STRUCTURE OF THE PROTEASE DOMAIN OF DEGS (DEGS-DELTAPDZ) AT 1.65 A
3LGTA:Y162A/H198P DOUBLE MUTANT OF DEGS-DELTAPDZ PROTEASE
3LGUA:Y162A MUTANT OF THE DEGS-DELTAPDZ PROTEASE
3LGVA:; B:; C:; D:; E:; F:; G:; H:; I:H198P MUTANT OF THE DEGS-DELTAPDZ PROTEASE
3LGWA:H198P/T167V DOUBLE MUTANT OF DEGS-DELTAPDZ PROTEASE
3LGYA:R178A MUTANT OF THE DEGS-DELTAPDZ PROTEASE
3LH1A:Q191A MUTANT OF THE DEGS-DELTAPDZ
3LH3A:; H:; I:; B:; C:; D:; E:; F:; G:DFP MODIFIED DEGS DELTA PDZ
(-)
Lysobacter enzymogenes [TaxId: 69] (2)
3M7TA:CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE SB2+3 E8A/R105S MUTANT
3M7UA:CRYSTAL STRUCTURE OF ALPHA-LYTIC PROTEASE SB1+2 R64A/E182Q MUTANT
(-)
Staphylococcus epidermidis [TaxId: 176280] (1)
4JCNA:STRUCTURE OF ESP, SERINE PROTEASE FROM STAPHYLOCOCCUS EPIDERMIDIS
(-)
Streptomyces griseus [TaxId: 1911] (8)
2GKVE:CRYSTAL STRUCTURE OF THE SGPB:P14'-ALA32 OMTKY3-DEL(1-5) COMPLEX
2NU0E:MOLECULAR STRUCTURES OF THE COMPLEXES OF SGPB WITH OMTKY3 AROMATIC P1 VARIANTS TRP18I, HIS18I, PHE18I, AND TYR18I
2NU1E:MOLECULAR STRUCTURES OF THE COMPLEXES OF SGPB WITH OMTKY3 AROMATIC P1 VARIANTS TRP18I, HIS18I, PHE18I AND TYR18I
2NU2E:ACCOMMODATION OF POSITIVELY-CHARGED RESIDUES IN A HYDROPHOBIC SPECIFICITY POCKET: CRYSTAL STRUCTURES OF SGPB IN COMPLEX WITH OMTKY3 VARIANTS LYS18I AND ARG18I
2NU3E:ACCOMMODATION OF POSITIVELY-CHARGED RESIDUES IN A HYDROPHOBIC SPECIFICITY POCKET: CRYSTAL STRUCTURES OF SGPB IN COMPLEX WITH OMTKY3 VARIANTS LYS18I AND ARG18I
2NU4E:ACCOMMODATION OF POSITIVELY-CHARGED RESIDUES IN A HYDROPHOBIC SPECIFICITY POCKET: CRYSTAL STRUCTURES OF SGPB IN COMPLEX WITH OMTKY3 VARIANTS LYS18I AND ARG18I
2QA9E:CRYSTAL STRUCTURE OF THE SECOND TETRAHEDRAL INTERMEDIATES OF SGPB AT PH 4.2
2QAAA:; B:CRYSTAL STRUCTURE OF THE SECOND TETRAHEDRAL INTERMEDIATES OF SGPB AT PH 7.3
(-)
Protein domain: Epidermolytic (exfoliative) toxin A (4)
(-)
Staphylococcus aureus [TaxId: 1280] (4)
1AGJA:; B:EPIDERMOLYTIC TOXIN A FROM STAPHYLOCOCCUS AUREUS
1DUAA:CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A
1DUEA:CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN A S195A MUTANT
1EXFA:EXFOLIATIVE TOXIN A
(-)
Protein domain: Exfoliative toxin B (2)
(-)
Staphylococcus aureus [TaxId: 1280] (2)
1DT2A:CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B
1QTFA:CRYSTAL STRUCTURE OF EXFOLIATIVE TOXIN B
(-)
Protein domain: Glutamic acid-specific protease (1)
(-)
Streptomyces griseus [TaxId: 1911] (1)
1HPGA:A GLUTAMIC ACID SPECIFIC SERINE PROTEASE UTILIZES A NOVEL HISTIDINE TRIAD IN SUBSTRATE BINDING
(-)
Protein domain: Glutamyl endopeptidase (2)
(-)
Bacillus intermedius [TaxId: 1400] (2)
1P3CA:GLUTAMYL ENDOPEPTIDASE FROM BACILLUS INTERMEDIUS
1P3EA:STRUCTURE OF GLU ENDOPEPTIDASE IN COMPLEX WITH MPD
(-)
Protein domain: Mitochondrial serine protease HtrA2, catalytic domain (1)
(-)
Human (Homo sapiens) [TaxId: 9606] (1)
1LCYA:6-210CRYSTAL STRUCTURE OF THE MITOCHONDRIAL SERINE PROTEASE HTRA2
(-)
Protein domain: Protease A (5)
(-)
Streptomyces griseus, strain k1 [TaxId: 1911] (5)
1SGCA:THE 1.8 ANGSTROMS STRUCTURE OF THE COMPLEX BETWEEN CHYMOSTATIN AND STREPTOMYCES GRISEUS PROTEASE A. A MODEL FOR SERINE PROTEASE CATALYTIC TETRAHEDRAL INTERMEDIATES
2SGAA:ELECTRON DENSITY CALCULATIONS AS AN EXTENSION OF PROTEIN STRUCTURE REFINEMENT. STREPTOMYCES GRISEUS PROTEASE AT 1.5 ANGSTROMS RESOLUTION
3SGAE:STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS
4SGAE:STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS
5SGAE:STRUCTURES OF PRODUCT AND INHIBITOR COMPLEXES OF STREPTOMYCES GRISEUS PROTEASE A AT 1.8 ANGSTROMS RESOLUTION. A MODEL FOR SERINE PROTEASE CATALYSIS
(-)
Protein domain: Protease B (20)
(-)
Streptomyces griseus, strain k1 [TaxId: 1911] (20)
1CSOE:CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-ILE18I IN COMPLEX WITH SGPB
1CT0E:CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-SER18I IN COMPLEX WITH SGPB
1CT2E:CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-THR18I IN COMPLEX WITH SGPB
1CT4E:CRYSTAL STRUCTURE OF THE OMTKY3 P1 VARIANT OMTKY3-VAL18I IN COMPLEX WITH SGPB
1DS2E:CRYSTAL STRUCTURE OF SGPB:OMTKY3-COO-LEU18I
1SGDE:ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
1SGEE:GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
1SGNE:ASN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B
1SGPE:ALA 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B
1SGQE:GLY 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B
1SGRE:LEU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B
1SGYE:TYR 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
2SGDE:ASP 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7
2SGEE:GLU 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7
2SGFE:PHE 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B
2SGPE:PRO 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
2SGQE:GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 6.5
3SGBE:STRUCTURE OF THE COMPLEX OF STREPTOMYCES GRISEUS PROTEASE B AND THE THIRD DOMAIN OF THE TURKEY OVOMUCOID INHIBITOR AT 1.8 ANGSTROMS RESOLUTION
3SGQE:GLN 18 VARIANT OF TURKEY OVOMUCOID INHIBITOR THIRD DOMAIN COMPLEXED WITH STREPTOMYCES GRISEUS PROTEINASE B AT PH 10.7
4SGBE:STRUCTURE OF THE COMPLEX OF STREPTOMYCES GRISEUS PROTEINASE B AND POLYPEPTIDE CHYMOTRYPSIN INHIBITOR-1 FROM RUSSET BURBANK POTATO TUBERS AT 2.1 ANGSTROMS RESOLUTION
(-)
Protein domain: Protease Do (DegP, HtrA), catalytic domain (5)
(-)
Escherichia coli [TaxId: 562] (4)
1KY9A:11-259; B:11-259CRYSTAL STRUCTURE OF DEGP (HTRA)
2ZLEA:1-214; H:2723-2936; I:3119-3332; J:3515-3728; K:3911-4124; L:4307-4520; M:4703-4916; B:397-610; C:793-1006; E:1535-1748; F:1931-2144; G:2327-2540CRYO-EM STRUCTURE OF DEGP12/OMP
3CS0A:11-259CRYSTAL STRUCTURE OF DEGP24
3MH4A:11-259HTRA PROTEASES ARE ACTIVATED BY A CONSERVED MECHANISM THAT CAN BE TRIGGERED BY DISTINCT MOLECULAR CUES
(-)
Thermotoga maritima [TaxId: 2336] (1)
1L1JA:; B:CRYSTAL STRUCTURE OF THE PROTEASE DOMAIN OF AN ATP-INDEPENDENT HEAT SHOCK PROTEASE HTRA
(-)
Protein domain: Protease PepD (2)
(-)
Mycobacterium tuberculosis [TaxId: 1773] (2)
1Y8TA:6-226; B:6-226; C:6-226CRYSTAL STRUCTURE OF RV0983 FROM MYCOBACTERIUM TUBERCULOSIS-PROTEOLYTICALLY ACTIVE FORM
2Z9IA:6-226; B:4-226; C:6-226CRYSTAL STRUCTURE OF RV0983 FROM MYCOBACTERIUM TUBERCULOSIS-PROTEOLYTICALLY ACTIVE FORM
(-)
Protein domain: Serine proteinase (1)
(-)
Streptomyces fradiae [TaxId: 1906] (1)
2SFAA:SERINE PROTEINASE FROM STREPTOMYCES FRADIAE ATCC 14544
(-)
Protein domain: Stress sensor protease DegS, catalytic domain (11)
(-)
Escherichia coli [TaxId: 562] (11)
1SOTA:42-254; B:42-254; C:42-254CRYSTAL STRUCTURE OF THE DEGS STRESS SENSOR
1SOZA:42-254; B:42-254; C:42-254CRYSTAL STRUCTURE OF DEGS PROTEASE IN COMPLEX WITH AN ACTIVATING PEPTIDE
1TE0A:37-254; B:37-254STRUCTURAL ANALYSIS OF DEGS, A STRESS SENSOR OF THE BACTERIAL PERIPLASM
1VCWA:42-254; B:42-254; C:42-254CRYSTAL STRUCTURE OF DEGS AFTER BACKSOAKING THE ACTIVATING PEPTIDE
2QF0A:; B:; C:; D:; E:; F:; G:; H:; I:STRUCTURE OF THE DELTA PDZ TRUNCATION OF THE DEGS PROTEASE
2QF3A:; B:; C:STRUCTURE OF THE DELTA PDZ TRUNCATION OF THE DEGS PROTEASE
2QGRA:STRUCTURE OF THE R178A MUTANT OF DELTA PDZ DEGS PROTEASE
2R3UA:; B:; C:CRYSTAL STRUCTURE OF THE PDZ DELETION MUTANT OF DEGS
2R3YA:43-254; B:43-254; C:43-254CRYSTAL STRUCTURE OF THE DEGS PROTEASE IN COMPLEX WITH THE YWF ACTIVATING PEPTIDE
2RCEA:; H:; I:; B:; C:; D:; E:; F:; G:DFP MODIFIED DEGS DELTA PDZ
3B8JA:Q191A MUTANT OF DEGS-DELTAPDZ
(-)
Protein domain: Trypsin (7)
(-)
Streptomyces griseus, strain k1 [TaxId: 1911] (7)
1OS8A:RECOMBINANT STREPTOMYCES GRISEUS TRYPSIN
1OSSA:T190P STREPTOMYCES GRISEUS TRYPSIN IN COMPLEX WITH BENZAMIDINE
1SGTA:REFINED CRYSTAL STRUCTURE OF STREPTOMYCES GRISEUS TRYPSIN AT 1.7 ANGSTROMS RESOLUTION
2FMJA:220-LOOP MUTANT OF STREPTOMYCES GRISEUS TRYPSIN
3BEUA:; B:NA+-DEPENDENT ALLOSTERY MEDIATES COAGULATION FACTOR PROTEASE ACTIVE SITE SELECTIVITY
3I77A:35/99/170-LOOPS OF FXA IN SGT
3I78A:35/99/170/186/220-LOOPS OF FXA IN SGT
(-)
Protein domain: V8 protease (3)
(-)
Staphylococcus aureus [TaxId: 1280] (3)
1QY6A:STRUCTUE OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS
1WCZA:CRYSTAL STRUCTURE OF AN ALKALINE FORM OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS
2O8LA:STRUCTURE OF V8 PROTEASE FROM STAPHYLOCOCCUS AUREUS
(-)
Family: Viral cysteine protease of trypsin fold (145)
(-)
Protein domain: 2A cysteine proteinase (1)
(-)
Human rhinovirus 2 [TaxId: 12130] (1)
2HRVA:; B:2A CYSTEINE PROTEINASE FROM HUMAN RHINOVIRUS 2
(-)
Protein domain: 3C cysteine protease (picornain 3C) (22)
(-)
Foot-and-mouth disease virus [TaxId: 12110] (2)
2BHGA:7-2053C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS
2J92A:7-2073C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS-CRYSTAL PACKING MUTANT (K51Q)
(-)
Human coxsackievirus a16 [TaxId: 31704] (3)
3SJ8A:CRYSTAL STRUCTURE OF THE 3C PROTEASE FROM COXSACKIEVIRUS A16
3SJ9A:CRYSTAL STRUCTURE OF THE C147A MUTANT 3C OF CVA16 IN COMPLEX WITH FAGLRQAVTQ PEPTIDE
3SJIA:CRYSTAL STRUCTURE OF CVA16 3C IN COMPLEX WITH RUPINTRIVIR (AG7088)
(-)
Human enterovirus 71 [TaxId: 39054] (3)
3OSYA:; B:; C:; D:; E:HUMAN ENTEROVIRUS 71 3C PROTEASE
3SJKA:CRYSTAL STRUCTURE OF THE C147A MUTANT 3C FROM ENTEROVIRUS 71
3SJOA:; B:; C:; D:; E:; F:; G:; H:STRUCTURE OF EV71 3C IN COMPLEX WITH RUPINTRIVIR (AG7088)
(-)
Human enterovirus b [TaxId: 138949] (3)
3Q3XA:; B:CRYSTAL STRUCTURE OF THE MAIN PROTEASE (3C) FROM HUMAN ENTEROVIRUS B EV93
3Q3YA:; B:COMPLEX STRUCTURE OF HEVB EV93 MAIN PROTEASE 3C WITH COMPOUND 1 (AG7404)
3RUOA:; B:COMPLEX STRUCTURE OF HEVB EV93 MAIN PROTEASE 3C WITH RUPINTRIVIR (AG7088)
(-)
Human hepatitis a virus hu/northern africa/mbb/1978 [TaxId: 12100] (2)
2A4OA:DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE BY A SERINE DERIVED BETA-LACTONE: SELECTIVE CRYTSTALLIZATION AND HIGH RESOLUTION STRUCTURE OF THE HIS102 ADDUCT
2CXVA:DUAL MODES OF MODIFICATION OF HEPATITIS A VIRUS 3C PROTEASE BY A SERINE-DERIVED BETALACTONE: SELECTIVE CRYSTALLIZATION AND HIGH-RESOLUTION STRUCTURE OF THE HIS-102 ADDUCT
(-)
Human hepatitis A virus [TaxId: 208726] (5)
1HAVA:; B:HEPATITIS A VIRUS 3C PROTEINASE
1QA7A:; B:; C:; D:CRYSTAL COMPLEX OF THE 3C PROTEINASE FROM HEPATITIS A VIRUS WITH ITS INHIBITOR AND IMPLICATIONS FOR THE POLYPROTEIN PROCESSING IN HAV
2H6MA:AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS
2H9HA:AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS
2HALA:AN EPISULFIDE CATION (THIIRANIUM RING) TRAPPED IN THE ACTIVE SITE OF HAV 3C PROTEINASE INACTIVATED BY PEPTIDE-BASED KETONE INHIBITORS
(-)
Human poliovirus 1 Mahoney [TaxId: 12081] (2)
1L1NA:; B:POLIOVIRUS 3C PROTEINASE
2IJD1:1-180; 2:1-180CRYSTAL STRUCTURE OF THE POLIOVIRUS PRECURSOR PROTEIN 3CD
(-)
Human rhinovirus 2 [TaxId: 12130] (1)
1CQQA:TYPE 2 RHINOVIRUS 3C PROTEASE WITH AG7088 INHIBITOR
(-)
Human rhinovirus sp. [TaxId: 169066] (1)
2XYAA:NON-COVALENT INHIBTORS OF RHINOVIRUS 3C PROTEASE.
(-)
Protein domain: automated matches (47)
(-)
Coxsackievirus b3 [TaxId: 103903] (1)
2VB0A:CRYSTAL STRUCTURE OF COXSACKIEVIRUS B3 PROTEINASE 3C
(-)
Foot-and-mouth disease virus (strain a10-61) [TaxId: 12112] (1)
2J92B:3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS-CRYSTAL PACKING MUTANT (K51Q)
(-)
Foot-and-mouth disease virus [TaxId: 12110] (1)
2BHGB:3C PROTEASE FROM TYPE A10(61) FOOT-AND-MOUTH DISEASE VIRUS
(-)
Foot-and-mouth disease virus [TaxId: 12112] (2)
2WV4A:; B:CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE IN COMPLEX WITH A DECAMERIC PEPTIDE CORRESPONDING TO THE VP1-2A CLEAVAGE JUNCTION
2WV5A:; B:; C:; D:CRYSTAL STRUCTURE OF FOOT-AND-MOUTH DISEASE VIRUS 3C PROTEASE IN COMPLEX WITH A DECAMERIC PEPTIDE CORRESPONDING TO THE VP1-2A CLEAVAGE JUNCTION WITH A GLN TO GLU SUBSTITUTION AT P1
(-)
Human coxsackievirus B3 [TaxId: 12072] (7)
2ZTXA:COMPLEX STRUCTURE OF CVB3 3C PROTEASE WITH EPDTC
2ZTYA:CRYSTAL STRUCTURE OF 3C PROTEASE FROM CVB3 IN SPACE GROUP C2
2ZTZA:; B:CRYSTAL STRUCTURE OF 3C PROTEASE FROM CVB3 IN SPACE GROUP P21
2ZU1A:; B:CRYSTAL STRUCTURE OF CVB3 3C PROTEASE MUTANT C147A
3ZYDA:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3
3ZYEA:CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A) OF COXSACKIEVIRUS B3
3ZZ6A:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 75
(-)
Human coxsackievirus [TaxId: 12072] (11)
2ZU3A:COMPLEX STRUCTURE OF CVB3 3C PROTEASE WITH TG-0204998
3ZZ3A:; B:CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (N126Y) OF COXSACKIEVIRUS B3
3ZZ4A:; B:CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF COXSACKIEVIRUS B3
3ZZ5A:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 74
3ZZ7A:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 81
3ZZ8A:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 82
3ZZ9A:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 83
3ZZAA:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 84
3ZZBA:CRYSTAL STRUCTURE OF 3C PROTEASE OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 85
3ZZCA:CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 83
3ZZDA:CRYSTAL STRUCTURE OF 3C PROTEASE MUTANT (T68A AND N126Y) OF COXSACKIEVIRUS B3 COMPLEXED WITH ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR 85
(-)
Human enterovirus [TaxId: 42789] (9)
3ZV8A:CRYSTAL STRUCTURE OF 3C PROTEASE OF ENTEROVIRUS 68
3ZV9A:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 74
3ZVAA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 75
3ZVBA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 81
3ZVCA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 82
3ZVDA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 83
3ZVEA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 84
3ZVFA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 85
3ZVGA:3C PROTEASE OF ENTEROVIRUS 68 COMPLEXED WITH MICHAEL RECEPTOR INHIBITOR 98
(-)
Human poliovirus 1 [TaxId: 12081] (1)
4DCDA:1.6A RESOLUTION STRUCTURE OF POLIOVIRUS 3C PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR
(-)
Human sars coronavirus [TaxId: 227859] (1)
2VJ1A:; B:A STRUCTURAL VIEW OF THE INACTIVATION OF THE SARS-CORONAVIRUS MAIN PROTEINASE BY BENZOTRIAZOLE ESTERS
(-)
Rhinovirus c [TaxId: 463676] (1)
2M5TA:SOLUTION STRUCTURE OF THE 2A PROTEINASE FROM A COMMON COLD AGENT, HUMAN RHINOVIRUS RV-C02, STRAIN W12
(-)
SARS coronavirus [TaxId: 227859] (12)
1WOFA:; B:CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR N1
2AMDA:; B:CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N9
2AMQA:; B:CRYSTAL STRUCTURE OF SARS_COV MPRO IN COMPLEX WITH AN INHIBITOR N3
2D2DA:; B:CRYSTAL STRUCTURE OF SARS-COV MPRO IN COMPLEX WITH AN INHIBITOR I2
2YY4  [entry was replaced by entry 5B6O without any SCOP domain information]
3E91A:; B:CRYSTAL STRUCTURE OF SARS-COV MPRO MUTANT IN P21 AT PH6.9
3EA7A:; B:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP P21
3EA8A:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A IN SPACE GROUP C2
3EA9A:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH ONE MOLECULE IN ONE ASYMMETRIC UNIT
3EAJA:; B:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE QUADRUPLE MUTANT STIF/A WITH TWO MOLECULES IN ONE ASYMMETRIC UNIT
3M3TA:SARS-COV MAIN PROTEASE MONOMERIC ARG298ALA MUTANT WITH N-TERMINAL ADDITIONAL RESIDUES (GLY-SER)
3M3VA:; B:SARS-COV MAIN PROTEASE TRIPLE MUTANT STI/A WITH TWO N-TERMINAL ADDITIONAL RESIDUE (GLY-SER)
(-)
Protein domain: Coronavirus main proteinase (3Cl-pro, putative coronavirus nsp2) (75)
(-)
Human coronavirus 229E [TaxId: 11137] (2)
1P9SA:; B:CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
2ZU2A:; B:COMPLEX STRUCTURE OF COV 229E 3CL PROTEASE WITH EPDTC
(-)
Human coronavirus [TaxId: 443239] (2)
3D23A:; B:; C:; D:MAIN PROTEASE OF HCOV-HKU1
3TLOA:; B:CRYSTAL STRUCTURE OF HCOV-NL63 3C-LIKE PROTEASE
(-)
Porcine transmissible gastroenteritis coronavirus [TaxId: 11151] (1)
4F49A:; B:; C:; D:2.25A RESOLUTION STRUCTURE OF TRANSMISSIBLE GASTROENTERITIS VIRUS PROTEASE CONTAINING A COVALENTLY BOUND DIPEPTIDYL INHIBITOR
(-)
Sars coronavirus sin2774 [TaxId: 235410] (2)
2BX3A:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P43212)
2BX4A:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (P21212)
(-)
SARS coronavirus [TaxId: 227859] (65)
1Q2WA:; B:X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS MAIN PROTEASE
1UJ1A:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO)
1UK2A:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH8.0
1UK3A:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) AT PH7.6
1UK4A:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE (3CLPRO) COMPLEXED WITH AN INHIBITOR
1Z1IA:CRYSTAL STRUCTURE OF NATIVE SARS CLPRO
1Z1JA:; B:CRYSTAL STRUCTURE OF SARS 3CLPRO C145A MUTANT
2A5AA:CRYSTAL STRUCTURE OF UNBOUND SARS CORONAVIRUS MAIN PEPTIDASE IN THE SPACE GROUP C2
2A5IA:CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP C2
2A5KA:; B:CRYSTAL STRUCTURES OF SARS CORONAVIRUS MAIN PEPTIDASE INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN SPACE GROUP P212121
2ALVA:2-301X-RAY STRUCTURAL ANALYSIS OF SARS CORONAVIRUS 3CL PROTEINASE IN COMPLEX WITH DESIGNED ANTI-VIRAL INHIBITORS
2C3SA:STRUCTURE OF SARS COV MAIN PROTEINASE AT 1.9 A (PH6.5)
2DUCA:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEINASE(3CLPRO)
2GT7A:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE AT PH 6.0 IN THE SPACE GROUP P21
2GT8A:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) IN THE SPACE GROUP P43212
2GTBA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PEPTIDASE (WITH AN ADDITIONAL ALA AT THE N-TERMINUS OF EACH PROTOMER) INHIBITED BY AN AZA-PEPTIDE EPOXIDE IN THE SPACE GROUP P43212
2GX4A:CRYSTAL STRUCTURE OF SARS CORONAVIRUS 3CL PROTEASE INHIBITOR COMPLEX
2GZ7A:STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE
2GZ8A:STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE
2GZ9A:STRUCTURE-BASED DRUG DESIGN AND STRUCTURAL BIOLOGY STUDY OF NOVEL NONPEPTIDE INHIBITORS OF SARS-COV MAIN PROTEASE
2H2ZA:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI
2HOBA:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE WITH AUTHENTIC N AND C-TERMINI IN COMPLEX WITH A MICHAEL ACCEPTOR N3
2OP9A:; B:SUBSTRATE SPECIFICITY PROFILING AND IDENTIFICATION OF A NEW CLASS OF INHIBITOR FOR THE MAJOR PROTEASE OF THE SARS CORONAVIRUS
2PWXA:CRYSTAL STRUCTURE OF G11A MUTANT OF SARS-COV 3C-LIKE PROTEASE
2Q6GA:; B:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE H41A MUTANT IN COMPLEX WITH AN N-TERMINAL SUBSTRATE
2QC2A:; B:CRYSTAL STRUCTURE OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE ASN214ALA MUTANT
2QCYA:CRYSTAL STRUCTURE OF A MONOMERIC FORM OF SEVERE ACUTE RESPIRATORY SYNDROME (SARS) 3C-LIKE PROTEASE MUTANT
2QIQA:STRUCTURE-BASED DESIGN AND SYNTHESIS AND BIOLOGICAL EVALUATION OF PEPTIDOMIMETIC SARS-3CLPRO INHIBITORS
2V6NA:CRYSTAL STRUCTURES OF THE SARS-CORONAVIRUS MAIN PROTEINASE INACTIVATED BY BENZOTRIAZOLE COMPOUNDS
2Z3CA:A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE
2Z3DA:A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE
2Z3EA:A MECHANISTIC VIEW OF ENZYME INHIBITION AND PEPTIDE HYDROLYSIS IN THE ACTIVE SITE OF THE SARS-COV 3C-LIKE PEPTIDASE
2Z94A:COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH TDT
2Z9GA:COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH PMA
2Z9JA:; B:COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH EPDTC
2Z9KA:; B:COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1600
2Z9LA:; B:COMPLEX STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH JMF1586
2ZU4A:COMPLEX STRUCTURE OF SARS-COV 3CL PROTEASE WITH TG-0204998
2ZU5A:COMPLEX STRUCTURE OF SARS-COV 3CL PROTEASE WITH TG-0205486
3ATWA:; B:STRUCTURE-BASED DESIGN, SYNTHESIS, EVALUATION OF PEPTIDE-MIMETIC SARS 3CL PROTEASE INHIBITORS
3AVZA:STRUCTURE OF SARS 3CL PROTEASE WITH PEPTIDIC ALDEHYDE INHIBITOR CONTAINING CYCLOHEXYL SIDE CHAIN
3AW0A:STRUCTURE OF SARS 3CL PROTEASE WITH PEPTIDIC ALDEHYDE INHIBITOR
3AW1A:; B:STRUCTURE OF SARS 3CL PROTEASE AUTO-PROTEOLYSIS RESISTANT MUTANT IN THE ABSENT OF INHIBITOR
3D62A:DEVELOPMENT OF BROAD-SPECTRUM HALOMETHYL KETONE INHIBITORS AGAINST CORONAVIRUS MAIN PROTEASE 3CLPRO
3F9EA:CRYSTAL STRUCTURE OF THE S139A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE
3F9FA:; B:CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 6.0
3F9GA:; B:CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 6.5
3F9HA:; B:CRYSTAL STRUCTURE OF THE F140A MUTANT OF SARS-CORONOVIRUS 3C-LIKE PROTEASE AT PH 7.6
3FZDA:MUTATION OF ASN28 DISRUPTS THE ENZYMATIC ACTIVITY AND DIMERIZATION OF SARS 3CLPRO
3M3SA:; B:CRYSTAL STRUCTURE OF SARS-COV MAIN PROTEASE ASN214ALA MUTANT WITH AUTHORIZE N-TERMINUS
3SN8A:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH CM-FF-H (SOAKING)
3SNAA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-NSFSQ-H (SOAKING)
3SNBA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-DSFDQ-H (SOAKING)
3SNCA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-NSTSQ-H (SOAKING)
3SNDA:; B:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-ESTLQ-H (COCRYSTALLIZATION)
3SNEA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AC-ESTLQ-H (SOAKING)
3SZNA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER SG75
3TITA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER SG81
3TIUA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA,BETA-UNSATURATED ETHYL ESTER INHIBITOR SG82
3TNSA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR SG83
3TNTA:CRYSTAL STRUCTURE OF SARS CORONAVIRUS MAIN PROTEASE COMPLEXED WITH AN ALPHA, BETA-UNSATURATED ETHYL ESTER INHIBITOR SG85
3V3MA:SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) 3CL PROTEASE IN COMPLEX WITH N-[(1R)-2-(TERT-BUTYLAMINO)-2-OXO-1-(PYRIDIN-3-YL) ETHYL]-N-(4-TERT-BUTYLPHENYL)FURAN-2-CARBOXAMIDE INHIBITOR.
3VB3A:; B:CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE IN APO FORM
4HI3A:; B:CRYSTAL STRUCTURE OF DIMERIC R298A MUTANT OF SARS CORONAVIRUS MAIN PROTEASE
4MDSA:DISCOVERY OF N-(BENZO[1,2,3]TRIAZOL-1-YL)-N-(BENZYL)ACETAMIDO)PHENYL) CARBOXAMIDES AS SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-COV) 3CLPRO INHIBITORS: IDENTIFICATION OF ML300 AND NON-COVALENT NANOMOLAR INHIBITORS WITH AN INDUCED-FIT BINDING
(-)
Transmissible gastroenteritis virus [TaxId: 11149] (3)
1LVOA:; B:; C:; D:; E:; F:STRUCTURE OF CORONAVIRUS MAIN PROTEINASE REVEALS COMBINATION OF A CHYMOTRYPSIN FOLD WITH AN EXTRA ALPHA-HELICAL DOMAIN
1P9UA:; E:; F:; B:; C:; D:CORONAVIRUS MAIN PROTEINASE (3CLPRO) STRUCTURE: BASIS FOR DESIGN OF ANTI-SARS DRUGS
2AMPA:; B:CRYSTAL STRUCTURE OF PORCINE TRANSMISSIBLE GASTROENTERITIS VIRUS MPRO IN COMPLEX WITH AN INHIBITOR N1
(-)
Family: Viral proteases (62)
(-)
Protein domain: automated matches (23)
(-)
Aura virus [TaxId: 44158] (3)
4AGJA:CRYSTAL STRUCTURE OF THE CAPSID PROTEIN (110-267) FROM AURA VIRUS IN COMPLEX WITH DIOXANE
4AGKA:CRYSTAL STRUCTURE OF CAPSID PROTEIN (110-267) FROM AURA VIRUS
4AUS  [entry was replaced by entry 4UON without any SCOP domain information]
(-)
Hepatitis C virus subtype 1a [TaxId: 31646] (15)
3SU0A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH DANOPREVIR
3SU1A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH DANOPREVIR
3SU2A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH DANOPREVIR
3SU4A:; B:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH VANIPREVIR
3SU5A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH VANIPREVIR
3SU6A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH VANIPREVIR
3SUEA:; B:; C:; D:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH MK-5172
3SUFA:; B:; C:; D:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH MK-5172
3SUGA:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH MK-5172
3SV6A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE IN COMPLEX WITH TELAPREVIR
3SV7A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT R155K IN COMPLEX WITH TELAPREVIR
3SV8A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT D168A IN COMPLEX WITH TELAPREVIR
3SV9A:CRYSTAL STRUCTURE OF NS3/4A PROTEASE VARIANT A156T IN COMPLEX WITH TELAPREVIR
4NWKA:CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH BMS-605339 AKA N-(TERT-BUTOXYCARBONYL)-3-ME THYL-L-VALYL-(4R)-N-((1R, 2S)-1-((CYCLOPROPYLSULFONYL)CARBA MOYL)-2-VINYLCYCLOPROPYL)-4-((6-METHOXY-1-ISOQUINOLINYL)OX Y)-L-PROLINAMIDE
4NWLA:; B:CRYSTAL STRUCTURE OF HEPATIS C VIRUS PROTEASE (NS3) COMPLEXED WITH BMS-650032 AKA N-(TERT-BUTOXYCARBONYL)-3-ME THYL-L-VALYL-(4R)-4-((7-CHLORO-4-METHOXY-1-ISOQUINOLINYL)O XY)-N-((1R,2S)-1-((CYCLOPROPYLSULFONYL)CARBAMOYL)-2-VINYLC YCLOPROPYL)-L-PROLINAMIDE
(-)
Hepatitis C virus [TaxId: 11103] (3)
2K1QA:NMR STRUCTURE OF HEPATITIS C VIRUS NS3 SERINE PROTEASE COMPLEXED WITH THE NON-COVALENTLY BOUND PHENETHYLAMIDE INHIBITOR
3KEEA:; B:; C:; D:HCV NS3/NS4A COMPLEXED WITH NON-COVALENT MACROCYCLIC COMPOUND TMC435
4K8BA:; B:CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE COMPLEXED WITH INHIBITOR
(-)
West Nile virus [TaxId: 11082] (2)
2GGVB:CRYSTAL STRUCTURE OF THE WEST NILE VIRUS NS2B-NS3 PROTEASE, HIS51ALA MUTANT
3E90B:; D:WEST NILE VI RUS NS2B-NS3PROTEASE IN COMPLEXED WITH INHIBITOR NAPH-KKR-H
(-)
Protein domain: NS3 protease (20)
(-)
Dengue virus 3 [TaxId: 408693] (2)
3U1IB:; D:DENGUE VIRUS PROTEASE COVALENTLY BOUND TO A PEPTIDE
3U1JB:APROTININ BOUND TO DENGUE VIRUS PROTEASE
(-)
Dengue virus type 2 [TaxId: 11060] (1)
2FOMB:18-167DENGUE VIRUS NS2B/NS3 PROTEASE
(-)
Hepatitis c virus subtype 1a [TaxId: 31646] (1)
3M5LA:CRYSTAL STRUCTURE OF HCV NS3/4A PROTEASE IN COMPLEX WITH ITMN-191
(-)
Human hepatitis C virus (HCV), different isolates [TaxId: 11103] (14)
1A1QA:; B:; C:HEPATITIS C VIRUS NS3 PROTEINASE
1A1RA:,C:; B:,D:HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX
1BT7A:THE SOLUTION NMR STRUCTURE OF THE N-TERMINAL PROTEASE DOMAIN OF THE HEPATITIS C VIRUS (HCV) NS3-PROTEIN, FROM BK STRAIN, 20 STRUCTURES
1CU1A:705-720,A:3-186; B:1705-1720,B:1003-1186CRYSTAL STRUCTURE OF AN ENZYME COMPLEX FROM HEPATITIS C VIRUS
1DXPA:,C:; B:,D:INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (APO STRUCTURE)
1DXWA:STRUCTURE OF HETERO COMPLEX OF NON STRUCTURAL PROTEIN (NS) OF HEPATITIS C VIRUS (HCV) AND SYNTHETIC PEPTIDIC COMPOUND
1DY8A:,C:; B:,D:INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR II)
1DY9A:,C:; B:,D:INHIBITION OF THE HEPATITIS C VIRUS NS3/4A PROTEASE. THE CRYSTAL STRUCTURES OF TWO PROTEASE-INHIBITOR COMPLEXES (INHIBITOR I)
1JXPA:,C:; B:,D:BK STRAIN HEPATITIS C VIRUS (HCV) NS3-NS4A
1N1LA:,C:; B:,D:CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN:NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND INHIBITOR (GW472467X)
1NS3A:,C:; B:,D:STRUCTURE OF HCV PROTEASE (BK STRAIN)
1RGQA:,D:; B:,C:M9A HCV PROTEASE COMPLEX WITH PENTAPEPTIDE KETO-AMIDE INHIBITOR
1RTLA:,C:; B:,D:CRYSTAL STRUCTURE OF HCV NS3 PROTEASE DOMAIN: NS4A PEPTIDE COMPLEX WITH COVALENTLY BOUND PYRROLIDINE-5,5-TRANSLACTAM INHIBITOR
1W3CA:,C:; B:,D:CRYSTAL STRUCTURE OF THE HEPATITIS C VIRUS NS3 PROTEASE IN COMPLEX WITH A PEPTIDOMIMETIC INHIBITOR
(-)
West Nile virus [TaxId: 11082] (2)
2FP7B:19-170WEST NILE VIRUS NS2B/NS3PROTEASE IN COMPLEX WITH BZ-NLE-LYS-ARG-ARG-H
2IJOB:5-176CRYSTAL STRUCTURE OF THE WEST NILE VIRUS NS2B-NS3 PROTEASE COMPLEXED WITH BOVINE PANCREATIC TRYPSIN INHIBITOR
(-)
Protein domain: NSP4 proteinase (1)
(-)
Equine arteritis virus, EAV [TaxId: 11047] (1)
1MBMA:; B:; C:; D:NSP4 PROTEINASE FROM EQUINE ARTERITIS VIRUS
(-)
Protein domain: TEV protease (nucleat inclusion protein A, NIA) (3)
(-)
Tobacco etch virus, TEV [TaxId: 12227] (3)
1LVBA:; B:CATALYTICALLY INACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH SUBSTRATE
1LVMA:,E:; B:CATALYTICALLY ACTIVE TOBACCO ETCH VIRUS PROTEASE COMPLEXED WITH PRODUCT
1Q31A:; B:CRYSTAL STRUCTURE OF THE TOBACCO ETCH VIRUS PROTEASE C151A MUTANT
(-)
Protein domain: Viral capsid protein (15)
(-)
Semliki forest virus [TaxId: 11033] (2)
1VCPA:; B:; C:SEMLIKI FOREST VIRUS CAPSID PROTEIN (CRYSTAL FORM I)
1VCQA:; B:SEMLIKI FOREST VIRUS CAPSID PROTEIN (CRYSTAL FORM II)
(-)
Sindbis virus [TaxId: 11034] (11)
1KXAA:SINDBIS VIRUS CAPSID, (WILD-TYPE) RESIDUES 106-264, TETRAGONAL CRYSTAL FORM
1KXBA:SINDBIS VIRUS CAPSID (S215A MUTANT), TETRAGONAL CRYSTAL FORM
1KXCA:SINDBIS VIRUS CAPSID (N190K MUTANT), TETRAGONAL CRYSTAL FORM
1KXDA:SINDBIS VIRUS CAPSID (N222L MUTANT), TETRAGONAL CRYSTAL FORM
1KXEA:SINDBIS VIRUS CAPSID (Y180S, E183G DOUBLE MUTANT), TETRAGONAL CRYSTAL FORM
1KXFA:SINDBIS VIRUS CAPSID, (WILD-TYPE) RESIDUES 1-264, TETRAGONAL CRYSTAL FORM (FORM II)
1SVPA:; B:SINDBIS VIRUS CAPSID PROTEIN
1WYKA:; B:; C:; D:SINDBIS VIRUS CAPSID PROTEIN (114-264)
1Z8YQ:114-264; R:114-264; S:114-264; T:114-264MAPPING THE E2 GLYCOPROTEIN OF ALPHAVIRUSES
2SNVA:THE REFINED STRUCTURE OF SINDBIS VIRUS CORE PROTEIN IN COMPARISON WITH OTHER CHYMOTRYPSIN-LIKE SERINE PROTEINASE STRUCTURES
2SNWA:; B:SINDBIS VIRUS CAPSID PROTEIN, TYPE3 CRYSTAL FORM
(-)
Venezuelan equine encephalitis virus [TaxId: 11036] (2)
1EP5A:; B:; C:CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN
1EP6A:; B:; C:CRYSTAL STRUCTURE OF THE CONSERVED CORE DOMAIN OF VENEZUALAN EQUINE ENCEPHALITIS CAPSID PROTEIN